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Abstract 
Mutations of the REP-1 gene are responsible for the X-linked retinal 
degeneration choroideremia (CHM). Rab Escort Protein-1 (REP-1) mediates the 
post-translational prenyl modification of Rab GTPases. In CHM patients, the related 
REP-2 partly compensates for the loss-of-function of REP-1, but a subset of Rabs 
remain underprenylated and thus inactive. A zebrafish model of CHM exhibiting a 
truncating mutation in the orthologous gene has been recently isolated and reported 
to lead to early lethality. This thesis characterises the development of the retinal 
phenotype observed in homozygous chm zebrafish. The retina develops normally for 
the first 4dpf followed by a catastrophic multi-layer degeneration by 5dpf. The chm 
zebrafish also exhibit severe multi-systemic disease and die usually on the fifth day 
post fertilitsation. Bioinformatic analysis of the REP family of proteins revealed a 
single REP isoform in fish, other non-mammalian vertebrates and invertebrates, 
suggesting that the intronless REP-2 resulted from gene duplication events within the 
mammalian lineage. Therefore REP may be considered to be an essential gene in 
zebrafish. In the chm zebrafish, maternally-derived functional REP allows initial 
successful development of the embryo, but by 5pdf only 40% of normal REP activity 
remains and unprenylated Rabs accumulate in the cytosol. This suggests the gradual 
loss of maternally-derived REP activity leads to the catastrophic phenotype and 
lethality observed. In its current form, the chm zebrafish has limited utility as a 
model for human disease. Introduction of REP-2 would yield a powerful model for 
CHM research. Alternatively, the chm zebrafish may be used to assess therapies, 
such as novel drug classes, which aim to boost REP activity. 
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"Education: 
that which reveals to the wise, and conceals from the stupid, 
the vast limits of their knowledge. " 
Mark Twain 
or 
"How is education supposed to make me feel smarter? 
Besides, everytime I learn something new, 
it pushes some old stuff out of my brain" 
Homer Simpson 
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Chapter One 
Introduction 
Introduction 
1.1 The retina 
The retina is the major light sensing organ in vertebrates, and the most 
metabolically active tissue in the body. Lining the interior surface of the eye, it 
detects light and transmits signals via the optic nerve to the image forming centres of 
the brain (figure 1.1). The neurosensory retina is composed of photoreceptor cells, 
the rods and cones, which detect photons of light and create an electrical signal, 
sensory neurons that transmit signals to the brain, and two plexiform layers of 
synapses (figure 1.2). Photoreceptor cells interdigitate with apical process of Retinal 
Pigment Epithelium (RPE) cells, which performs supportive functions for the 
photoreceptors. The outer segments of the photoreceptors contain stacked membrane 
disks, into which are embedded complexes of opsins and the light responsive 
chromophore I 1-cis-retinal. On absorption of a photon, retinal isomerises from cis to 
trans, activating the phototransduction cascade, that results in hyperpolarisation of 
the cell and blocks the release of neurotransmitters. 
cornea 
pupil 
lens 
; -` 
iris 
ciliary 
body 
Figure 1.1: Anatomy of the eye. Light enters through the pupil and is focused by the lens onto the 
retina. A thin piece of retina is enlarged in a photomicrograph to show the arrangement of cellular 
laminae. Counter intuitively, light has to pass through the layers of neural cells before reaching the 
photoreceptors. Note that the choroid lies underneath the retinal pigment epithelium, and supplies 
blood to the outer retina. (From Kolb 2003) 
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Figure 1.2 Organisation of the retina Light is detected in the photoreceptor outer segments (OS). 
Photoreceptor cell bodies constitute the Outer Nuclear Layer (ONL). Photoreceptors synapse with 
horizontal and bipolar cells at the Outer Plexiform Layer (OPL). Horizontal, bipolar and amacrine 
cells constitute the Inner Nuclear Layer (INL). Bipolar and amacrine cells synapse with cells of the 
Ganglion Cell Layer (GCL) in the Inner Plexiform Layer (IPL). Ganglion cells convey signal via the 
optic nerve to the brain. Glial Muller cells are also present throughout the neural retina. (From Kolb 
2003) 
Cone cells sense light under photopic conditions (bright light). Primates have 
three types of cone cells, red sensitive, blue sensitive and green sensitive. Visual 
acuity in primates in derived from the high density of cone cells in a 400µm disc on 
the retina known as the fovea. The circular area that surrounds the fovea for 5-6mm 
is the macula. Finally, the periphery of the retina is composed mainly of rod cells, 
capable of sensing single photons of light, allowing vision under scotopic conditions 
(dim light). 
Damage to the macula is the primary consequence of age-related macular 
degeneration (AMD), the commonest cause of visual loss in the Western World 
(Rattner & Nathans 2006). A range of early-onset monogenic retinopathies have 
been characterised in recent years, giving insight into the pathological process of 
retinal disease. 
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1.1.1 The Photoreceptors 
The rod and cone photoreceptors have distinctive morphology, comprising an 
outer segment packed with photosensitive pigments connected through a cilium to 
the main cell body and synaptic terminal (figure 1.3). The photoreceptors are in a 
constant state of growth and renewal. New membrane discs are formed in the cell 
body, while the outer stacks containing light-damaged proteins and lipids are shed 
from the outer membrane. As photoreceptor tips are cast off they are phagocytosed 
by the cells of the RPE, and constituent molecules are recycled and made available to 
photoreceptors again for further growth. 
O 
segment 
inm 
Synarlic 
terminal 
I'LLsma 
nw mbranc 
Mitochondria 
(Ellipsoid 
bodyl 
Endplaxmic 
reticvlum 
Smaptic ribbon 
with vesicles 
Figure 1.3 Generalised structure of a vertebrate rod photoreceptor Opsins and photopigments are 
embedded in membraneous discs of the outer segments. Distal tips of the outer segments are shed 
daily. Cone photoreceptors have similar cell body structure, but the outer segments have shorter 
conical morphology. (From Fain 2006) 
Visual transduction begins in the photoreceptor outer segments, with the 
photo-isomerisation of opsin bound 11-cis retinal. The outer segments contain 
stacked membranes, or discs, in which the opsin: chromophore complexes are 
embedded. The spectral sensitivity of opsins determines the functional range of the 
photoreceptor; for example, the three primate cone photoreceptors have greatest 
sensitivities to short (S, -430nm), medium (M, -530nm) and long (L, -560nm) 
21 
Introduction 
wavelengths, but their tuning is broad enough to respond across the visible spectrum 
(- 400-700nm) (Solomon & Lennie 2007). 
Following photo-isomerisation to 1 1-trans retinal undergoes a six-step 
regeneration process, known as the visual cycle (Thompson & Gal 2003). This 
involves export of the spent photopigment to the Retinal Pigment Epithelium (RPE), 
where trans-retinal is converted to trans retinol (vitamin A), before isomerisation to 
cis-retinol and then oxidation to regenerate cis-retinal. 
1.1.2 The Retinal Pigment Epithelium 
The RPE is an apically polarised monolayer which functions in support of the 
photoreceptor cells and forms part of the blood-brain barrier (Clark 1986). At the 
apical surface, microvilli extend into the interphotoreceptor space allowing 
continuous contact between the photoreceptor outer segments and the RPE. Each 
RPE cell is in contact with between fifty and one hundred photoreceptor cells. 
Glucose 
Figure 1.4 Functions of the Retinal Pigment Epithelium The RPE performs multiple functions in 
support and maintenance of the photoreceptors. Apical microvilli (MV) of the RPE interdigitate with 
photoreceptor outer segments (OS). The choroidal capillaries lie underneath the RPE and provide 
circulation for the outer retina. PEDF, pigment epithelium derived growth factor; VEGF, vascular 
epithelium growth factor. (from Strauss 2005) 
As shown in figure 1.4, the RPE performs many essential functions to support 
the photoreceptors; failure of any of these can lead degeneration of the retina and 
loss of visual function (Strauss 2005). RPE cells contain melanosomes (pigment 
granules) to absorb stray photons, preventing reflection of light back onto 
photoreceptors and damage from light radiation. Metabolic end products from the 
photoreceptors are removed from the inter-photoreceptor space, and oxygen, glucose, 
LlphtAbsorptlon Epýtlid TranspoA Gila Vls ual Cycle- i Phapocyrosls 
' 
Secretwn 
11 -cis retina 
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vitamin A, fatty acids and other nutrients from the choroidal blood flow are 
transported across the RPE to supply the photoreceptors. The RPE stabilises the ion 
composition in the subretinal space, maintaining photoreceptor excitability. As 
previously described, 11-cis retinal is regenerated by enzymes in the RPE, and the 
RPE digests shed outer segment discs and toxic molecules. Finally, the RPE releases 
factors promoting survival, proliferation and differentiation of retinal cells. 
The basal surface of the RPE is attached to Bruch's membrane, which 
together form the blood-retina barrier. Bruch's membrane is a stratified extracellular 
matrix complex across which nutrients are transported in a bi-directional manner. It 
is composed of a thick layer elastic layer of microfibrils composed of fibrillins-1 and 
-2 and fibulin-1. The elastic layer is surrounded on both sides by a collagenous layer 
(see figure 1.6). 
1.1.3 The Choroid 
The choroid is a network of capillary vessels encompassing the outer retina, 
also known as the choriocapillaris. It supplies oxygen and nutrients to the RPE and 
photoreceptors, while the intra-ocular blood vessels support inner retinal neurons 
apical to the ONL. The choroid lies underneath Bruch's membrane and the RPE. 
Like the RPE, choroidal epithelial cells are pigmented to prevent light damage to 
surrounding tissues. 
1.2 The Genetic Basis of Macular Degeneration 
Macular degeneration is the commonest cause of vision loss in the Western 
world, affecting the young and old. The commonest subtype, age-related macular 
degeneration (AMD) causes severe blindness in more than 8 million people world 
wide, including 75% of age-related blindness in the Western world. Its phenotype is 
characterised by choroidal neovascularisation and the accumulation of proteins and 
lipids (known as drusen) beneath the RPE within Bruch's membrane. 
AMD is a complex genetic trait with many environmental risk factors (see 
figure 1.5). Recent publications suggest there may also be an immunological 
contribution to AMD pathogenesis. The His402 variant of Complement Factor H 
(CFH) confers a substantially increased risk of AMD to homozygous individuals 
relative to homozygotes for the Tyr402 haplotype; heterozygotes have an 
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intermediate risk (Edwards el al 2005,1 lageman ei al 2005,1 laines el a/ 2005, Klein 
ei al 2005). 
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Figure 1.5: AMD involves aging changes plus additional pathological changes. Oxidation 
damages the RPF and the choriocapillaris during life. Normally, this would result in increased 
lipofuscin levels in the RPE; lipidisation, protein cross-linking and the formation of extraccllular 
deposits within ßruch's membrane, which thickens and decreases in permeability; and decreased 
choroidal blood flow. Damage to the RP[ and choroid also induces an inflammatory response. In 
AMD, this inflammatory response leads to "pathogenic" changes to the extraccllular matrix. The 
abnormal I'M in turn, results in altered angiogenic stimuli and the growth of new choroidal blood 
vessels, and drown türmation (from Zarbin 2004). 
CFIH is a negative regulator of the complement cascade, which hinds activated 
Complement Factor 3 (known as C3b in its activated state) and promotes it's 
proteolytic digestion by Complement Factor I. Furthermore, 20 of 84 CHI 
polymorphisms are also associated with increased AMIS risk (l. i et al 2006). "These 
data imply that variation in ('Eli expression could be a strong determinant in AMD 
risk. 
A second locus at IOg26, LO('387715, encoding a "hypothetical gene" as 
predicted by bioinformatic analysis, confers an eight-fold increased risk for AMD 
when homozygous for A1a69 variant relative to Ser69 hornozygotes (Rivera et ed 
2005, Schmidt et al 2006). Individuals homozygous for both His402 CHI and Ala69 
LO(387-'15 have a 55-fold increased risk of AMD relative to those homozygous for 
the low-risk variants. Two further complement regulatory proteins, Complement 
factor 13 (RF) and Component 2 (C2), also possess sequence variants which are two 
to three-fold increased in frequency among AM[) patients (Gold el (l 2006). 
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Together, these four loci account for around 55% of genetic risk for AMD, and could 
potentially act by creating a positive feedback loop of activated complement and pro- 
inflammatory peptides (Rattner & Nathans 2006). 
A further subset of macular degenerations, summarised below, have an early 
onset pathology. These are the monogenic diseases Dominant Drusen, Best disease, 
Sorsby's Fundus Dystrophy, autosomal recessive Stargardt disease, and autosomal 
dominant Stargardt-like disease. Biochemical and histopathology studies (Ambati et 
al 2003) suggest common molecular pathogenic mechanisms may be responsible. 
While none of these disease genes is responsible for AMD, it is hoped that 
understanding their molecular pathology will offer insights into the pathogenesis of 
AMD and the other maculopathies. 
1.2.1 Best's disease 
Best's disease, also known as Vitilliform Macular Dystrophy, is an autosomal 
dominant maculopathy characterised by large extracellular accumulations of 
"lipofuscin like" material beneath the RPE of the macula. Lipofuscin consists of 
auto-fluorescent lipid-protein aggregates commonly founding neuronal tissues, and 
accumulates in post-mitotic cells like the RPE. 
Typically a slow progressive dominant disorder with juvenile onset. Best's 
disease is incompletely penetrant, suggesting another factor is needed for expression 
of the phenotype (Stone eta! 2001). The disease gene VMD2 is located at 11g13 and 
encodes the integral membrane protein bestrophin (Marquardt et al 1998, Petrukhin 
et al 1998). Bestrophin is an anion channel which localises to the basolateral 
membrane of the RPE although its function in pathogenesis is poorly understood 
(Marmorstein et a! 2000). When the gene was screened in an AMD patient cohort, 
the frequency of base changes was no different to the control population (Lotery et al 
2000), suggesting bestrophin does not play a role in AMD. 
1.2.2 Sorsby Fundus dystrophy 
Sorsby Fundus Dystrophy (SFD) is an autosomal dominant disorder caused 
by mutation of the TIMP3 gene on chromosome 22 (Lin et a12006, Barbazetto et al 
2005 Jacobson et al 2002, Gregory et al 1995). Tissue Inhibitor MetalloProteases 
(TIMP) are the most important type of endoprotease for extracellular matrix 
maintenance, and TIMP-3 is expressed ubiquitously, including in the RPE. The 
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disease causes subretinal deposits of collagenous material, thickening of Bruch's 
membrane, which may inhibit movement of small molecules between the RPE and 
choroid, and neovascularisation. All known disease mutations introduce new cysteine 
residues, which could disrupt tertiary structure through erroneous formation of 
disulphide bridges (Weber et al 1994). The mutations map to the C-terminus of 
TIMP-3, which is involved in binding matrix metalloproteases. Ser-Cys mutants 
accumulate in Bruch's membrane. Symptoms of SFD include nightblindness, and 
can be treated with vitamin A, leading to the hypothesis that the disease blocks the 
passage of vitamin A from the capillaries in the choroid to the photoreceptors 
(Jacobson et al 1995). Interestingly, it has recently been reported that TIMP-3 is a 
binding partner of fibulin-3, leading to the hypothesis that TIMP-3 may bind 
exclusively to a matrix protein in Bruch's membrane to produce the disease 
phenotype (Klenotic et a! 2004). TIMP-3 is also known to inhibit VEGF-stimulated 
angiogenesis by blocking the binding of VEGF to VEGF receptor-2 (Qi et a! 2003). 
Failure of this function by mutated TIMP-3 may contribute to the neovascularisation 
observed in SFD. When T1MP3 was screened in an AMD patient cohort, no 
association was found between AMD and TIMP3 (de la Paz et al 1997, Felbor et al 
1997) suggesting it is not directly involved in AMD. 
1.2.3 Stargardt disease 
Stargardt disease is the only maculopathy to be inherited in an autosomal 
recessive pattern, and is also the most common with an incidence of I in 10,000 of 
the population. It is characterised by the appearance of lipofuscin-like protein 
deposits in the RPE underlying the macula and fovea, resulting in bilateral loss of 
vision. The disease-causing gene is ABCA4 at the lp2l-22 locus (Arnell et al 1998, 
Maugeri et al 1999). ABCA4 localises to photoreceptor outer segments, where it 
translocates all-trans retinal phosphatidylethanolamine from the outer segment disc 
lumen to cytosol (Molday et a! 2000). Failure of this process leads to formation of 
the toxic molecule A2E, and can induce apoptosis and dissolve cell membranes 
(Stone et al 2001). Although statistically significant variants in ABCR have been 
reported in the dry form of AMD (Allikmets et al 1997), this data has been found to 
be based upon a bias data set and no evidence has been found to suggest that ABCR 
has a role in AMD (Stone et al 1998, Allikmets eta! 1999). 
26 
Introduction 
1.2.4 Stargardt-like dominant macular dystrophy 
This disease has many phenotypical similarities to Stargardt's disease but is 
inherited in an autosomal dominant fashion, through a dominant negative 
mechanism. One form is linked to chromosome 6g14 (STGD3), and mutations have 
been identified in ELOVL4, which is part of the fatty acid elongation pathway found 
exclusively in the photoreceptors (Edwards et a! 2001). Co-expressed wild-type and 
disease associated ELVOL4 mutants form aggregated complexes of protein adjacent 
to the nucleus (Grayson & Molday 2005). These results suggest that aberrant 
subcellular localisation of wild type protein is contributes to the development of 
Stargardt-like macular dystrophy. No statistically significant variant has been found 
in the ELOVL4 gene of AMD patients (Ayyagari et al 2001). A second form of 
Stargardt-like disease (STGD2) maps to 13q34 but no gene has been identified. 
STGD4 is linked to chromosome 4p, but no gene has yet been found (Kniazeva et al 
1999). 
1.2.5 RDS-associated pattern dystrophy 
Mutations in RDS result in a variety of phenotypes, including retinitis 
pigmentosa, a degeneration of the photoreceptors, pattern dystrophy, and Adult 
Vitelliform Macular Dystrophy (AVMD). Pattern dystrophies are disorders of the 
RPE resulting in characteristic patterns of sub-retinal deposits at the macula, which 
do not necessarily result in vision loss. An Argl72Trp mutation of RDS, which 
encodes peripherin, has been linked to autosomal dominant macular dystrophy 
(Downes et al 1999). Peripherin is a membrane associated glycoprotein which 
localises to the photoreceptor outer segments. The phenotypic expression of disease 
in the RPE in pattern dystrophy is therefore likely to result from the close interaction 
between the photoreceptors and RPE. AVMD is often confused with Best disease, 
although it has a later onset. Mutations in RDS/peripherin were found in around 20% 
of AVMD patients, suggesting further genetic heterogeneity (Felbor et al 1997). No 
mutations in RDS/peripherin have been linked to AMD (Shastry & Trese 1999). 
1.2.6 Dominant Drusen 
Dominant Drusen (DD) disease is characterised by yellow white deposits of 
protein (drusen) accumulating below the RPE, as shown in figure 1.6. The drusen are 
distributed in a characteristic peripapillary and radial fashion at the macula and 
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around the optic disc (Michaelides et al 2006). Visual acuity is lost between the 
fourth and fifth decade of life. Drusen are also a hallmark of AMD, thus this 
dystrophy may potentially be very relevant for the understanding of AMD pathology. 
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Figure 1.6 Drusen formation at the interface between the inner collagenous layer of Bruch's 
membrane and the RPE (Taken from Johnson et a12004) 
The disease gene was mapped to chromosome 2p16 between marker loci 
D2S2352 and D2S2251 (Kermani et al 1999). Dominant Drusen was initially thought 
to be two diseases, Malattia Leventinese (ML) and Doyne's Honeycomb Retinal 
Dystrophy (DHRD) until a single mutation in EFEMPI was found to be responsible 
for both (Stone et al 1999). AC>T base pair transition at codon 345 replaces an 
arginine with a tryptophan residue; this codon is conserved in human, rat and mouse. 
EFEMPI encodes fibulin-3, a secreted extracellular matrix protein. The R345W 
mutant fibulin-3 has been shown to be inefficiently secreted and retained within cells 
(Marmorstein et al 2002). Stone et al screened EFEMPI in 162 affected patients and 
found 160 to be heterozygous for the mutation, suggesting a dominant mode of 
inheritance. One homozygous patient had a retinal phenotype similar to heterozygous 
patients of a similar age. The remaining patient was re-examined and found to have a 
71, 
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phenotype more common of typical AMD. A causative link was thus established 
between fibulin-3 and Dominant Drusen. To date, no other disease associated 
mutations have been found in the fibulin-3 gene. 
Genetic heterogeneity in Dominant Drusen has been suggested in several 
studies, as only a proportion of patients have mutation in EFEMPI(Sauer et a12001, 
Guymer et al 2002). Polymorphisms identified in EFEMP] are listed in table 1.1; 
none are associated with disease pathogenesis. Sauer et al found no other disease 
associated mutations in EFEMP1 in sporadic cases (although they did not screen 
exons 1 and 2); three different polymorphisms and two intragenic polymorphic 
repeats were present in similar frequencies in controls. The R345W mutation was 
present in only 70% of familial cases and 6% of sporadic cases (Tarttelin eta! 2001). 
No other mutation was found in EFEMP1 in these patients. Another study found no 
evidence of mutation in fibulin-3 or fibulin-4 in a family of DD patients (Toto et al 
2002). Recent analysis of 54 patients (35 familial, 19 sporadic) revealed three novel 
polymorphisms but again these were not disease associated (Narendran et a! 2005). 
Exon Sequence change % in cases % in controls Reference 
1 29C>T 1.96 4.39 Narendran et al 2003 
5 287A>G 3.85 4.35 Sauer et a12001 
6 (Intron 5) A>G 19.23 15.69 Narendran et al 2003 
10 (Intron 9) C>T 11.32 9.56 Sauer et al 2001 
11 (intron 12) (ttg)9-12 repeat 7.55 5.31 Sauer et al 2001 
12 112A>C 0 0.87 Narendran et al 2003 
12 (3' UTR) delT 3.77 3.47 Sauer et al 2001 
Table 1.1 Sequence changes found in EFEMPI in Dominant Drusen patients not harbouring 
R345W mutation (adapated from Narendan et at) 
Non-penetrance was observed in a 62-year-old asymptomatic man carrying 
the R345W mutation (Michaelides et al 2006). Furthermore, of twenty-four 
Dominant Drusen patients carrying the R345W mutation, these authors observed 
extreme variability in interocular, intrafamilial and interfamilial visual loss, natural 
history, opthalmoloscopic findings, autoflourescent imaging and psychophysical data 
(Michaelides et al 2006). Variability in penetrance is likely linked to other 
environmental and genetic risk factors, such as smoking (a significant risk factor for 
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AMD), and allelic variation in CFH, LOC387715 and/or TIMP3. Combined, these 
observations suggest other unidentified genes also cause early onset drusen. 
A second locus linked to dominant drusen was mapped to 6q14 in a family 
with clinically heterogeneous dominant drusen and macular degeneration, who 
experienced moderate visual loss (Stefko et a12000, Kniazeva et a! 2000). This locus 
appears to be distinct from the adjacent North Carolina Macular Dystrophy 
(MCDR1) and ELOVL4 loci and as yet no disease gene has been identified. 
No coding sequence variations in EFEMPI were identified in a screen of 494 
AMD patients, excluding this gene as a candidate locus for AMD (Stone et al 1999). 
1.2.6.1 The biology of drusen 
Drusen are deposits of lipids and proteins between Bruch's membrane and the 
RPE which are associated with AMD. They may be classified as hard or soft. The 
presence of only hard drusen is not associated with loss of vision, as they are 
frequently seen in elderly patients with no vision loss. As such they are considered a 
normal part of the aging process and non-pathogenic. Soft drusen can be further 
subdivided into hydrophilic and hydrophobic drusen. Hydrophilic drusen are 
associated with "wet AMD", while hydrophobic drusen are associated with "dry 
AMD" and atrophy. Their causal association with AMD is likely to be due to an 
impaired movement of small molecules across Bruch's membrane at the site of 
drusen deposits. This would have adverse effects upon the underlying RPE and 
photoreceptors, and RPE cells overlying drusen appear vacuolated and swollen 
(Anderson et al 2002). 
Drusen deposits may contain immunoglobulins, activated complement 
proteins C3 and C5, complement regulators including CFH, and the Alzheimer's 
disease amyloid-ß (Aß) peptide. They may also contain lipids, including oxidised 
lipids, and proteins associated with intracellular stress such as ubiquitin (Crabb et al 
2002, Rattner & Nathans 2006). It is likely that these constituent molecules originate 
from the RPE, (and thus may have been initially phagocytosed from the 
photoreceptors) and the circulating blood. 
In dominant drusen, large drusen deposits are described around the edge of 
the optic nerve head in DHRD, and additionally small discrete drusen are seen 
radiating into the peripheral retina in ML. Characteristically, drusen are seen before 
the sixth decade of life, but later than this in AMD. 
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1.3 The fibulins 
The fibulins are a family of extracellular matrix proteins expressed 
throughout the body, and have an increasingly recognised role in organogenesis, 
haemostastis and tissue homeostasis. During development, fibulins are expressed in 
the basement membranes and at sites undergoing epithelial-mesenchymal 
transformation (Timpi et al 2003). The six known fibulins have a common modular 
structure with between six and nine calcium binding Epithermal Growth Factor -like 
(cbEGF-like) domains, flanked by a C-terminal fibulin domain, and have variable 
composition of the N-terminal domain (Argraves et al 2003). Fibulins -3, -5 and -6 
have all been implicated in retinal disease and will be considered further here. 
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Figure 1.7 Domain structure of the fibulins. The repeating domain structures of the six members of 
the fibulin gene family are shown: epithelial growth factor (EGF)-like domains, calcium-binding 
EGF-like domains, anaphylatoxin domains of fibulin I and fibulin 2, and immunoglobulin domains of 
fibulin 6. Alternative splice sites are known for fibulin 1-4, but only those of fibulin-1 are illustrated 
owing to their role in tumour cells. (Adapted from Argraves et al 2003) 
1.3.1 Fibulin-3 
The FBLN3 gene is also known as EFEMPI, for Epidermal growth Factor 
containing Fibrillin-like extracellular Matrix Protein 1. Fibulin-3 is a monomeric 493 
amino acid protein with a predicted molecular mass of 55kDa, and has approximately 
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60% identity at the protein level with fibulin-4. An alternative splicing pattern 
whereby the 41 bp exon 2 may be present (exon I spliced to exon 2) or absent (cxon I 
spliced directly to exon 3), although the function of these two transcripts remains 
unclear (Blackburn et a/ 2003). 
Fibulin-3 is strongly expressed in the extracellular matrix of brain, heart, 
lung. placenta, medium-sized vessels and eye tissue. RT-PCR of RNA extracts found 
fibulin-3 to be expressed in human RPE, choroid and neuroscnsory retina. Fibulin-3 
is weakly expressed in kidney and pancreas (Giltay et a! 1999, Stone et a! 1999). 
Normally, fibulin-3 is restricted to the photoreceptor inner and outer segments, and 
the inner and outer plexiform layers, although the source of fibulin-3 protein remains 
unclear. Interestingly, fibulin-3 mRNA was not detected in mouse GCL. Fibulin-3 
may not be required by murine GCL, or fibulin-3 in human nerve cell layers may not 
be derived from ganglion cells (Blackburn cl a! 2003). 
During development, fibulin-3 mRNA was detected in human RPE as Carly 
as 8.6 weeks after conception, and in fetal murine eyes as early as E9.5, suggesting a 
role for fibulin-3 in the developing mammalian eye. Fibulin-3 expression is thought 
to be regulated by oestrogen levels. (Blackburn et al 2003). Interestingly, estrogens 
also regulate expression of T1 NIP genes and other genes important for extracellular 
matrix turnover. 
In dominant drusen, fibulin-3 is found to accumulate betwccn the RPC and 
Bruch's membrane. Some, but not all, of the drusen examined stained positive for 
fibulin-3, but a defined region between the RPE and deposit always stained for 
fibulin-3. Similar fibulin-3 staining was observed between RI'C cells and druscn in 
AMD patients, suggesting a strong link between DD and AMD (Marmorstein cl al 
2002). As wild-type fibulin-3 is expressed in AMD patients, the pathogenic 
mechanism may involve an oxidative, thermal or other stress-causing process leading 
to denaturation of fibulin-3. 
The binding partners of fibulin-3 have not been charactcriscd. llowcvcr, a 
study of the binding partners of TIMP-3 highlighted a strong interaction with fibulin- 
3 (Klenotic ct al 2004). The C-terminus of TIh1I'-3 was involved in the interaction. 
Analysis of donor eyes from a DD patient showed accumulation of both TIM P-3 and 
fibulin-3 between the RPE and Bruch's membrane, around druscn. Drusen stained 
more strongly for TIMP-3 than fibulin-3. It has been suggested that TIMP-3 binds to 
a matrix molecule, and binding to fibulin-3 supports this hypothesis. Klenotic et a! 
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suggest that following either inherited mutation or oxidative damage, cross-linked, 
degradation resistant complexes of fibulin-3 and TIMP-3 may inhibit molecular 
trafficking across Bruch's membrane, contributing to macular disease in SFD and 
DD. No other interactions or physiological role for fibulin-3 are known. 
An R345W mutation of fibulin-3 is associated with dominant drusen. The 
mutation is situated in the final cbEGF-like domain. These domains are around forty 
residues long and contain three disulphide bridges, in the pattern Cysl-Cys3, Cys2- 
Cys4, Cys5-Cys6. The R345W mutation is adjacent to Cys2, as shown in figure 1.8. 
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Figure 1.8 Consensus sequence of the cbEGF modules of fibulins. Six cysteine residues (Cl-C6, 
yellow) form three disulfide bonds (Cl-C3, C2-C4, C5-C6). Highly conserved amino acids are shown 
in blue. Hemicentin-1 is also known as fibulin-6 (adapted from Handford et a/2000) 
Both wild-type and R345W fibulin-3 are detected in both cell lysates and 
culture media when expressed in cultured ARPE-19 and RPE-J cell lines, suggesting 
it is a secreted protein. However, the mutant form is more abundant and in the lysate 
and less abundant in the media that WT, suggesting inefficient secretion. The 
R345W mutant also migrates faster than wild type protein under non-reducing 
conditions, suggesting erroneous intramolecular disulphide bond formation and 
misfolding in the mutated protein. Fibulin-3 contains 40 cysteine residues, 
accounting for 8% of primary sequence. Immunofluorescence staining of cells 
expressing R345 W fibulin-3 shows intense punctuate staining of the cytoplasm 
suggestive of the endoplasmic reticulum (ER). Pulse chase experiments show an 8 
hour half time for secretion of wild-type fibulin-3, but secretion of only 13% of 
R345W fibulin-3 over 24 hours (Marmorstein et a! 2002). 
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1.3.2 Fibulin-5 
Fibulin-5 is a heavily glycosylated 49kD extracellular matrix protein of 448 
amino acids, which in adults in found primarily in tissues containing elastic fibres, 
including the lungs, aorta, uterus and skin, where it is involved in the development of 
the elastic fibre network. (Elastic fibres have also been shown to contain fibulins I 
and 2). Fibulin-5 is thought to bind elastic fibres to cells and is needed for the 
assembly of elastic fibres during development (Timpl et al 2003). A Ser227Pro 
mutation between Cys3 and Cys4 of cbEGF3 (see figure 1.8) in a large 
consanguineous family causes a severe form of recessive cutis laxa, resulting in loose 
and sagging skin and variable systemic involvement (Loeys et al 2002). 
The FBLN5 gene has been screened for mutations in a large cohort of 402 
AMD patients (Stone et al 2004). Seven amino acid changing mutations were found: 
Val60Leu, Arg71Gln, Pro87Ser, Ilel69Thr, Arg31Trp, Ala363Thr and Gly412Glu. 
These were all missense mutations, where each mutation was present in a single 
AMD patient and absent in controls. These seven patients were also observed to have 
small circular drusen, although these could have been hard drusen commonly seen as 
part of the normal aging process in the eye. 
This study also screened the genes for fibulins -1, -2, -4 and -6 in 402 AMD 
patients. None of these genes showed significant association between amino acid 
variations and AMD. 
A recent screen of 805 European AMD patients and 279 controls identified 
two novel heterozygous missense mutations, G1nl24Pro and Gly267Ser, present in 
one and two patients respectively and absent in controls (Lotery et al 2006). 
Additionally, Lotery et al investigated the secretion of fibulin-5 mutants from 
cultured COST cells and predicted folding energies of the nine known AMD 
associated and two known cutis laxa associated mutants. They found secretion of the 
AMD associated Gln 124Pro, I1el69Thr, G1y267Ser and Gly412 Glu mutants to be 
reduced, and secretion of the two cutis laxa mutants to be significantly reduced. 
These authors suggest misfolding and reduced secretion of fibulin-5 may impair 
elastinogenesis and consequently impair maintenance of the integrity of Bruch's 
membrane. 
Recently, confirmation of the localisation of fibulin-5 to Bruch's membrane 
and the intercapillary pillars of the choroid in healthy human eyes, and the presence 
of fibulins-5 in basal deposits and drusen in AMD patients, has provided further 
34 
Introduction 
support for the proposed pathogenesis of fibulin-5 in extracellular deposit formation 
in AMD (Mullins et al 2007). 
1.3.3 Fibulin-6 
Fibulin-6 was originally known as Hemicentin-1 but was reclassified as 
fibulin-6 owing to its structural similarities to the fibulin protein family at the 
carboxyl terminus. The 600kD protein of 5635 amino acids is encoded by 107 exons, 
and is much larger than the other fibulins due to it's large N-terminal domain 
consisting of 48 immunoglobulin domains. Nematodes defective in hemicentin have 
defective cell-cell and cell-matrix interactions, suggesting a role for fibulin-6 in the 
extracellular matrix (Vogel et al 2001). 
A Gln5345Arg mutation is linked to autosomal dominant AMD in a large 
pedigree (Schultz et a12003) This mutation was also identified in two AMD patients 
and one control in Stone et al's screen of 402 AMD patents (Stone et al 2004); 
however, re-examination of the control showed small round drusen near the optic 
nerve, similar to changes seen in AMD patients with fibulin-5 changes. 
The 5345 position is strictly conserved, and glutamine to arginine mutation 
changes both the size and charge of the amino acid side chain. In the other fibulins, 
this position in the domain is occupied by a tyrosine or phenylalanine, which is 
involved in hydrophobic packing interactions with the adjacent cbEGF domain. The 
disease associated mutation in fibulin-6 is located in the carboxyl cbEGF domain, as 
in fibulin-3. Recently, it has been suggested that the G1n5345Arg substitution may 
not be a causal mutation, as it is present as a low frequency polymorphism in 1160 
AMD controls (Fisher eta! 2007). 
FBLN6 is found at chromosomal locus 1g31, which lies within the AMD 
locus at chromosome 1g25-31 (Schultz et a! 2006). Investigation of FBLN6 in 1162 
AMD patients found none of the rare polymorphisms which alter amino acid 
sequence to be associated with AMD (Fisher et a! 2007). However, rare variants of 
fibulin-6 may still confer susceptibility to AMD in some families. Therefore it is 
likely there are other AMD genes on the long arm of chromosome 1. The CFH gene 
is found at chromosome 1g32, and is thought to account for up to 50% of AMD 
cases. 
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1.4 Choroideremia 
Originally described in 1872, choroideremia (OMIM 313100) is a progressive 
retinopathy inherited in an X-linked fashion, caused by mutation in the REP-1 gene. 
Patients develop nightblindness from childhood. Visual loss progresses from the 
midperiphery, with central vision preserved until the final stage of disease, in the 
fifth or sixth decade of life (McCulloch 1969). Associated moderate myopia and 
blue-green colour blindness have also been reported. Female carriers show fundus 
changes but retain good visual function. 
1.4.1 Clinical consequences 
Diagnosis is achieved by examination of the fundus, and more recently, 
molecular analysis (van Bokhoven et al 1994; van den Hurk et al 1997, MacDonald 
et at 1998). Changes in the choroidal vasculature also produce a distinctive 
fluorescein angiogram pattern. 
Young patients and female carriers display depigmentation of the fundus and 
pigmentary stippling, reflecting degeneration of the RPE. Atrophy of the larger 
choroidal vessels occurs around the optic disc. In the intermediate stage of disease, 
the pattern of RPE and choroidal atrophy spreads inwards from the midperiphery and 
outwards from the optic disc. All sizes of choroidal vessels are affected, apart from 
those underlying the macula. Finally all vessels atrophy, except those in the far 
periphery and macula atrophy, and the fundus appears off-white (see figure 1.9). 
Histological examination of eyes with advanced disease shows absence of 
photoreceptor outer segments, RPE and choroid. 
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Figure 1.9 Fundus photography of normal, choroideremia and carrier retina I he fundus of 
choroideremia patients is off white or yellow, depigmented, and has some small islands of choroid. 
Asymptomatic carriers have more subtle peripheral changes. (Taken from 
http: //webvision. med. utah. edu/ClinicalERG. html) 
A recent study of choroideremia patients measuring the thickness of retinal 
laminae describes remodelling of the retina across seven decades of disease, as 
shown in figure I. 10 (Jacobson et al 2006). Young hemizygotes (7-12 years old) had 
small areas of photoreceptor abnormalities colocalised with normal or abnormal 
RPE, but no abnormal RPE with normal photoreceptors was seen. In the peripheral, 
rod rich retina, normal thickness was maintained for twenty years before a slow 
decline leading to a thinner, disorganised, bilaminar retina in 34- and 56- year old 
patients. The cone rich fovea became thickened decades before cone dysfunction is 
apparent through loss of visual acuity, but eventually thins to subnormal levels. 
Jacobson et al speculated that retinal thickening is caused by Muller cell activation 
and hypertrophy in response to photoreceptor stress. 
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Figure 1.10 Model of retinal remodelling in choroideremia Thickening in earliest detectable stage 
(1). Loss of photoreceptor nuclei, outer segment shortening and RPE depigmentation in clinical 
disease (II and III) results in thinned, disorganised, unlaminated retina (IV). Muller cells filled in grey 
indicate gliosis. (Adapted from Jacobson et al 2006) 
There is considerable variability, even within families, of the age of symptom 
onset and the subsequent rate of disease progression and severity (Cremers 1995; 
Jacobson et al 2006). In extreme cases, first stage changes have been seen in boys 
younger than four, and only slight abnormalities in a 45- year old patient. Variation 
within female carriers results from cellular mosaicism of random X-inactivation; in 
exceptional cases, disease may arise through homozygosity or X autosome 
translocations. 
A heterozygous carrier was reported to have abnormal depigmented RPE of 
irregular thickness, and abrupt transition between areas of normal and absent 
photoreceptors (Flannery et al 1990). Autofluorescent particles, presumably 
lipofuscin, were seen in pigmented RPE cells. Density and length of photoreceptors 
did not appear to correlate with RPE pigmentation, as photoreceptor loss was also 
seen in areas of normal RPE. Other areas had normal choroid and neurosensory 
retina adjacent to abnormal RPE. In areas of atrophy, abnormal photoreceptors 
accompanied reduced choroidal number and diameter of choroidal capillaries. 
Capillaries and photoreceptors were absent in areas of complete atrophy. The choroid 
was only normal in areas of normal photoreceptors. Deposits on Bruch's membrane 
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suggested previously functioning RPE phagocytosis had failed. These authors 
suggest their findings are consistent with a disease primarily of the RPE, but 
acknowledge this study does not show causation. 
Another female carrier was histologically examined by Syed et al. They 
observed little change to the choroid and normal melanin granule distribution, but 
lipofuscin granule accumulation in the RPE, and preferential loss of the rod 
photoreceptors (Syed et al 2001). Survival of photoreceptors adjacent to severely 
abnormal RPE was observed. End stage disease was characterised by loss of 
virtually all photoreceptors and damaged choriocapillaris, suggesting photoreceptor 
and RPE diseases are independent. Immunostaining revealed Rab Escort Protein 
(REP-1) staining of the rod inner segments, cell bodies (in a vesicular fashion) and 
synapses in normal areas, but no staining of the rod outer segments or cone cells. In 
degenerated areas, amacrine cells were REP-1 positive, and Muller cells were 
hypertrophied. Therefore these authors proposed the rods are the primary site of 
disease, and disease of the RPE is independent. 
The cellular origin of choroideremia continues to be debated, with the 
choroid, RPE and photoreceptors all implicated as the primary site of disease. Study 
of the early stages of degeneration is needed to understand the causes of widespread 
retinal degeneration. 
1.4.2 Genetic basis of choroideremia 
The X-linked recessive pattern of inheritance was first noted by two 
independent authors in 1942. Estimates of incidence vary between 1 in 50000 and I 
in 100000, classifying choroideremia as a rare disorder. Within North America 
incidence varies widely, with choroideremia being the most prevalent retinal 
degeneration on the West Coast. Strong founder effects in inheritance have been 
observed, resulting in a low number of common mutations in North American 
populations, and a high incidence of deletions in European families (Cremers 1995; 
Seabra 1996). 
Choroideremia has been linked to chromosome Xg21.2 (Cremers et al 1990), 
and the gene responsible identified as Rab Escort Protein 1 (Seabra et al 1993a; 
Andres et al 1993). The gene spans 150kb of choromsome Xg21.2, contains fifteen 
exons, and encodes a 653 amino acid protein (van Bokhoven et al 1994). It is 
flanked by genes associated with mental retardation and deafness type 3, hence these 
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syndromes are associated with choroideremia in patients with large deletions in the 
Xg21 region. 
Characterisation of the Rab Escort Protein 1 (REP-1) gene allowed screening 
of patients to identify the underlying mutations. Over 100 mutations to the REP-1 
gene have been associated with choroideremia to date, and are listed fully in 
Appendix 1. Mutations have been detected in approximately 60% of familial cases, 
and 30% of sporadic cases (Preising 2004). 
Deletions encompassing REP-1 vary in size from a few kilobases, removing a 
single exon, to -15Mb across the entire REP-1 gene and most of the Xq21 band (van 
den Hurk et al 1997, Fujiki et al 1999, McTaggart et al 2002, van den Hurk et al 
2003). Amongst European families, 25% of mutations involve a large deletion 
overlapping the REP-1 gene. In contrast, no deletions have been found in American 
families to date (van den Hurk et al 1997, Preising et al 2004). Translocations 
disrupting REP-1 have been found in three female carriers, with autosomal 
breakpoints at 7p14 (X breakpoint in REP-1 exon 3 or 4), 13pl2 (X breakpoint in 
REP-1 exon 12) and 4pl6 (X breakpoint in REP-1 intron 8) (Garcia-Hoyos et al 
2005, Lorda-Sanchez et al 2000, van Bokhoven et al 1994, Cremers et al 1990). 
Nonsense, frameshift and splice site mutations have been identified, and all 
mutations give rise to premature termination codons, as detailed in table 1.2 (van 
den Hurk et al 2003, Seabra 1996). No phenotypic correlation could be found 
between the site of the premature stop codon (and therefore the length of product 
peptide) and disease severity in studies of Japanese (Fujiki et al 1999) and Swedish 
(Ponjavic et al 1995) studies. Interestingly, recombinant REP-1 lacking only 49 C- 
terminal amino acids is unable to interact with RabGGTase in vitro (F. P. M. Cremers 
& M. Seabra unpublished observations, reported in van den Hurk eta! 1997). 
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Mutation Basechange Exon Nucleotide 
Classification 
& Remarks Reference 
van Bokhoven et at 
Microdeletion del DXS349 - ex 8 1 to 8 Deletion 1994 
van Bokhoven et at 
Microdeletion del DXS349 - ex 8 1 to 8 Deletion 1994 
van Bokhoven et at 
Microdeletion del ex I- pJ36 1 to 15 Deletion 1994 
del DXS110 - van Bokhoven et al Microdeletion DXS233 1 to 15 Deletion 1994 
del DXS110 - van Bokhoven et al 
Microdeletion pJ7.6A 1 to 15 Deletion 1994 
Microdeletion del DSX95 - DXS72 1 to 15 Deletion Preising 1999 
Vnencak Jones et at 
Microdeletion del ex 1-8 1 to 8 Deletion 1996 
Microdeletion del ex 1 -15 1 to 15 Deletion Pon'avic et al 1995 
del DXS1 002 - van Bokhoven et al 
Microdeletion pJ7.6A 1 to 15 Deletion 1994 
van Bokhoven et al 
Microdeletion del ex I- DXS165 1 to 15 Deletion 1994 
van Bokhoven et at 
Microdeletion del DXS110- pJ1 1 to 15 Deletion 1994 
Microdeletion del ex 1- DXS72 1 to 15 Deletion Preising 1999 
del DXS95 - Microdeletion DXS165 1 to 15 Deletion Preising 1999 
Microdeletion del ex 1- 15 1 to 15 Deletion Fujiki et at 1999 
Microdeletion del ex 3- 15 3 to 15 146 Deletion Schwatrz et at 1993 
van Bokhoven et al 
Microdeletion del ex 3-8 3 to 8 146 Deletion 1994 
van den Hurk et al 
Microdeletion del ex 1, UTR - 49 1 1 to 49 Deletion 2003 
van den Hurk et at 
49+5G>T del ex 2-5 intron I Splice defect 2003 
van den Hurk et at 
116+IG>A intron 2 Splice defect 2003 
van den Hurk et at 
Micodeletion del ex 3- 12 3 to 12 Deletion 2003 
IVS1-1 -c t to -t tac 3 80 Splice site Fuiiki et al 1999 
IVS1+1 -a tat -atat 3 146 Splice site Fujikl et al 1999 
van Bokhoven et al 
(X; 7) 3 or 4 Translocation 1999 
Trp 47 ter TGG-TAG 3 170 Nonsense Fu'iki et at 1999 
van den Hurk et al 
117 189del 189+1G>A intron 3 Deletion 2003 
van den Hurk et at 
190 197de1 190-2A>G intron 3 Deletion 2003 
van Bokhoven et at 
IVS3-14t- ct t -c t Intron 3 345 Splice site 1994 
Beaufrere et at 
323delT GTG-G G 4 323 Frameshift 1997a 
Beaufrere et al 
333delT TTT- TT 4 333 Frameshift 1997b 
van den Hurk et at 
314 315ins98 314+10127 T>A intron 4 Deletion 2003 
tag T CAG GAT-tag 
345deITCAG GAT 5 345 Frameshift Fu'iki et at 1999 
Microdeletion del ex 5-8 5 to 8 347 Deletion McTa art et al 1998 
Gin 106 ter CAG-TAG 5 345 Nonsense Nesslinger et at 1996 
Microdeletion del ex 11 - 14 11 to 14 379 Deletion Schwatrz et al 1993 
MacDonald et at 
Ala 117 Ala GCG-GCA 5 383 Polymorphism 1996 
402delT Frameshift Itabashi et al 2004 
van Bokhoven et al 
ACA GGG-AC_ 1994, Itabashi et al 
555del AG GG 5 555 Frameshift 1004 
Beaufrere et at 
Glu 177 ter GAA-TAA 5 559 Nonsense 1997a 
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Mutation Basechange Exon Nucleotide 
Classification 
& Remarks 
Reference 
GTG CCA-GT 
594delGG _ CA 5 594 Frameshift Fü iki et al 1999 
van Bokhoven et al 
610insA GAA-GAAA 5 610 Frameshift 1994 
649 - 652 van den Hurk et at TACTdel Y217fs, ter X230 5 649-652 2003 
Gin 209 ter CAA-TAA 5 655 Nonsense Fu'iki et at 1999 
682deIGCAC GCAC- 5 682 frameshift Preisin 1999 
T>G -8 ex6 van den Hurk et al 
slice donor site unknown 6 ? no mRNA" 2003 
Vnencak Jones et al 
del5b 6 Frameshift 1996 
L1 instertion, L1 Insertion, van den Hurk et at 
exon6del L235 Q273del 6 deletion 2003 
Arg 239 ter CGA - TGA 6 Nonsense Francis et al 2005 
van den Hurk et al 
Arg 239 ter 2003 
Preising & 
Arg 240 ter CGA-TGA 6 745 Nonsense Pawlowitski 1996 
van den Hurk et al 
779delA AAT- AT 6 779 Frameshift 1997 
Francis et at 2005, 
van den Hurk et al 
Ar 253 ter CGA - TGA 6 Nonsense 2003 
Tyr 254 ter TAT-TAG 6 792 Nonsense Preising 1999 
Preising & 
Pawlowitski 1996, 
van den Hurk et al 
1997, Fujiki et al 
1999, Beaufrere et at 
Arg 267 ter CGA-TGA 6 829 Nonsense 1997a 
Fujiki et al 1999, van 
Ar 270 ter CGA-TGA 6 808 Nonsense den Hurk et at 2003 
van den Hurk et al 
Glu 272 ter G>T 6 814 Nonsense 2003 
van den Hurk et al 
941-2A>G Intron 7 Splice defect 2003 
G860C G to C intron7 850 Splice site Potter et at 2004 
van Bokhoven et al 
1994, van den Hurk 
Ar 293 ter CGA-TGA 7 907 Nonsense et al 2003 
van den Hurk et at 
Tyr 308 ter T>G 7 924 Nonsense 2003 
Microdeletion del ex 8- DXS165 8 to 15 969 Deletion Kusters et at 1996 
van den Hurk et at 
Gin 334 ter CAA- TAA 8 1030 Nonsense 1997 
Ser 340 ter TCA-TAA 8 1049 Nonsense Trujillo et al 1998 
Ser 345 ter TCA-TGA 8 1064 Nonsense Fujiki et at 1999 
1163insAAT TA T -TA TAA T 8 1163 Frameshift Nesslin er et at 1996 
van Bokhoven et at 
1183insC C AG-CCAG 8 1183 Frameshift 1994 
Garcia-Hoyes et al 
;4 21; 16 intron8 Translocation 2005 
van Bokhoven et al 
Microdeletion del ex 9-13 9 to 13 1196 Deletion 1994 
van Bokhoven et at 
Microdeletion del ex 9- pJ15 9 to 15 1196 Deletion 1994 
Ser 403 ter TCA-TGA 9 1238 Nonsense Fu iki et at 1999 
Cys 406 ter TGC-TGA 9 1248 Nonsense Nesslinger et at 1996 
van den Hurk et al 
IVS9 +1 -a AA t-AAat IVS9 1274 Splice site 1997 
1313deITC ATC-A 10 1313 Frameshift Fuiiki et at 1999 
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Mutation Basechange Exon Nucleotide Classification Reference & Remarks 
CAAA TAC-CAAC 
1374insC TAC 10 1374 Frameshift Fü iki et al 1999 
intron van den Hurk et at 
IVS10+2ins t taa t taa 10 1379 Splice site 1997 
van den Hurk et al 
1992, Rudolph et al 
1388deICCinsG TCC A-T GA 11 1388 Frameshift 2003 
1393deIG GCA- CA 11 1393 Frameshift Nesslin er et at 1996 
van Bokhoven et at 
; 12 12 Translocation 1999 
Microdeletion del ex 12 12 Deletion Schwatrz et al 1993 
van Bokhoven et at 
Microdeletion del ex 12 - pJ36 12 to 15 Deletion 1994 
Gln 471 Leu CAG-CAT 11 1442 Splice site Donelly et at 1994 
intron 
IVS11-1 -a to ATT-taa ATT 11 1143 Splice site McTaggart et at 1998 
van den Hurk et at 
Microdeletioni del ex 12 12 ? ? 2003 
CCA GGA. van den Hurk et al 
1478delA CC GAA 12 1478 Frameshift 1992 
van den Hurk et at 
Glu 491 ter GAG-TAG 12 1501 Nonsense 1992 
van den Hurk et al 
Ser 495 ter TCA-TAA 12 1514 Nonsense 1992 
Cys 499 ter TGC-TGA 12 1527 Nonsense Schwatrz et at 1993 
1531_1532 van den Hurk et al 
ins15 T511del, lnslFX513 12 to 13 1531-1532 Termination 2003 
intron van Bokhoven et at 
IVS12-2a-g a-g 12 1540 Splice site 1994 
1608A-CC AAA-AACC 13 1608 Frameshift Hotta et at 1997 
van den Hurk et at 
1614deITGTT TTT TTG-TT 13 1614 Frameshift 1992 
intron 
IVS13+3inst gta-gtta 13 1639 Splice site Sankila et al 1992 
ýk Jones et at 
2 bp del 14 Frameshift 1996 
intron 
IVS13+3a-c a-c 13 1639 Beaufrere et al 1998 
IVS13+3a-c taa tca intronl3 1639 Splice site Beaufrere et at 1998 
van den Hurk et at 
Trp 548 ter G>A 14 1644 Nonsense 2003 
1679delTT CTT-C 14 1679 Frameshift Schwatrz et al 1993 
Ar 555 ter AGA-TGA 14 1693 Nonsense Forsythe et al 1997 
Ser 558 ter TCA-TGA 14 1703 Nonsense Beaufrere et at 1996 
van den Hurk et at 
Cys 575 ter C>A 14 1725 Nonsense 2003 
1789dei G GCA- CA 13 1789 Frameshift Fu'iki et at 1999 
Vnencak Jones et at 
Microdeletion del ex 15 15 1800 Deletion 1996 
Preising & 
PavAowitski 1996, 
van den Hurk et at 
IVS14-1 -a -a intron14 1801 Splice site 1997 
Table 1.2 Patient mutations associated with choroideremia del, deletion; IVS, intervening 
sequence. Point muations shown in figure 1.15 are highlighted in bold. (Adapted and updated from 
www. retina-international. org/sci-news/repmut. html) 
A single missense mutation has been reported, as unpublished data in Seabra 
1996, describing briefly a "possible missense mutation" and absent REP-1 in 
lymphoblast cell cultures derived from the patient, suggesting the point mutation 
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gives rise an unstable protein, or another unidentified mutation exists (Seabra 1996). 
No other missense mutations have subsequently been identified in choroideremia 
patients. 
One patient experienced the insertion of a full length L1 retrotransposon 
(-6kb) in the reverse orientiation into the coding sequence of exon 6 (van den Hurk 
et al 2003). RT-PCR analysis and sequencing of RNA from the patient revealed 
direct splicing of exon 5 onto exon7. Absence of exon 6 from the REP-1 mRNA 
maintains the reading frame but amino acids 235 through 273 are lost from the 
protein product. This is the third human disorder which has been linked to full 
length L1 insertion, the others being caused by disruption of retinitis pigmentosa 
type 2 and ß-globin genes. The same study revealed activation of a cryptic exon, due 
to a T>A substitution within intron 4, which causes the inclusion of 98bp of intronic 
sequence in the REP-1 transcript and subsequently leads to a premature stop codon. 
This is the only intronic mutation remote from the splice site to have been identified 
to date. RT-PCR of REP-1 mRNA has identified mutations to the coding region of 
mRNA in 43% of patients in this study. There is about 180kb of intronic sequence in 
the REP-1 gene so it is likely further intronic mutations will be identified, which 
may clarify the cause of exon skipping in some patients. 
Patients for whom no exonic or splice site mutations can be identified can be 
diagnosed by immunoblot analysis using an antibody against the C-terminus of 
REP-1 protein (MacDonald et al 1998). 
1.5 Functionality of Rab Escort Protein 
1.5.1 Rabs as cellular membrane organisers 
The Rab protein family is the largest of the Ras superfamily of small 
GTPases, comprising sixty known human proteins. They are key regulators of 
intracellular membrane trafficking and vesicular transport, a multi-step process 
involving anterograde and retrograde movement along both the secretory and 
endocytic pathways. Rabs are cytosolic proteins which associate with the 
cytoplasmic face of intracellular membranes in an organelle specific manner, and so 
display specific subcellular localisation, as illustrated in figure 1.11. Some Rabs are 
ubiquitously expressed and regulate fundamental pathways, whereas others are 
specialised for tissue-specific organelles and processes, as summarised in table 1.3 
(Zerial et al 2001; Seabra et al 2002). 
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Figure 1.11 Rabs in Intracellular Trafficking: Subcellular Localisations The biosynthetic pathway 
transports proteins from the endoplasmic reticulum (ER) through the Golgi complex to the cell 
surface. From the trans-Golgi network (TGN), molecules can enter either constitutive secretory 
vesicles (CV) or regulated secretory vesicles (RV). Phagocytosed material first reaches the early 
endosomes (EE), and can be recycled back to the surface directly or via a perinuclear recycling 
endosome (RE) compartment, or transported to late endosomes (LE) and lysosomes. Melanosome 
(M), a lysosome-related organelle, move within pigment cells in an actin- and myosin-dependent 
manner, generating pigmentation. (From Stenmark and Olkkonen 2001) 
Rab Localisation Function C-terminal 
motif 
Rab I ER-Golgi, cis-Golgi ER-Golgi and intra-Golgi transport CC 
Rab3 Synaptic vesicles, PM Regulated secretion, including CXC 
neurotransmitters 
Rab5 EE, Claithrin coated vesicles, PM PM 4 EE transport and EE - EE CCXX 
fusion; EE motility 
Rab6 ER, Golgi, TGN Retrograde Golgi-ER and intra CXC 
Golgi traffic; Golgi-ER vesicle 
motility 
Rab7 LE EE-LE, LE-lysosome 
Rabb TGN, post Golgi secretory vesicles, Polarised secretion, TGN-PM CXXX 
PM transport (CVLL) 
Rab9 LE, TGN LE-TGN transport 
Rabl I Recycling endosomes, TGN, PM Endocytic recycling 
Rab27a Melanosomes, cytolytic granules Lytic granule release, melanosomes CXC 
transport 
Yptl ER-Golgi, cis-Golgi ER-Golgi and intra-Golgi transport CC 
(yeast) 
Table 1.3 Rab localisation and function PM, plama membrane; EE, early endosomes; TGN, trans 
Golgi network; LE, late endosomes 
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Rabs utilise their intrinsic GTPase activity to switch between active GTP- 
bound and inactive GDP-bound states. When activated, Rabs recruit a range of 
effector proteins to the membrane, enabling control of cargo selection, vesicle 
budding, movement, docking and fusion. After hydrolysis, the GDP bound Rab can 
be extracted from the membrane and returned to the donor compartment by Rab GDP 
dissociation inhibitor (RabGDI) (Seabra & Wasmeier 2004). 
1.5.2 Lipid Modification of Rab Proteins 
Ras superfamily proteins are intrinsically soluble. They require post- 
translational prenyl lipid modification for membrane association and correct 
function. This may be in the form of a 15 carbon farnesyl or 20 carbon 
geranylgeranyl pyrophosphate, which is covalently attached via a thioester linkage to 
C-terminal cysteine residues. Prenyl modification is catalysed by one of three protein 
prenyltransferases. Farnesyl transferase (FTase) and geranylgeranyl transferase 
(GGTaseI) singly prenylate the C-terminal CAAX motif of Ras, Rho and Rac family 
proteins. In contrast, Rab family proteins are exclusively geranylgeranyl prenylated 
by Rab geranylgeranyl transferase (RabGGTase) (Leung et a! 2006). 
Rabs may be singly or doubly prenylated, depending on their C-terminal 
cysteine motif, CAAX, CXXX, CC or CXC. The majority of Rabs (87%) undergo 
double prenylation in a two-step digeranylgeranylation reaction (Thoma et a! 2001a; 
Farnsworth et al 1994; Shen & Seabra 1996). Correct prenylation of Rabs is required 
for proper membrane targeting, thus maintaining specificity of Rab function and 
consequently membrane trafficking (Gomes et a12003; Calero et a! 2003). 
1.5.3 Rab Geranylgeranyl Transferase 
RabGGTase catalyses the covalent attachment of geranylgeranyl lipid 
moieties to newly synthesised Rab proteins. (Casey & Seabra 1996; Leung et al 
2006). Unlike the other prenyl transferases, RabGGTase cannot bind its substrate 
protein directly, and instead requires association with Rab Escort Protein (Andres et 
al 1993; Shen & Seabra 1996). RabGGTase is a heterodimeric enzyme composed of 
60kDa a-subunit and 38kDa ß-subunit, with 30% homology to FTase and GGTase 
(Armstrong et al 1993). It catalyses prenyl transfer to both C-terminal cysteines 
(Farnsworth et al 1994). 
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The substitution of Ala by Gly at a splice acceptor site in the a-subunit of 
RabGGTase gives rise to the mouse mutant gunmetal, a model for the rare autosomal 
recessive human disease Hermansky-Pudlak syndrome, causing partial albinism, 
prolonged bleeding and platelet dysfunction (Detter et al 2000). This phenotype 
reflects defects in lysosome and lysosome-like organelles, such as melanosomes and 
platelet dense granules. The mutation reduces RabGGTase activity to 30% of normal 
level, resulting in hypoprenylation of Rab27a and other, unidentified, Rabs. 
Although reduction in RabGGTase activity is seen in all tissues, underprenylation of 
Rabs is specific to the platelets and melanocytes (Zhang et al 2002). In addition, 
different subsets of Rabs appear to be underprenylated between tissues (Seabra et al 
2002). It remains unclear whether underprenylation reflects variation of Rab 
expression between tissues, or differences between Rabs in their affinity for 
RabGGTase. 
1.5.4 Rab Escort Protein 
Rab Escort Protein (REP) is an accessory protein for the prenylation of Rabs 
by RabGGTase. Two REP homologues, REP-I and REP-2, are known in mammals. 
REP-1 was first purified as "component A" of RabGGTase, when 
RabGGTase was thought to be composed of two loosely associated components able 
to attach prenyl lipids to Rab proteins (Seabra et al 1992a). "Component B" 
represented the catalytic subunit now know as RabGGTase (Seabra et al 1992b). 
REP-1 is a 73kDa, 653 residue polypeptide ubiquitously expressed in rat tissues 
(Desnoyers et al 1996). 
Identification of REP-1 as the choroideremia gene product followed 
demonstration of a functional deficiency of component A in lymphoblasts from 
choroideremia patients (Seabra et al 1993a). The deficiency was more pronounced 
when Rab3a was a substrate, achieving 20-25% of normal prenylation, than when 
Rabla was the substrate, when 70-80% of the normal level was reached. This 
implied there must be a second compensatory REP still active in choroideremia 
lymphoblasts, which displays some level of substrate specificity. Total loss of 
prenylation activity would likely be fatal in utero. A null mutant of the yeast REP 
homologue, MRS6, is lethal (Waldherr et al 1993; Jiang & Ferro-Novick 1994). An 
autosomal homologue, REP-2, was later shown to functionally replace REP-1 in 
vitro (Cremers et al 1994). 
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Whilst attempting to clone the 5' end of the REP-1 cDNA, an autosomal 
homologue, designated choroideremia-like (CHML), was found. It was later 
renamed Rab Escort Protein -2 (REP-2) following demonstration of its functional 
properties. REP-2 is encoded by an intronless gene, only 2304bp in length (Cremers 
et al 1992). It localises to chromosome 1g42, where it sits within intron I of the 
panopsin gene (Halford et a! 2001). This locus is also linked with Usher Syndrome 
Type 2 (USH2), an autosomal recessive disease causing moderate deafness and 
progressive visual loss (von Bokhoven et al 1994). However, SSCP-PCR analysis of 
the REP-2 ORF in 19 USH2 patients found no disease-specific mutations, and the 
USH2a disease gene has since been identified as usherin on chromosome lg41 
(Eudy et a11998, Kremer eta! 2006). 
The REP-2 protein is 656 residues long, of which 71% share sequence 
identity with REP-1 (Cremers et al 1992). Both REP-1 and REP-2 are ubiquitously 
expressed, albeit the proportions of REP-1 and REP-2 vary from tissue to tissue; 
brain and eye contain mostly REP-1 (Desnoyers et al 1996). REP-2 can partly 
substitute for REP-1 in prenylation of Rabs, although there is some variation in 
substrate specificity. The molecular basis for this effect remains unclear. 
1.5.4.1 Rab Escort Protein function 
Interest in the choroideremia gene product led to further elucidation of REP 
function. This can be divided into three parts, as summarised in figure 1.12: (1) the 
binding of newly synthesised Rabs, (2) the presentation of Rabs to RabGGTase for 
prenylation and (3) the delivery of Rabs to target membranes. 
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Figure 1.12 Rab Escort Protein function REP binds newly synthesised Rabs, present Rabs to 
RabGGTase for prenylation. After prenylation, REP remains bound to the prenylated Rab and escorts 
it to it's target membrane. REP then recycles to assist the prenylation of other newly synthesised Rabs. 
As REP-1 has been implicated in human disease, it has been preferentially 
used in functional and structural studies of Rab prenylation. REP forms a stable 
complex with newly synthesised, unprenylated Rabs in a 1: l ratio (Anant et al 1998). 
REP then presents the Rab to RabGGTase for prenylation. RabGGTase itself does 
not bind Rabs, but interacts only with REP (Shen & Seabra 1996); thus the REP: Rab 
complex is the true substrate of the prenylation reaction (Anant et al 1998). 
RabGGTase then catalyses addition of prenyl lipid groups to the Rabs' carboxyl 
cysteines (Andres et al 1993). Prenylated Rabs remain bound to REP-I, which 
escorts them to their target membrane (Alexandrov et al 1994). Presumably, the 
doubly prenylated Rabs are too hydrophobic to exist freely in the cytosol, hence the 
need for a chaperoning service following prenylation. 
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Two pathways have been proposed for Rab protein prenylation; the classical 
pathway, as described above, and an alternative pathway. The alternative pathway 
may occur when REP, RabGGTase and geranylgeranyl pyrophosphate (GGpp), are 
present at elevated concentrations relative to Rab (Thoma et al 2001 b). Interaction 
between REP and RabGGTase is dramatically strengthened by the presence of 
GGpp. Therefore, a REP: RabGGTase: GGpp complex can be formed, with 
subsequent Rab association being rate determining for prenylation. However, little is 
known about the cellular concentration and localisation of isoprenoids, so it is 
unknown if the metabolic conditions within living cells would ever favour the 
alternative pathway. 
Following prenylation, REP escorts Rabs to their target membrane. The 
mechanism of delivery to membranes remains poorly understood. It is believed to 
require a specialised GDI-displacement factor (GDF) to promote dissociation of the 
Rab: REP complex and mediate membrane insertion of the prenylated Rab (Seabra & 
Wasmeier 2004). The yeast integral membrane protein Yip3 has been demonstrated 
to promote dissociation of the GDI: Rab9 complex on endosomes (Sivars et a! 2003). 
Having solved the structure of a doubly prenylated yeast Rab, Yptl, in complex with 
GDI, Pylypenko et al propose a mechanism whereby RabGDI delivers and extracts 
prenylated Rabs from membranes in concert with a GDF (Pylypenko et a! 2006). As 
GDI and REP share structural and functional features (see section 1.3.4.2), an 
analogous mechanism can be inferred for delivery of newly prenylated Rabs to 
membranes by REP, as shown in figure 1.13. 
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Figure 1.13 Model for GDI/REP-mediated membrane delivery of Rabs by interaction with 
putative Rab receptors Rab: GDI/REP complex docks with putative GDF, and undergoes 
conformational change leading to sequential transfer of first then second prenyl lipid into the 
membrane. The Rab C-terminus is freed from GDl/REP, and GDI/REP is released from the GDF to 
return to the cytosol. GDF, green; Rab, yellow; GDI/REP, grey. Orange oval represents hydrophobic 
cavity of GDI/REP which binds Rab. (From Pylypenko et a/ 2006) 
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1.5.4.2 Structural features of the REP/GDI superfamily 
RabGDIs are essential mediators of Rab membrane association and recycling 
(Alory & Balch 2001). They deliver Rabs to donor membranes during vesicle 
formation and retrieve the spent Rabs from membranes after membrane fusion. The 
Rabs are then recycled back to a cytosolic pool, where they are maintained in 
complex with GDI to enhance solubility. The functional features of REPs and GDIs 
are summarised in table 1.4. 
Function REP RabGDI 
Bind unprenylated Rabs Yes No 
Bind RabGGTase/ assist in prenylation Yes No 
Complex with prenylated Rab in cytosol Yes Yes 
Deliver Rab to membranes Yes Yes 
Extract Rab from membranes In vitro In vivo 
Table 1.4 Functional properties of REP/GDI superfamily 
REP has a conserved two domain structure; a large cylindrical domain I and a 
smaller domain II. While the structure of apo-REP-1 has not been solved, two crystal 
structures of REP-l complexes have been described: REP-I: Rab7 and REP- 
1: RabGGTase. Domain I is composed of four ß-sheets and six a-helices; domain II 
comprises five a-helices, and is tilted at an angle with respect to domain I. 
Several structural features are conserved within the REP/GDI superfamily, 
and correlate with defined regions of sequence homology known as Sequence 
Conserved Regions (SCRs) (see figure 1.14) (Schalk et al 1996). Domain I contains 
a highly conserved Rab Binding Platform (see section 1.3.4.3) and the Mobile 
Effector Loop, which is thought to mediate interaction with membranes via a 
putative GDF. Domain II is the site of the REP: RabGGTase interface, and hence is 
less conserved in GDI. 
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Figure 1.14: Sequence conserved regions between REP and GDI superfamily proteins CBR, C- 
ternminus binding region. Arrowheads indicate the first point mutations in REP-I identified, by van 
den Hurk et a/ 1992, which are highlighted in bold in table 1.2. These represent the following 
mutations: (a) delCCinsG at base 1388, resulting in premature stop codon at position 451; (b) G>T 
substation at base 1501 introducing nonsense mutation at E491 X, C>A substation at base 1514 
introducing at nonsense mutation at S495X, and delA at base 1478 frameshift mutation resulting in 
premature stop codon at position 481; (c) 1614deITGTT frameshift mutation resulting in premature 
stop codon at position 534. (d) is not described in van den Hurk et al 1992, nor is it referenced in 
Schalk et a/ 1996, who adapted the figure from Waldherr et a/ 1993. Waldherr ei a/ show no point 
mutations beyond 600 residues. (Adapted from Schalk et a/ 1996) 
The REP/GDI superfamily is defined primarily by conserved structural 
elements involved in complex formation with Rabs, as shown in figure 1.15. These 
have been conserved throughout eukaryotic evolution, with REP orthologues 
identified in yeast (Waldherr et al 1993) and plants (Hala et al 2005). Most of SCRI 
is buried within the core of domain I and forms the core structural scaffold. SCR2 
covers the hydrophobic regions involved in Rab C terminus coordination and 
geranylgeranyl lipid binding. lt also includes helix D and helix E of domain Il, which 
interact with RabGGTase in REPs. The residues of the extreme N-terminus and 
SCR3 fold back together to form the structural elements responsible for Rab 
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recognition and membrane delivery, encompassing the Rab Binding Platform and 
Mobile Effector Loop. The most striking difference between REPs and GDIs is a 
REP specific insert between SCRI and SCR2 of domain I. Its function remains 
unknown and its structure is not resolved in structures published to date (Schalk et al 
1996; Rak et al 2004). 
1.5.4.3 REP: Rab complex 
There are two regions of contact between Rab7 and REP-1, the Rab Binding 
Platform (RBP) and the C terminus Binding Region (CBR) (Rak et al 2004; figure 
1. I5). The globular domain of Rab7 interacts with the RBP, a motif conserved 
between members of the REP/GDI superfamily. 
(a) 
F 
Cterm 
Figure 1.15: Structure of the REP-1: Rab7 complex (a) Ribbon diagram of REP-1 (blue) bound to 
Rab7 (yellow). C terminus of Rab7 is bound by a hydrophobic pocket within domain II of REP-l. 
REP-1 Domain I, blue; Domain II, grey; RBR, Rab Binding Platform (red); CBR, Cterminal Binding 
Region (orange) Geranylgeranyl lipid is red ball and stick. 
(b) Rab binding elements of REP-l. Residues involved in complex formation with Rab7 are coloured 
according to their conservation within the Rep/GDI superfamily. Invariant residues - blue; Conserved 
residues - green; REP-1 specific residues - red. (Adapted from Rak et a12004) 
In addition to the RBP, the Rab C-terminus coordinates with the CBR of 
REP-l. Interaction occurs within a hydrophobic cavity, where hydrophobic C- 
terminal side chains interact with main-chain hydrogen bonds. The diversity of Rab 
C-terminal sequences precludes direct interaction with the Rab side chains. Fixation 
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of the Rab C-terminus within the CBR is essential for prenylation to occur. Within 
the ternary catalytic complex, this orientates the Rab carboxyl cysteines towards the 
RabGGTase active site. To maintain solubility of REP-l, its C-terminus acts as a lid 
over the hydrophobic pocket and any isoprenoids contained within. 
The RBP and CBR are composed of residues invariant between REP and GDI 
proteins. Surrounding residues are conserved within the REP/GDI superfamily, while 
the REP-I specific residues are located at the REP: Rab7 interface (see figure 1.15b). 
1.5.4.4 REP: RabGGTase complex 
The structure of the REP: RabGGTase complex has been solved (Pylypenko 
et at 2003). While the structures within REP domain I recognise Rabs, REP domain 
II is the site of the REP: RabGGTase interface. Contact occurs between RabGGTase 
cc-subunit helices 8,10 and 12, and helices D and E of REP-I domain II (figure 1.16). 
RabGGTase undergoes a conformational change upon binding of prenyl lipids to its 
active site, thus allowing allosteric regulation of affinity for REP. A long range 
intramolecular signalling event displaces RabGGTase helix 8 at the REP binding 
site, enabling the highly conserved REP F279 residue to form hydrophobic 
interactions with side chains lining the cleft between helices 8 and 10 of 
RabGGTase. Additionally, the highly conserved REP R290 forms hydrogen bonds 
with F220 and T22I of RabGGTase. 
REP-1 
r ,,,, I 
RabGGTase 
Figure 1.16 Stucture of the REP-1: RabGGTase complex (left) and co-ordination of conserved 
REP-I residues at the REP-1: RabGGTase interface (right). REP-1 is coloured blue; RabGGTase 
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a-subunit shown in green, ß subunit in grey, pink and orange. Red ball and stick represents bound 
farnesyl lipid. Superimposition of GDI (turquoise) onto REP-1 (white) shows REP specific F279 
protrudes into cleft between RabGGTase (yellow) helices 8 and 10, whereas GDI specific F143 
clashes with RabGGTase binding site. (Adapted from Pylypenko et al 2003 and Leung et a/ 2006) 
The essential role of F279 in complex formation is demonstrated by the 
failure of REP-I F279A to interact with RabGGTase. F279 is conserved throughout 
all eukaryotic REPs. GDI is unable to substitute for REP in the prenylation reaction 
as it is unable to bind RabGGTase. The conserved, GDI-specific F135 residue 
clashes with RabGGTase residues at the REP binding site (Pylypenko et al 2003). In 
REP, this position is occupied by a conserved valine. R290 was previously identified 
as essential for interaction between the yeast homologs of REP and RabGGTase 
(Alory & Balch 2000). Helices D and E of domain 11 are highly conserved within 
REPs but not GDIs, due to their interaction with RabGGTase. 
Ral 
Ctermini 
RabGGTase 
0 subunit 
Rau 
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RBP 
REP Domain I 
CBR 
41 
Figure 1.17: Proposed ternary complex structure Unprenylated Rab shown in yellow. Following 
prenylation. the Rab C-terminus migrates to a lipophilic cavity within REP. The proposed position of 
a prenylated Rab C-terminus within REP lipid binding region is shown in pink. The RabGGTase 
active site is occupied by lipid (red ball and stick); RabGGTase a-subunit shown in sky blue, ß- 
subunit in green. (From Rak et al 2004) 
The structure of the catalytic ternary Rab: REP-I: RabGGTase complex has 
been predicted from the structures solved to date (shown in figure 1.17), and the 
following model of the prenylation reaction proposed (Rak et al 2004). Unprenylated 
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Rabs are recognised by the Rab Binding Platform on REP-1. The Rab C terminus is 
threaded through a hydrophobic pocket within REP towards the RabGGTase active 
site, which catalyses covalent attachment of prenyl lipids. Then, binding of further 
GGpp to the RabGGTase active site inverts the conformational change within 
RabGGTase and expels prenylated Rab from the active site. The prenyl group(s) 
migrate to a hydrophobic cavity within REP-1 domain II. Enlargement of the pocket 
to accommodate the lipid separates REP helices D and E, displacing F279 and R290 
at the REP-1: RabGGTase binding site. This decreases REP: RabGGTase affinity and 
frees the REP: Rab complex. 
1.5.5 Efficiency of Rab prenylation 
Following elucidation of the structure of the Rab7: REP-1 complex, direct 
comparison between REP-1 and REP-2 structural features could be made (Rak et al 
2004). Only two positional changes between the REPs map to Rab binding areas. An 
A252V substitution is unlikely to affect Rab binding as only a main chain oxygen is 
involved in hydrogen bonding to Rab L192. The Y365F substitution was also 
investigated; but REP-1 Y365F and REP-2 F370Y mutants showed wild-type affinity 
levels for Rab7 (known to be an efficient prenylation substrate), and Rab prenylation 
was unaffected. Using a substrate with lower prenylation efficiency, such as Rab27a 
or Rab3, could further our understanding of the factors controlling REP-2: Rab 
interaction. 
REP-1 and REP-2 are equally efficient in allowing RabGGTase to prenylate 
Rabla, Rab5a and Rab6 (Cremers et al 1994). However when Rab3 is the substrate, 
REP-1 is four-fold more active than REP-2. Overall, Rab3 family proteins are poorer 
substrates than CC Rabs for prenylation, but the effect is exacerbated with REP-2. 
This is not solely due to differences in the prenylation motif, as CXC is common to 
Rab3 and Rab6. Only six residues along the REP binding surface are non-conserved 
between Rabla, Rab7 and Rab27a, suggesting overall Rab: REP affinity results from 
numerous small factors influencing the geometry and flexibility of individual Rab 
proteins (Rak et al 2004). 
Differences in Rab prenylation seem to arise from variation in catalytic 
efficiency, rather than the affinity of Rabs for the catalytic enzymes REP and 
RabGGTase. The binding affinities of Rabla and Rab27a for REP-1 and REP-2 are 
not significantly different (Larijani et al 2003). Furthermore, the REP-1: Rab27a 
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complex has higher affinity for RabGGTase than REP-2: Rab27a, 
implying substrate 
selectively occurs during formation of the ternary RabGGTase: REP: Rab complex. 
Functional studies of Rab27a prenylation with both REP homologs showed 
rates of Rab prenylation differed by only two-fold increase between REP-2 and 
REP- 
1, similar to that observed with Rab7 (Rak et al 2004). These authors also reported 
stronger binding of Rabs to REP-1 than REP-2, and that Rab27a has generally lower 
affinity for both REPs than other Rabs. The presence of eqimolar Rab7 completely 
inhibits prenylation of Rab27a. Hence they conclude Rab27a does not compete 
successfully for REP in choroideremia cells. 
1.5.6 A subset of Rabs remain unprenylated in choroideremia 
Choroideremia patients suffer a deficiency of REP-1 activity, as 
demonstrated by the restoration of RabGGTase activity to CHM lymphoblast 
extracts by addition of purified REP-1 (Seabra et al 1993a). This leads to the 
accumulation of unprenylated Rabs, including Rab27a, in the cytosol where they are 
unable to function correctly (Alory & Balch 2000, Seabra et al 1995, Tolmachova et 
al 2006). The severity of choroideremia is limited to an eye phenotype as REP-2 
partly compensates for the loss of REP-1 function. However REP-2 displays varying 
substrate specificity; prenylation of Rab3A, a component of neural synaptic vesicles, 
in CHM lymphoblasts is only 25% of normal levels. The absence of a neurological 
phenotype in choroideremia implies that 25% of normal Rab3A prenylation must be 
sufficient for synaptic vesicle function. 
This variation in Rab prenylation was proposed to underlie the disease 
mechanism of choroideremia. Given the high rates of membrane turnover within the 
photoreceptors and RPE, (Berman 1991) these tissues may be unusually sensitive to 
a defect in Rab prenylation if they require Rabs that depend preferentially on REP-1 
for prenylation. 
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Figure 1.18 A subset of Rabs remain underprenylated in the absence of REP-1 
Efforts were made to identify Rabs that may be selectively underprenylated 
by REP-2, and thus could have a role in molecular pathology of choroideremia 
(figure 1.18). Unprenylated Rab27a selectively accumulates in the cytosol of CHM 
lymphoblasts, such that only 20-30% of the total protein remains in the membrane 
fraction (Seabra et al 1995). Rab27a has shown lower affinity for REP- I and REP-2 
than other Rabs tested (Cremers et al 1994). This has led to the current hypothesis 
that choroideremia develops due to an inability of Rab27a to compete with other 
Rabs for prenylation in CHM cells, where REP-1 is missing. 
Indeed, Rab27a is highly expressed in the RPE and choroiocapillaris, which 
degenerate in choroideremia. Rab27a is also expressed in the intestine, pancreas and 
spleen. Photoreceptors did not show significant levels of Rab27a expression. Cells of 
the RPE and choriocapillaris are particularly sensitive to inactivation of Rab27a. 
Investigations continue into the functional role that Rab27a plays in these tissues. 
Some evidence was seen that other Rabs may accumulate unprenylated in CHM 
cells, although they have not been identified to date (Seabra et al 1995, Tolmachova 
et a12006) 
Interestingly, Rab27a is the only Rab specifically implicated in human 
genetic disease to date. Griscelli Syndrome, a rare autosomal recessive disorder 
results from defects in the RAB27A gene. Patients have silvery hair, caused by 
accumulation of pigment in melanocytes, and heterogeneous immune deficiency, 
owing to uncontrolled T-cell and macrophage activation. Normally, Rab27a localises 
to the melanosomes and cytolytic granules (Seabra et a! 2002b). 
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Recently, Rab27a has been shown to regulate melanosome distribution in the 
RPE, allowing the melanosomes to migrate to the apical processes of RPE cells 
(Futter et al 2004). In the ashen mouse, which lacks Rab27a, melanosomes are 
excluded from the apical processes of RPE cells. It is possible that failure of 
melanosomes to move to the apical processes of RPE cells in CHM patients may 
contribute to retinal degeneration, by reducing protection of photoreceptor outer 
segments from light damage. Rab27a may also play a role in phagosome maturation 
(Futter 2006). Indeed, impaired phagocytosis of photoreceptor outer segments by 
CHM RPE cells compromises photoreceptor function. Additionally, accumulation of 
undegraded material in the RPE damages RPE function, reinforcing photoreceptor 
damage. 
Several possible models have been proposed to explain the tissue specificity 
of choroideremia. Other tissues that employ Rab27a are unaffected in choroideremia 
patients, so at least some Rab27a must be prenylated in these patients, which must be 
sufficient for proper function of non-retinal tissues. The trafficking pathways which 
require Rab27a may not be essential in other tissues, and hence their function is not 
impaired. There may be a greater requirement for Rab27a function in the retina, or 
Rab27a may experience greater competition for prenylation in the presence of more 
Rabs, or less REP-2. Speculation remains as to the molecular mechanisms underlying 
the degeneration of the photoreceptors, RPE and choroid. 
1.6 Animal Models for Choroideremia 
The slow clinical development of choroideremia, combined with genetic 
diagnosis, makes choroideremia an attractive candidate for ocular gene therapy 
intervention. A faithful animal model of human disease is required for preliminary 
testing. 
1.6.1 The Choroideremia Mouse 
Initial attempts to generate a REP-1 null mouse failed owing to lethality of 
the mutation when transmitted through the female germline (van den Hurk et al 
1997). Death occurred in utero in hemizygous males and heterozygous females that 
had inherited the mutant allele from their mother (due to preferential inactivation of 
the paternal X chromosome in mice), suggesting a requirement for REP-1 in murine 
extra-embryonic tissues. Further investigation revealed severe growth retardation by 
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E9.5, especially in hemizygous males, and severe defects in vasculogenesis in the 
early embryo. Death occurred by El 1.5. Thus REP-1 is implicated as essential for 
murine trophoblast development and vascularisation of the yolk sac and placenta 
(Shi et al 2004). Carrier females were established and showed photoreceptor cell 
degeneration, encouraging further attempts to engineer a conditional knock out of 
REP-1. 
A sophisticated conditional knock out approach was utilised to generate a 
choroideremia mouse model suitable for gene therapy studies (Tolmachova et al 
2006). Generation of males with an inducable Chm allele allowed induction of the 
mutation in the germline in adulthood. When mated with WT females, viable female 
carriers were created by avoiding transmission of the Chm allele through the 
maternal germline. 
Analysis of the prenylation status of Rabs in mice carrying null alleles 
showed 50% of Rabs to be in the cytosolic fraction. No significant shift in 
subcellular localisation was seen for Rab8 and Rabl1. This was confirmed by in 
vitro prenylation assays, which showed underprenylated Rabs in cytosolic extracts 
from the eyes of general knockout Chm"" mice. Additionally, in vitro prenylation 
assays of cytosolic fractions from RPE-specific and neural retina-specific tissue 
restricted knockouts produced markedly different patterns of unprenylated Rabs. 
This suggests that different Rabs may underlie independent molecular pathology of 
choroideremia in RPE and photoreceptor cells. 
In early development of Chm""1' mice (P17) there is a noticeable delay in 
formation in the outer segments, and the ONL is reduced in thickness, although the 
photoreceptor layer is apparently normal by one month old. Some areas of RPE are 
depigmented at P7 while others appear normal, suggesting Chm knockout causes 
early RPE defects and delays photoreceptor development, but the overall appearance 
of the retina is normal by one month old. 
The Chm"""" mice experience early onset, progressive, retinopathy. Small 
areas of depigmentation are apparent in one month old animals, which were 
noticeable expanded by two months of age. These areas are confluent by four 
months, by which time whitish autofluorescent flecks appear between areas of intact 
retina. These flecks likely represent RPE depigmentation and lipid accumulation. 
Heterozygous-null animals also show reduction in electroretinogram amplitude. 
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Histological analysis revealed the Chm""YwT photoreceptors underwent late- 
onset progressive degeneration. Two-month-old female carriers show slight 
reduction in ONL thickness, from 10-12 to 8-10 nuclei thick. At seven months there 
were on average 7-8 nuclei, and only 5-6 nuclei by eight months. The phenotype in 
eight month old animals was variable between mildly affected areas and areas of 
severe degeneration where only 1-2 nuclei were left. Patchy depigmentation of the 
RPE, thinning of the RPE and frequent abnormal cells proximal to the RPE were 
also observed in Chm""mice but not in controls. Electron microscopy of 
Chm"' mice at nine months showed depigmentation of the basal area of RPE 
cells proximal to wild type morphology of ROSs; whereas severely depigmented 
RPE cells are adjacent. Conversely, further pigmented RPE cells are adjacent to 
severely degenerated photoreceptors, suggesting there is no direct correlation 
between photoreceptor degeneration and depigmentation of the RPE, and that these 
processes may be independent. 
Analysis of the tissue restricted knockouts expressing no REP-1 in the RPE 
(induced with tamoxifen at 6-8 weeks old) showed RPE degeneration without 
deleterious effects on the photoreceptors up to 14 months after induction, while the 
RPE showed changes consistent with Chm""" phenotype. Conversely, knockouts 
restricted to the neural retina exhibited photoreceptor damage: shorter outer 
segments and fewer nuclei in the ONL relative to controls within two months of 
induction, and mild RPE damage consistent with secondary changes following 
photoreceptor death (as seen in other mouse models for photoreceptor disease). 
Taken together, these results reflect independent degeneration of the photoreceptors 
and RPE, suggesting a cell autonomous pathology. Later mild secondary effects 
arise from the supportive role of the RPE towards the photoreceptors. Clinical 
management of choroideremia should therefore target both the RPE and 
photoreceptor cell types. 
1.6.2 The Choroideremia Zebrafish 
A choroideremia mutation has been isolated in zebrafish, in a gene 
homologous to human REP-1 (Starr et al 2004). The ru848 strain has a nonsense 
mutation (CAA 4 TAA), truncating the REP-1 polypeptide at codon 33. The 
phenotype shows recessive inheritance, and is lethal after six days. This was the first 
successful animal knockout of REP-1 reported. 
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Choroideremia fish were generated by random chemical mutagenesis with N- 
ethyl-N-nitrosourea (ENU) and identified in a screen for hearing defects. At 5 days 
post-fertilisation (dpf) mutants failed to respond to acoustic stimuli despite avoiding 
touch stimulus. They also had defective swimming behaviour, moving in circles or 
with a corkscrew motion. 
By 5dpf, the mutants have an uninflated swim bladder, noticeably smaller 
eyes and irregular eye pigmentation, characterised by patchy iridiphore distribution 
(figure 1.19). Oedema of the heart and abdomen was reported from 5dpf onwards. 
Mutants began to die from 5dpf. Although incapable of movement to the surface for 
feeding, death was not caused by starvation as wild-type fish can survive ten days 
without food. 
Figure 1.19 Wild-type and Choroidermia zebrafish at 5dpf Incident illumination (B) shows 
smaller eyes and sparse reflective iridiphores in mutants. Scale bars = 500µm (From Starr et al 2004) 
The neuromasts are sensory organs comprised of multiple hair cells, and are 
responsible for mechanotransduction in aquatic vertebrates (Nusslein-Volhard & 
Dahm, 2002). Mutant fish have only two of the eight neuromasts, and the hair 
bundles were degenerate or completely absent. The hair cells develop normally but 
degenerate from 30hpf onwards, with fewer hair cells from 60 hours post fertilisation 
(hpf), suggesting a role for REP-1 in hair cell survival. Starr et at observed that the 
first two neuromasts to differentiate are the same two which remain at 5dpf; the 
remaining hair cells are in the centre of these neuromasts, corresponding to the tether 
cells which are among the first cells to differentiate in the inner ear. Therefore they 
speculated that the oldest hair cells are most stable, possibly because they receive 
full-length REP-I protein translated from maternal RNA. 
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Figure 1.20 Transmission electron micrograph of wild-type (a) and chm (b) outer retina at 5dpf 
Mutant retina shows dishevelled outer segments and RPE to be hypertrophic and disorganised. 
Arrowhead indicates cytoplasmic inclusion in RPE cell. OS, Outer Segments; PEN, Pigment 
Epithelial Nucleus; CL, Choroid Layer; Scale bars = 5µm (From Starr et a! 2004) 
The retinal phenotype was described from electron microscopy images of the 
outer retina at 5dpf, as depicted in figure 1.20. Starr et al reported that the retinal 
layers were disrupted in mutants. The RPE was particularly disordered, with some 
cells invading the ONL. Small, dense, presumably pyknotic cells were present 
throughout the neural retina. Additional degeneration occurred on the posterior 
surface of the developing lens. Discrete cytoplasmic inclusions, comprising around 
ten well organized laminae, were observed in RPE cells and putative Schwann cells 
of the developing otic ganglion. Each structure was surrounded by a lightly stained, 
amorphous mass, but no bounding membrane was present. Starr et al speculate that 
the inclusions may be accumulations of unprenylated Rabs, or other proteins whose 
processing is interrupted. 
Mutant fish were rescued by injection of wild-type REP-1 RNA; conversely 
morpholino knock down of REP-1 in wild-type embryos produced the choroideremia 
phenotype. Thus REP-1 mutation was confirmed as responsible for the 
choroideremia phenotype in zebrafish. 
REP-1 RNA was detected in all adult zebrafish tissues tested by Starr et al: 
skeletal muscle, heart, liver, ovary, testis and eye; corresponding with ubiquitous 
expression of REP-I in mammals (Desnoyers et al 1996) They also found REP-1 to 
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be expressed in wild-type zebrafish embryos at 2hpf, before embryos start 
transcribing their own RNA. No investigations were made into REP-1 expression in 
choroideremia fish. 
During their research, Starr et al did not find evidence of a second REP in the 
zebrafish or pufferfish Fugu rubripes genome; however these databases were 
incomplete at the time. They also saw no evidence of exon skipping in the REP-1 
gene, which could remove the nonsense mutation. Therefore, they propose that 
specificity of the choroideremia phenotype for hair cells in zebrafish may relate to a 
susceptibility to low levels of prenylated Rabs in these cells, whereas other cell types 
can maintain some function from Rabs prenylated by maternal transcripts in the very 
early embryo. 
Overall, the retinal phenotype of the choroideremia zebrafish shows 
remarkable similarities to human disease, with degeneration of the photoreceptors 
and RPE. The focus of this study was the auditory system, while the visual system 
demands further characterisation in light of its relevance for the study of human 
choroideremia disease. 
1.6.3 Advantages of zebrafish as a model for choroideremia 
The zebrafish holds several advantages over the mouse for study of 
choroideremia, and the vertebrate retina in general (Goldsmith 2001; Goldsmith & 
Harris 2003). Fish have a shorter generation time than mice, reaching sexual maturity 
within three months, and each breeding pair can produce several hundred eggs per 
week. Zebrafish have extremely rapid extrauterine embryogenesis, throughout which 
the embryo remains mostly transparent. The retina is fully differentiated and 
functional by approximately 72hpf. Retinal architecture is similar to humans with a 
similar cone density and colour vision. By contrast mice are nocturnal and hence 
have adopted rod based vision. 
In the context of choroideremia, this offers the opportunity to study the 
choroidal vasculature. It is often difficult to observe the blood vessels directly in 
living embryos due to their opacity or internal development within the mother. Very 
little is currently known about the cellular defects and molecular processes leading to 
choroidal damage in choroideremia. 
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1.7 Zebrafish Development 
1.7.1 General Development 
The zebrafish has become a favoured model for developmental biologists, 
thanks to rapid external development, transparent embryo and prolific breeding. 
Some general features of zebrafish development and characterisation are outlined in 
the following figures. 
Medial Dorsal 
eye 
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Figure 1.21 General orientation of Zebrafish Nasal also referred to as anterior; posterior also 
referred to as temporal or caudal. Given for general reference in descriptive text. 
The zebrafish Danio rerio is a teleost fish of the Cyprinidae family. Native to 
the Ganges and Brahmaputra river systems, zebrafish inhabit tropical freshwater 
habitats, often associated with rice cultivation. Their diet is mainly zooplankton, and 
some algae and insects. Adults may reach 35mm in length. Life span is one year in 
the wild, and between eighteen months and two years in captivity. The life cycle is 
essentially linked to the monsoon season, spawning in shallow water around plant 
roots in response light onset at dawn. Fertilisation is external. 
Due to their small size, embryonic fish receive all their oxygen requirements 
through simple diffusion. Nutrition is obtained from the yolk sac. This structure also 
harbours maternal factors, necessary for all cellular processes that occur before the 
activation of the embryonic genome at the midblastula transition. In zebrafish, this 
occurs between cell cycles 10 and 13, corresponding to the 512 cell stage, at 
approximately 3.3hpf (Kane & Kimmel 1993). A transitional period follows when 
both maternal and embryonic gene products, sometimes derived from the same gene, 
cooperate to run developmental processes. 
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Maternal mRNAs are degraded by embryonic microRNAs at the midblastula 
transition. Some maternal products endure after the midblastula transition; for 
example, maternally derived Tcf-3/Hdl and Lzr/pbx4 are required for anteroposterior 
brain patterning after the midblastula transition (Pelegri 2003). Details of how 
maternally derived factors interact with zygotic gene products remain unknown. 
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Figure 1.22 Early embryonic development of zebrafish Adapted from Kimmel et al 1995 by 
www. kirbylab. duhs. duke. edu/resources 
Zebrafish embryogenesis is completed within 48 hours, and follows well 
defined pattern (figure 1.22) when maintained at standard temperature. Development 
may be slowed by cooling the embryos, most easily by incubating at room 
temperature. Hatching occurs between 48 hpf and 72 hpf, but varies within each 
clutch and hence is of little utility as a developmental staging point. After hatching, 
development of the jaw leads to a recognisable protruding mouth, and the swim 
bladder inflates, as shown in figure 1.23 and figure 1.24. Once inflated, the fish may 
swim vertically through water and commence hunting for food. 
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Figure 1.23 Development during hatching period and early larval stage 48 hpf =2 dpf (a, b); 72 
hpf =3 dpf (c, d) showing progressive lateral lateral movement of yellow pigment with xanthophore 
pigment cell migration and migration of melanophores in lateral stripe; 120 hpf = 5dpf (e, f) showing 
inflated swim bladder and reflective iridiphores on eye and dorsal surfaces. Scale bar = 250µm 
Adapted from Kimmel et a! 1995 
swim bladder 
Figure 1.24 Anatomy of 5dpf zebrafish 
Pigment patterns are diverse amongst the Danio family, but their importance 
within an ecological and behavioural context is poorly understood. Three types of 
pigment cell are found in the zebrafish: melanophores contain melanin and appear 
black, xanthophores contain pteridines and appear yellow, and iridescent iridophores 
coloured by purines (guanine, hypoxanthine and adenine). Melanophores and 
xanthophores differentiate from the neural crest and migrate in a lateral, then 
dorsoventral fashion to produce the larval pigment pattern. 
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The first melanophores develop in the eyes, specifically the RPE, at 24 hpf 
and then extend from the hindbrain in a posterior then ventral direction. At 42hpf the 
first xanthophores are visible as a yellow tinge to the dorsal head. Iridophores appear 
in the eye from 43hpf. At 48hpf, the xanthophores are distinctly yellow, and patches 
of iridophores appear over the abdomen. By 50hpf, the early larval melanophore 
stripes have organised. With the addition of iridophores to the melanophore stripes 
and a strong yellow colouring to the head and tinge to the dorsal surface and flanks, 
larval pigment patterning is complete around 72hpf. The adult pigment pattern of 
alternating stripes of dark melanophores and iridophores and light xanthophores and 
iridophores develops later, during morphogenesis (Quigley & Parichy 2002; Ziegler 
2003; Kelsh 2004). 
Zebrafish larvae adapt their pigmentation in response to light intensity as a 
camouflage method, by expanding or aggregating melanosomes (pigment granules) 
within the melanophores. Retinal ganglion cells project directly into the 
hypothalamus, which signals to the pituitary gland to release antagonistic hormones 
(Balm & Groneveld 1998). Under bright light, hormonal action causes aggregation 
of melanosomes within the melanophore, and the fish appears lighter. Under low 
light, the melansomes are widely distributed across the melanophore, making the 
animal appear darker. Blind fish perceive their environment to be dark, and 
accordingly maintain diffuse melanosomes and so appear darker (Figure 1.25). 
Pigmentation of larvae can therefore be used a surrogate visual assay. 
b 
Figure 1.25 Perceived darkness by blind larvae induces camouflage mechanism (a) Wild-type (b) 
Blind mutant From Goldsmith and Harris 2003 
68 
Introduction 
Transparency of the developing zebrafish embryo allows detailed study of 
vascularisation and angiogenesis. A transgenic fish expressing EGFP under the flil 
promoter (a known endothelial marker) permits detailed analysis of embryonic 
vasculature and vascular defects (figure 1.26) (Lawson & Weinstein 2002). 
Figure 1.26 EG FP expression in the %asculajurc ul list //r: t. (, l /' ttii cuic adult (a) and 7dpf 
larval (b) zebrafish From Lawson & Weinstein 2002 
The teleost lineage underwent a whole genome duplication approximately 
350MYA (Jaillon et al 2004; Christoffels et al 2004; Aparicio 2002). The zebrafish 
diverged from other teleost fishes between II OMYA and I69MYA. The pufferfishes 
Tetraodon nigroviridis and Takifugu rubripes, two popular models for fish genomic 
studies, diverged between 60MYA and 80MYA (Volff 2005). 
1.7.2 Development of the Zebrafish Eye 
The zebrafish retina closely resembles the human retina. They share a similar 
cellular organisation, all major cell types and cone-rich vision (figure 1.27 and 1.28). 
Zebrafish retinogenesis is fast, and they exhibit adult retinal morphology and visual 
response by 3dpf. For these reasons, and its compatibility with genetic studies, the 
zebrafish has become a favoured model for the vertebrate retina. 
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Figure 1.27 Similar retinal structure in humans and zebrafish From Goldsmith and Harris 2003 
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Figure 1.28 Cellular organisation in the zebrafish retina Retinal circuitry is very similar to 
humans, as described in section 1.1. Rod and cone photoreceptors synapse with horizontal and bipolar 
cells in the OPL. Bipolar and amacrine cells synapse with cells of the Ganglion Cell Layer in the IPL. 
Ganglion cells convey signal via the optic nerve to the brain. Glial Muller cells are also present 
throughout the neural retina. From Goldsmith and Harris 2003 
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The most striking difference between human and zebrafish retinas is the 
complexity and organisation of cone photoreceptors in the zebrafish retina. Zebrafish 
have five types of photoreceptors, classified by the spectral sensitivity of their 
opsins: rods, red/green double cones, and blue and UV cones. Rods express 
rhodopsin, long single cones express blue opsin, short single cones express UV 
opsin, and each member of a double cone pair expresses red or green opsins 
(Raymond 1993; Vihtelic 1999). In contrast, mammals have lost all but two opsins 
during the nocturnal stages of their evolution, but some primates including humans 
have re-evolved trichromatic vision (Bowmaker 1998; Bowmaker & Hunt 2006; 
Solomon & Lennie 2007). 
In the human retina cones are concentrated within the macula, whereas cones 
are spread across the whole zebrafish retina, and arrayed with rods in a highly 
ordered mosaic (figure 1.29) (Fadool et al 2003). The outer limiting membrane 
(OLM) is a belt of cell junctions that dissects the photoreceptor cell body, 
subdividing it into apical and baso-lateral domains. In adult zebrafish, rod nuclei are 
localised basal to the OLM and cone nuclei localised apical to it (Branchek & 
Bremiller 1984; Raymond et al 1993; Tsujikawa & Malicki 2004). A region of the 
adult temporal retina becomes particularly cone rich, suggesting that zebrafish have 
highest visual acuity in the anterior visual field (Schmitt & Dowling 1996). 
Figure 1.29: Photoreceptor mosaic in zebraflsh retina Taken in plane of photoreceptors. GFP 
expressing rods (green), immunolabelled UV-sensitive opsin (red), DAPI labelled cone nuclei (blue; 
b, blue-sensitive cone; g, green-sensitive cone; r, red-sensitive cone), merged. From Fadool 2003 
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In the absence of eyelids, fish move melansomes of the RPE to the tips of the 
apical processes to protect the photoreceptor outersegments from free radical 
damage. Albino fish, who lack melanosomes, suffer severe photoreceptor and RPE 
damage if exposed to constant light (Vihtelic et al 2000). 
Morphogenesis of the zebrafish retina is extremely rapid, and complete 
within 72hpf. The optic lobe is defined around 12hpf, the lens appears around 20hpf, 
and the first pigment granules accumulate in the RPE around 24hpf. Ganglion cells 
are the first retinal neurons to become postmitotic, around 28hpf (Malicki 2000). 
Neurogenesis first occurs in an area known as the ventronasal patch; in the lower 
half of the retina, nasal of the optic nerve. Differentiation spreads by cell-cell 
contacts, hence from the ventronasal patch spreads firstly in a nasal direction, then 
dorsal, and finally to the temporal retina (the choroid fissure and optic nerve exit 
block immediate contacts with the temporal retina) (Schmitt & Dowling 1996). All 
retinal cell types differentiate first in the ventronasal patch, and spread in the pattern 
described. Ganglion cells are followed rapidly be neurons of the INL, and then the 
photoreceptors of the ONL (Neumann 2001). 
Photoreceptors arise between 43hpf and 48hpf. UV cones are first to develop 
distinctive morphology, followed by the other cones, and finally rods. Opsins are 
first expressed from 50hpf in the ventronasal patch, already forming the 
characteristic photoreceptor mosaic (Raymond et al 1995). At 60hpf, the first cone 
outer segments develop in the ventral retina. At 74hpf, outer segments develop in the 
dorsal and peripheral margins, and the eye cup becomes elongated along the dorsal- 
ventral axis (Schmitt & Dowling 1996). All photoreceptor cell types are visible by 
morphology by 12dpf (Branchek & Bremiller 1984; Tsujikawa & Malicki 2004; 
Raymond eta! 1995). 
The vast majority of neurons of the central retina are born and organised into 
distinct laminae by 60hpf. Laminae become progressively more stratified as 
neuroepithelial cells differentiate into neurons and glia until 72hpf. The visual 
system becomes functional between 60hpf and 80hpf, as evidenced by optokinetic 
(saccade movement of eyes) and optomotor (ability of fish to position itself in 
midstream in response to visual cues) responses in larvae. (Malicki 2000). 
At the retinal margin, cells remain undifferentiated and neurogenesis 
continues throughout life (Marcus et al 1999). Neuron growth slows rapidly between 
3dpf and 4dpf, concomitant with onset of visual response. Zebrafish photoreceptors 
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follow a central-to-peripheral gradient of maturity, meaning peripheral cells are 
systematically younger than their central neighbours. Retinal cell birth continues in 
the peripheral germinal zone, which extends in a crescent including the dorsal, 
temporal and ventral margins. It is thought that the ability to continually regenerate 
neurons in fish arises from their relatively small size at birth, and hence requirement 
to add further neurons with growth. 
Development of the zebrafish lens is less well characterised than retinal 
development. The lens forms from 20hpf and unlike other vertebrate species, 
delaminates from the surface ectoderm as a solid cluster of cells, at 36hpf (Dahm et 
a! 2007). Cells differentiate into a monolayer of lens epithelial cells and primary lens 
fibre cells, resulting in an embryonic lens nucleus within concentric layers shells of 
lens fibre cells. Secondary fibre cells differentiate between 60hpf and 84hpf into 
organelle-free cells that express crystalline. Placement of the zebrafish lens 
protruding from the eye ball in larval and adult fish suggests that zebrafish maintain 
high-resolution panoramic vision throughout life. The final lens morphology is 
similar to other vertebrate species. The lens contains two cell types: primary lens 
fibres, composing the lens proper, and a surrounding monolayer of lens epithelial 
cells. Cells at the nucleus of the lens are oldest, and growth proceeds 
circumferentially at the perimeter among the fibre cells. However, the differences in 
development limit the use of zebrafish as a model for mammalian lens development 
studies. 
To date, over 545 eye development mutations have been reported, from large 
scale chemical mutagenesis (Malicki et al 1996; Fadool 1997; Malicki & Driever 
1999; Neuhauss et al 1999; Vihtelic & Hyde 2002) and retroviral insertional 
mutagenesis (Golling et al 2002; Armstrong et al 2004; Gross et al 2005) screens. 
These may be broadly classified as disorders of growth retardation, neuronal 
patterning and retinal lamination, photoreceptors, RPE, lens, peripheral margin, 
retinal containment (blowout mutants), cyclopia, behaviour (failure to responds to 
visual assays despite normal retinal morphology), and non-specific retinal 
degeneration. This last class may well arise from mutation in an essential 
housekeeping gene. In all photoreceptor mutants identified, the photoreceptors 
initially differentiate successfully, but degenerate in later stages of development. As 
the photoreceptors occupy a significant proportion of the eye, photoreceptor death 
may be identified as a reduction in eye size (Tsujikawa & Malicki 2001). 
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Forward genetics and insertional mutagenesis approaches have led to 
identification of mutated genes (Schonthaler et al 2005; Starr et al 2004; Bahadori et 
al 2006; Lieschke & Currie 2007), opening novel avenues of investigation for 
human disease. 
Transgenic approaches are extremely useful for studying gene expression and 
function in embryos. Microinjection of early embryos with either mRNA or 
antisense morpholino oligonucleotides results in transient gene overexpression and 
knockdown respectively (Nasevicius & Ekker 2000). Stable lines of transgenic fish 
expressing fluorescent reporter proteins, such as theii: EGFP and rhodopsin: EGFP 
lines, can be used to visualise developmental processes in tissues of interest (Lawson 
& Weinstein 2002; Perkins et al 2002; Fadool 2003). Transplantation of blastomeres 
from mutant into wild-type embryos allows study of cell-autonomous and non-cell 
autonomous phenotypes by looking for rescue of mutant cells in a wild-type 
environment. For example, photoreceptor death was both cell autonomous and 
nonautonomous ebony mutants, but strikingly nonautonomous in ivory mutants. 
Rescue of ivory mutants is facilitated by a long-range diffusible factor within the 
retina (Goldsmith et a! 2003). 
1.8 Outstanding issues surrounding Choroideremia 
The molecular trigger for choroideremia disease is not yet fully understood. 
In choroideremia patients, Rab prenylation requirements are partly fulfilled by REP- 
2. However a subset of Rabs, including Rab27a, has lower affinity for the 
prenylation machinery, and are retained in the cytosol unprenylated and therefore 
unable to function. How reduced levels of prenylated Rab27a lead to retinal disease, 
and whether other Rabs are also involved, remains unclear. In addition, the cell type 
harbouring the primary site of choroideremia pathology remains debated. The rod 
photoreceptors, RPE and choroid have all been implicated in disease pathology. It is 
unknown if cells types degenerate independently, or given their interdependent 
functions, through a cascade mechanism. Study of the early stages of RPE and 
photoreceptor degeneration would give greater understanding of the origin of 
widespread retinal degeneration. 
Syed et al (2001) performed histological studies on a female choroideremia 
carrier. They observed independent loss of photoreceptors and RPE, and 
degeneration of the choroid only in areas where the underlying tissues were severely 
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damaged. Immunocytochemistry with a REP-1 antibody showed the protein is 
present in the cytoplasm of rods but not cones; these authors therefore suggested the 
rod photoreceptors to be the primary site of disease. 
Flannery et al observed a heterozygous female carrier of choroideremia 
(Flannery et al 1990). They reported abnormal appearance of RPE throughout the 
eye, even in areas adjacent to normal choroid and neural retina; hence they supposed 
the RPE to be the site of primary damage, but acknowledged they had no conclusive 
evidence for this hypothesis. Another study reported primary changes in the 
choroidal capillaries, but concluded the RPE was the likely site of disease (Cameron 
et al 1987). 
To date, no study has focused on the histological changes to the choroid, and 
little is known about its role in choroideremia pathogenesis. The zebrafish system 
offers the possibility of creating a double mutant, expressing GFP as a vascular 
reporter and displaying the choroideremia phenotype. Successful generation of this 
model would allow the first detailed in vivo analysis of development and 
degeneration of the choroiocapillaris in choroideremia. 
Independent loss of photoreceptors and RPE is again observed in the 
conditional knock-out choroideremia mouse model (Tolmachova et al 2006), 
suggesting that choroideremia degeneration is a cell-autonomous process. However, 
following the completion of my current study, Krock et al published findings from 
the choroideremia zebrafish model, concluding that degeneration of choroideremia 
zebrafish retina is non cell autonomous (Krock et a! 2007). 
My thesis primarily aims to characterise the progression of retinal 
degeneration of the choroideremia zebrafish and assess its suitability as a model for 
human choroideremia disease. All methods used in this thesis are described in 
Chapter Two. 
Chapter Three describes studies of the cellular responses to the pathogenic 
R345W mutation in fibulin-3. I examined the subcellular localisation and trafficking 
of fibulin-3, and also the pathogenic effects of R345W fibulin-3 to aid understanding 
of the disease mechanisms in Dominant Drusen maculopathy. This work is discussed 
in light of the publication of a link between fibulin-3 mutation and VEGF 
upregulation (Roybal et a! 2005). 
In Chapter Four, I describe the development of our genotyping protocols for 
the identification of heterozygous and homozygous fish. I report the attempts to 
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generate a choroideremia mutant line expressing the fli1: EFGP reporter gene, to give 
the first description of the choroidal vasculature in an animal model of 
choroideremia. The choroideremia zebrafish retinal phenotype is described in detail 
through histological examination of mutant retinas. I also characterised the progress 
of the choroideremia degeneration from 48hpf in the fish as a whole, and focusing on 
the retinal degeneration. 
Chapter Five comprises a bioinformatic study of REP protein evolution in the 
vertebrates, with particular emphasis on the fishes. I extended this analysis to cover 
the eutherian and metatherian mammals in detail following the recent publication of 
the first marsupial genome, providing interesting insights into the evolution of 
mammalian REP-2. 
The functionality of REP in the choroideremia zebrafish is investigated in 
Chapter Six. The genetic content of the embryonic fish and yolk sac are studied to 
assess the maternal contribution to mutant survival. I report the development of a 
functional assay using zebrafish protein extracts as a source of REP to measure the 
level of REP activity in the choroideremia zebrafish. Zebrafish cytosolic extracts are 
also used as a source of Rabs to assay the extent of unprenylated Rabs in 5dpf 
choroideremia fish. 
Finally, I discuss the implications of my results as a whole. The results of my 
study lead us to contest the theories put forward to date regarding the source of 
retinal degeneration in choroideremia zebrafish. I propose an alternative explanation 
for the choroideremia phenotype in zebrafish, with implications for its use as a model 
system for human disease. 
76 
Chapter Two 
Materials & Methods 
Materials & Methods 
2.1 Aquaculture Methods 
2.1.1 Aquaculture 
Zebrafish were housed in 3L tanks holding up to 20 fish per tank, on a 
Aquatic Habitat Stand Alone Aquaria, that provides a constant flow of fresh water. 
Fish water was prepared four parts distilled H2O to one part tap water. Water 
temperature was maintained between 27°C and 28.5°C. Tanks were cleaned regularly 
to prevent growth of algae. Fish were monitored twice daily and any ill fish isolated 
to prevent spread of infection. Fish were euthanized in tricaine solution (Sigma). The 
day-night cycle was controlled with an automatic timer on the light switch (14hr 
light/10 hour dark). Fish were fed live brine shrimp twice daily, supplemented with 
flake food or blood worm when breeding (ZM Systems). 
Before breeding, roughly equal numbers of male and female fish were placed 
in plastic breeding boxes with plastic plants to replicate natural breeding conditions. 
Breeding boxes have mesh bottoms allowing eggs to fall to the bottom of the tank 
and prevent adult fish eating embryos. One hour after "dawn", fish were removed 
from breeding boxes and eggs collected by siphoning water through a plastic tea- 
strainer. Eggs were transferred to Petri dish and maintained in clean fish water. After 
6 hours, unfertilised eggs were removed to prevent rotting eggs retarding growth of 
fertile embryos. As embryos hatched, chorions were removed to prevent growth of 
parasites that may attack embryos. 
After five days, larval fish were transferred to large plastic boxes containing 
5mm fish water, and feeding commenced with a very small pinch of baby powder 
(ZM Systems) once daily. Water levels in the tank were increased daily by adding 
fresh water. After ten days young fish were transferred to the system, although water 
flows were kept very low to avoid harming fish. After 14 days, the diet was 
supplemented with several drops of live brine shrimp. After 21 days, or once all fish 
had ceased surface feeding, fish were placed on brine shrimp only diet. As fish grew, 
the filters within the tank were replaced with larger filters. Zebrafish generally reach 
sexual maturity within three months. 
2.1.2 Imaging of Zebrafish Embryos 
Zebrafish embryos were fixed in 4% paraformaldehyde-PBS solution 
overnight, then transferred to 0.1% sodium azide - PBS for storage. Fish were 
mounted in speciwrap histology paper and serially dehydrated through 10 minute 
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washes in 50% ethanol, 70% ethanol, 90% ethanol, and 3x 100% ethanol, before 
transfer to oil of cedarwood. A sectioning service was kindly provided by Lorraine 
Lawrence. Haematoxylin and Eosin (H&E) stained wax sections were imaged with a 
digital camera mounted on an Olympus 1x71 microscope, and a Olympus AX70 
wide-field microscope. Live zebrafish were imaged throughout development using a 
Nikon SMZ1500 live imaging microscope system. 
2.1.3 Finclipping Adults 
Adult fish were anaesthetised by immersing in tricaine solution for up to one 
minute. The caudal fin tip was carefully removed with a scalpel, and the fish returned 
to several washes of fresh fish water. Fish were kept in individual tanks with water 
changed daily to prevent infection while their wounds healed. 
2.1.4 Dissection of Embryos 
Zebrafish embryos were euthanised in tricaine solution, and yolk sacs were 
removed using 25G hypodermic syringe as a "scalpel". Alternative approaches using 
micropipette needles and surgical scalpels were unsuccessful. 
2.2 Bacterial techniques 
2.2.1 Transformation of competent Escherichia coli cells 
XL-10 Ultracompetent E. coli cells (Stratagene) were thawed on ice. 20 µl of 
XL-10 cells were incubated with 1 µl ß-mercaptoethanol (stratagene) for 5 mins 
before DNA samples were added to a concentration of -1 ng/pl. The cells were 
incubated for 30 mins on ice, heat shocked at 42°C for 45 seconds and placed on ice 
for 2 min. 100 µl of LB medium was added and the cells were allowed to recover for 
1 hr in a 37°C incubator with agitation at 300 rpm. Samples were plated onto LB agar 
plates, containing appropriate antibiotic (50 µg/ml ampicillin or 33 µg/ml 
kanamycin) and incubated inverted at 37°C for 12-16 hrs. Colonies of transformed 
cells were then selected to grow in 2ml LB broth with the appropriate antibiotic at 
37°C for 8 hours. Glycerol stocks of the transformed bacteria were made by adding 
750µl of bacterial culture with 500µ1 of 50% glycerol and stored at -80°C. 
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2.2.2 Small scale preparation of DNA 
E. coli transformed with plasmid constructs were grown overnight in LB 
Broth containing 25µg/mL kanamycin for GFP-constructs and pDsRed2-C1, and 
25µg/mL ampicillin for pcDNA4 (Invitrogen) constructs. Plasmid DNA was 
harvested using a Qiagen midiprep kit as per manufacturer's instructions. Purified 
DNA was resuspended in 200µL dH2O, and DNA yield was calculated by 
spectrophotometry. Constructs were validated by HpaII digest to confirm the 
presence or absence of the R345W mutation. 
2.3 Tissue Culture methods 
2.3.1 Cell culture 
Cells were incubated in a humidified incubator at 37°C with 10% C02. 
COS7, HeLa, HEK293 and ARPE-19 cells were grown in Dulbecco's Modified 
Eagle's Medium (DMEM) (Invitrogen) supplemented with 10% fetal calf serum 
(PAA laboratories), 100 units/mL penicillin/streptomycin (Sigma), 2mM L- 
Glutamine (Sigma) at 37°C with 5% CO2. 
2.3.2 Passaging of adherent cell lines 
Cells were washed with PBS, then incubated with 2mL Trypsin/EDTA (1X) 
per T75 culture (Life Technologies), and dishes were agitated to dislodge the cells. 
Trypsin was quenched by the addition of 15m1 complete medium and cells were 
pelleted by centrifugation at 1000 g for 5 mins. The pellet was resuspended in 10 ml 
complete media, and the cells were plated at the appropriate dilution in full medium. 
2.3.3 Preparation of cell stocks 
Cells were washed in PBS incubated with 2mL Trypsin/EDTA (1X) per T75 
culture (Life Technologies) until cells were dislodged. Trypsin was quenched by the 
addition of 15m1 complete medium and cells were pelleted by centrifugation at 1000 
g for 5 mins. The pellet was resuspended in lml complete media supplemented with 
10% (v/v) dimethyl sulfoxide (DMSO), aliquoted into cryotubes and stored at -80°C 
for 24 hours, before transferring to liquid nitrogen for storage. 
To thaw cells rapidly, frozen cryotubes were placed in a 37°C water-bath 
until cells had thawed. Cells were resuspended in 10 ml complete medium 
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centrifuged at 1000 g for 5mins. The supernatant containing DMSO was removed 
and cells were plated in fresh complete medium. 
2.3.4 Transient transfections 
Cells were seeded onto coverslips in 24 well plates as required and 
transfected at 50% confluency. Tranfection was performed using Lipofectamine 
(Invitrogen) as per the manufacturer's protocol. To allow formation of complexes, 
1µg plasmid DNA per well was incubated in and 5% Lipofectamine in OPTI-MEM 1 
(Invitrogen) for 30minutes at room temperature. Complexes were diluted to 200µL 
per well in OPTI-MEM before adding dropwise onto cells. Cells were incubated for 
5 hours at 37°C, then medium was replaced with DMEM supplemented with 10% 
fetal calf serum. Media was replaced with complete culture medium after 24 hours, 
and fresh media applied every 48 hours thereafter. Cells were transfected with empty 
vector and untransfected as negative controls for each experiment. 
Co-transfections for were performed as above, but substituting for 0.5µg 
DsRed plus 0.5µg non-GFP mutant, wild-type or vector only constructs. 
2.3.5 Immunocytochemistry and confocal microscopy 
After transfection with plasmid constructs, the medium was removed and 
cells were washed with PBS. Cells were permeabilised using permeabilisation buffer 
(80mM KPIPES pH 6.8,5mM EGTA, 1mM MgCl2,0.05% (w/v) saponin) for 5 
minutes and were then fixed in 3% (w/v) paraformaldehyde in PBS for 15 minutes. 
Excess fixative was removed by washing 3 times in PBS. The coverslips were 
mounted onto microscope slides using Vectashield Hardset mounting medium 
(Vectalab). 
For immuno-detection, the cells were further incubated in 50mM NH4Cl for 
10 minutes to block free aldehyde groups which may react non-specifically with the 
antibodies. The coverslips were then incubated in PBS containing 0.5% (w/v) BSA 
and 0.05% (w/v) saponin for 15 minutes (Blocking solution). Cells were then 
incubated with primary antibodies diluted in Blocking solution for 1 hour, followed 
by 5 washes in Blocking solution to remove any surplus antibody. Cells were 
incubated in the secondary antibody diluted in Blocking solution for a further hour, 
before repeated washing and mounting as before. 
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Samples were observed using a Leica DM-IRBE confocal microscope. 
Images were processed using Leica software associated with the microscope. The 
settings on the confocal microscope used to capture these images were maintained 
throughout the experiment, and so these images within each figure can be internally 
compared. Cells were transfected with untransfected and empty vector as controls. 
2.3.6 Temperature Block Assay 
Cells were grown overnight on coverslips in 24-well plates. Transfection of cells was 
performed as detailed above for 4 hours. The transfection medium was then replaced 
with complete medium supplemented with 20mM HEPES buffer and cells were 
placed at 20°C for 3 hours to block exit of protein from the Golgi. Cells may be fixed 
at this point or they may be further incubated at 37°C for 1 hour to remove the block 
and allow recovery. 
2.3.7 Cell Survival Assay 
Cells were transiently co-transfected with pDsRed2-C21 vector, and either 
fibulin-3 WT, or R345W empty pcDNA4 vector. Following transfection, 4 coverslips 
of each treatment were fixed at 24hour intervals for 5 days. Cells were fixed in 3% 
paraformaldehyde for 10 minutes, washed 3 times in PBS, quenched in ammonium 
chloride for 10 minutes and washed again in PBS. Coverslips were mounted onto 
glass slides using Vectashield Hardset mounting medium (as before). 
Images of coverslips were taken at eight predesignated reference points (see 
figure 2.1). The number of cells expressing DsRed, as a marker for transfection, were 
recorded for each image and results given as total number of transfected cells viewed 
per coverslip. These data reflects the number of transfected cells across roughly 24% 
of slide. 
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Figure 2.1: Relative positions of areas sampled on coverslips in cell survival experiments 
Diameter of coverslip =13mm 
Area of coverslip = 132 732 290µm2 
Area of field of view = 2380 x 1780µm 
=4 236 400 µm2 
Area of coverslip examined =4 236 400 pm2x 8 
= 33 891 200 µm2 
Proportion of coverslip examined = 25.5% 
Some of the fields of view will overhand the edge of the coverslip, thus not 
fully 25.5% of coverslip is examined. This area does include the greatest density of 
transfected cells: it was noted that most of the transfected cells were in the outer 
portion of the coverslips. This is likely because after seeding most cells settled in the 
centre of the wells, and were therefore most confluent at time of transfection. 
2.3.8 Staurosporine treatment 
Cells were incubated inIpM staurosporine in complete DMEM for 3 hours and then 
harvested as described below. 
2.4 DNA techniques 
2.4.1 Plasmid constructs 
Constructs of wild-type and R345W fibulin-3 had been previously 
synthesised in our laboratory (Blackburn et a! 2002). Briefly, A clone of fibulin-3 
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WT clone was obtained from IMAGE consortium (360091) and subjected to site 
directed mutagenesis (Stratagene) R345W to create the mutant clone. Each clone was 
amplified with forward primers containing and EcoRl site and reverse primers 
containing an Apal site. 
Forward 5' ATGGCTGAATTCACAATGTTGTTGAAACCC 3' 
EcoRl 
Reverse 5' ATAGTGGGGCCATTTTCATTTGGGCCCATGGCT 3' 
Apal 
Double digest with EcoRI and Apal was performed to remove the inserts. 
The fragments encoding WT and R345W FBLN3 were cloned into the pEGFP-N2 
(BD Biosciences), creating a fusion of GFP with the N-terminal of the fibulin-3 
proteins. Constructs were routinely sequence verified and validated by HpaII digest 
(Tarttellin et a12001) pDsRed2-C1 vector (Clontech) was kindly provided by Dr M. 
Cheetham. 
2.4.2 Extraction of DNA from adult and embryonic zebrafish tissue 
GNT-K extraction buffer was prepared by adding 10µL Proteinase-K to lmL 
stock GNT buffer (50mM KCL, 1.5mM MgC12,10mM Tris-HC1 pH8.5,0.01% 
gelatine, 0.45% Nonidet P40,0.45% TWEEN20). 200µL GNT-K buffer was added 
to each sample and initially incubated at 55°C overnight. Further investigation 
showed that 2hours was sufficient to dissolve zebrafish finclips and embryos. Once 
dissolved, proteinase-K was denatured by heating to 95°C for 15minutes, after which 
samples were centrifuged for 4 minutes at 13000g and the supernatant retained. 
For NaOH DNA extraction, samples were immersed in a solution of 25mM 
NaOH, 0.2mM EDTANa2 pH12, then vortexed, heated to 95°C for 10 minutes and 
subsequently cooled to 4°C before addition of equal volume of 40mM Tris-HC1 pH5. 
Alternatively, samples were immersed in 100uL "Finclip buffer" 10mM Tris 
pH8.2m 10mM EDTA, 200mM NaCl, 0.5% SDS, 200gg/ml Proteinase K, vortexed, 
and incubated for 3 hours at 55°C, after which samples were centrifuged for 1min at 
13000g and the supernatant retained (Westerfield 2000). 
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2.4.3 DNA quantification by spectroscopy 
Nucleic acid concentration was determined by measuring absorbance at 
260nm using a ND 1000 Nanodrop spectrophotometer. 
2.4.4 Separation of DNA by gel electrophoresis 
DNA separation was performed using 0.5-3% (w/v) Tris-Acetate EDTA 
(TAE) agarose gels depending on the size of the DNA. Agarose was dissolved in lx 
TAE buffer by boiling at 100°C followed by cooling. When the solution was hand- 
warm, ethidium bromide was added and the mixture was poured into a gel castor. 
Gels were electrophoresed at 100 V in lx TAE buffer and calibrated with 1 kb DNA 
ladder of appropriate size. DNA stained with ethidium bromide was visualised using 
UV illumination and a charge-coupled device (CCD) camera associated with a PC, 
and software was used to acquire images of gel. 
2.4.5 Standard Polymerase Chain Reaction 
PCR was performed using 10-70 ng/µl of DNA template, 2.5 µM of each 
primer, 0.25 mM deoxynucleotide triphosphates (Invitrogen), Ix DNA polymerase 
reaction buffer (10mM Tris-HC1 pH8.3,50mM KCI, 1mM MgCI2), 0.05 U/µl Taq 
DNA polymerase (Invitrogen) made up to final volume in MilliQ H2O. Control PCR 
reactions in the absence of template were performed in parallel. The conditions for 
PCR were as follows: an initial step of denaturation of DNA template at 94°C for 10 
minutes. This was followed by 32 cycles of 94°C for 40 seconds, annealing of 
forward and reverse primers at 64°C for 40 seconds, and extension of each primer at 
72°C for 1 minute. For Clal primers, annealing temperature of 62°C was used; 57°C 
was used for CHM primers. A final extension time of 10 minutes at 72°C was added 
to ensure elongation of products was complete. PCR was performed using a Cetus 
DNA Thermal Cycler (Perkin Elmer). PCR products were analysed by agarose gel 
electrophoresis. 
2.4.6 DNA sequencing 
DNA sequencing reactions consisted of 1 µg of DNA plasmid and 12.8 pmol 
of sequencing primer. Automated DNA sequencing was carried out by the ABC 
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sequencing service at Imperial College London. DNA sequencing results were 
analysed using Gene Jockey II software. 
2.4.7 Restriction enzyme digestion of DNA 
PCR contaminates were removed using QiaQuick PCR Purification kit 
(Qiagen). DNA was digested using 1 U/µl of restriction enzyme (New England 
Biolabs, Invitrogen) in the appropriate buffer supplied by the manufacturer and was 
carried out between 2-24 hours at 37°C. BSA was required with some enzymes for 
optimal activity. DNA was subsequently analysed and purified by agarose gel 
electrophoresis. 
2.5 Protein techniques 
2.5.1 Subcellular fractionation 
Adherent cells were harvested mechanically [or using MPer reagent (Pierce) 
as per manufacturer's instructions, where noted in Chapter 3] transferred to 15 ml 
tubes and centrifuged at 1000 xg for 5 minutes at 4°C. The supernatant was 
aspirated and cells were washed with PBS and centrifuged once more. Cells were 
then resuspended in hypotonic lysis buffer. 
Zebrafish embryos were euthanised in tricaine solution, and yolk sacs were 
removed if necessary. Fish were snap frozen in liquid nitrogen and stored at -80°C, 
and thawed on ice before use. 
Samples were immersed in hypotonic buffer (10mM Tris pH 7.5,10mM 
NaCl, 1% SDS, Ix Roche Protease Inhibitor Cocktail for total extract; 50mM 
HEPES 7.5,1mM NaCl, 1mM DTT, Ix Protease Inhibitor Cocktail for subcellular 
fractionation) and lysed by sonication. 
Lysates were centrifuged at 800 xg for 10 minutes at 4°C to obtain the post- 
nuclear supernatant (PNS). PNS was used for all immunoblotting experiments in 
Chapter Three. For subcellular fractionation, the PNS was transferred to a Beckman 
Centrifuge Tube and subjected to ultracentrifugation at 100,000 xg for 1 hour at 4°C 
using a TLA45 Beckman rotor. The supernatant (S 100) containing the cytosolic 
fraction was transferred to a fresh tube and the pellet (P 100) containing the 
membrane fraction was resuspended in an equivalent volume of lysis buffer. 
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2.5.2 Protein quantification by spectroscopy 
Protein concentration of lysates and recombinant proteins was determined by 
measuring absorbance at 280nm using a ND 1000 Nanodrop spectrophotometer. 
2.5.3 Protein Quantification by BCA assay 
Protein concentrations in Chapter Three was determined using the 
bicinchoninic acid (BCA) protein assay kit (Pierce) for the colourimetric detection 
and quantitation of total protein, following the manufacturer's protocol. Standard 
curves were constructed using bovine serum albumin (BSA) over a concentration 
range of 2000 pg/ml to 25 gg/ml and plotted using Sigmaplot 2001. 
2.5.4 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
Proteins were separated by 12% (v/v) SDS-PAGE. Separating gels of 12% 
(v/v) acrylamide in separating buffer and stacking gels of 5% (v/v) acrylamide in 
stacking buffer were prepared using 30% acrylamide mix, polymerised with APS and 
TEMED as described (Sambrook et a! 2001). Gradient gels were prepared using a 
4M urea in 7.5% acrylamide solution and 8M urea in 15% acrylamide solution. 
Solutions were mixed and poured using a gradient mixer to ensure a smooth 
transition between concentrations. Samples were prepared by adding SDS-PAGE 
loading buffer followed by boiling at 100°C for 10 minutes. Electrophoresis was 
performed in a "Mighty Small" apparatus (Hoefer), using lx Running Buffer at 40 
mA per gel. The gels were calibrated with pre-stained low range SDS-PAGE 
standards (Bio-Rad). 
2.5.5 Western immunoblotting 
Proteins were transferred onto polyvinylidene fluoride (PVDF) membranes 
using a Hoefer TE22 mini tank transfer unit at 500 mA for 1 hour. 
In Chapter Three successful transfer was confirmed by incubation with 
Amido Black stain (10% acetic acid, 40% methanol, 50% H2O, 0.1%(w/v) Amido 
black) and destaining with three washes in destain solution (20% methanol, 7.5% 
acetic acid, 72.5% H20). In section 3.5, transfer was confirmed by reversible 
Ponceau staining (BioRad) as per manufacturer's instructions. 
Following transfer, the membranes were blocked with 5% (w/v) non-fat dry 
milk in PBS with 0.1% (w/v) Tween-20 (PBST) for 1 hour. Membranes were 
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incubated with primary antibodies diluted in 1% Marvel/PBST for 3 hours or 
overnight. After three washes of 10 minutes with PBST, the membranes were 
incubated with secondary antibodies conjugated to horseradish peroxidase (HRP) or 
alkaline phosphatase (AP) for 1 hour and then washed as above. Detection of bound 
antibdies was achieved using the Supersignal West Pico Chemiluminescent Substrate 
(Pierce), ECL Plus Western Blotting Detection System (Amersham), or AP 
Colourimetric Development System (BioRad) according to the manufacturer's 
instructions. 
2.5.6 Immunoprecipitation of proteins 
After preparation of cell lysates, the post-nuclear supernatant precleared by 
incubation with 50µL protein A agarose bead solution at 4°C for 4 hours. Precleared 
supernatant was incubated with the specific antibody at 4°C overnight. This was 
followed by incubation with Protein A-agarose beads at 4°C for 3 hours, as directed 
in Protein A Immunoprecipitation Kit (Roche) and proteins recovered as per 
manufacturer's instructions. Samples were then analysed by SDS-PAGE and 
immunoblotting. 
2.5.7 In vitro Prenylation Assay 
In vitro prenylation of Rab proteins with zebrafish extract as a source of REP 
was performed in reaction buffer containing 50mM HEPES pH 7.5,5mM MgC12, 
1mM NP40 and 1mM DTT. Each reaction contained 5µM recombinant human or 
canine Rab protein, 100nM recombinant rat RabGGTase, and 1mM tritiated 
geranylgeranyl pyrophosphate (GGpp), or 50nM tritiated GGpp supplemented with 
5µM unlabelled GGpp. Also added to the reaction were lx Protease Inhibitors and Ix 
Phosphatase Inhibitors. Prenylation was initiated by the addition of cytosolic extract 
containing a source of REP. As a negative control, reactions were also performed in 
the absence of recombinant RabGGTase. As a positive control, zebrafish extracts 
were used as a source of GGTaseI to prenylate 5µM recombinant human GST- 
Racla, using the same reaction conditions but omitting RabGGTase. Reactions were 
incubated at given temperature for the designated period, then stopped by the 
addition of 10%HC1 in ethanol, and incubated for 30 minutes at room temperature. 
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Glass microfibre filter discs (Whatman) were moistened with water and 
placed on a filter pump, then equilibrated in ethanol. The proteins were placed on the 
filter discs and washed three times with ethanol. The filter discs holding the 
prenylated Rabs were placed in scintillation vials containing 4m1 of UltimaGold 
Universal scintillation fluid (Perkin Elmer). The radioactivity of the precipitated 
proteins was measured using a Beckman LS6000SC scintillation counter. 
In vitro prenylation assays of unprenylated Rabs from zebrafish cytosolic 
extracts were prepared as above, but substituting recombinant Rabs with 2µM 
recombinant REP, and only I µM unlabelled GGpp. Zebrafish protein extracts were 
added to a concentration of 4µg /µL. Reactions were incubated for 45 minutes at 
37°C. 5µL of loading buffer was added to each reaction and aliquots were boiled for 
5 minutes at 95°C. Aliquots were separated SDS-PAGE on a 12.5% gel, and the 
proteins fixed by incubation for 1 hour in a solution of 40% ethanol and 10% acetic 
acid. Gels were incubated for 20minutes in AMPLIFY solution (Amersham) before 
drying in a 60°C oven and exposure to autoradiography film for two weeks. 
2.6 Bioinformatic approaches 
2.6.1 Survey of complete genomes 
The GOLD genome database (http: //www. genomesonline. org/) was surveyed 
to identify all completed genomes available, from which a representative selection 
was made, including all available chordate genomes. Fugu (versions 4.0), Ciona 
(version 2.0) and X. tropicalis (version 4.1) genomes were accessed though the Joint 
Genome Institute website. All other genomes were accessed directly via Genbank 
(see table 2.1) 
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Species Genome database 
Homo sapiens htt p: //www. ncbi. nlm. nih. govBLAST/ 
Mus musculus hn : //www. ncbi. nlm. nih. gov/BLAST/ 
Rattus norvegicus htt p: //www. ncbi. nlm. nih. govBLAST/ 
Gallus gallus http: //www. ncbi. nlm. nih. gov/BLAST/ 
Xenopus tropicalis http"//iei-psf org! Xentr4/Xentr4. home. html 
Xenopus laevis h" : //www. ncbi. nlm. nih. izov/BLAST/ 
Danio rerio btt T/ D: //www. nebi. nim. nih. izov/BLAS 
Tak gu rubripes http"//iei-psf org/Takru4/Takru4. home. html 
Tetraodon nigrovirides htt p: //www. ncbi. nlm. nih. govBLAST/ 
Ciona intestinalis http: //jgi-asf. org/Cioin2/Cioin2. home. html 
Drosophila melanogaster htt p: //www. ncbi. nlm. nih. govBLAST/ 
Caenorhabditis elegans htt p: //www. ncbi. nlm. nih. govBLAST/ 
Saccaromyces cerevisiae htt p: //www. ncbi. nlm. nih. govBLAST/ 
Neurospora crassa htt p: //www. ncbi. nlm. nih. govBLAST/ 
Aspergillusfumigatus ht tn: //www. ncbi. nlm. nih. govBLAST/ 
Table2.1 Genomic databases used for identifying REP and GDI protein sequences 
2.6.2 Identification of sequences 
REP and GDI protein sequences were identified by using simple protein 
BLASTP (Altshul et al 1990) searches; limiting results by species and maintaining 
all other default settings. Each genome database was queried with known human 
REP-1, REP-2 and GDIa protein sequences; and also S. cereviseae REP and GDI to 
ensure no sequence was missed from our analysis due to bias created by the query 
sequence. Sequences from each species were aligned to identify any duplicate entries 
in the databases, and surplus sequences discarded. Some sequences were as yet 
unidentified, hence ClustalW (Higgins et al 1994) analysis and BLASTP against the 
Genbank database were performed to identify to which protein family they belonged. 
Finally, Pfam (www. sanger. ac. uk/ Software/Pfam; Finn et al 2006) was used to 
identify all proteins with GDI domains in each species, and Superfamily 
(http: //supfam. mrc-lmb. cam. ac. uk/ SUPERFAMILY; Madera et al 2004) used to 
find proteins containing both "FAD/NAD binding domains" + "FAD linked 
reductase C terminal domains" to ensure no REP/GDI protein was omitted due to 
lack of sensitivity in BLAST search algorithms. 
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2.6.3 Generation of phylogenic trees 
Sequences identified were aligned using the ClustalX 1.83 (Thompson et al 
1997, Chenna et al 2003) algorithm program with default parameters (Gap open 
penalty = 10.0, Gap extension penalty = 0.2, Protein Matrix = Gonnet, ENDGAP =- 
1, GAPDIST = 4). CLUSTALX default parameters were used as they gave good 
alignment of known conserved structural motifs e. g. Helix D of REP. Alignments of 
REPs only, GDIs only, vertebrate sequences only (REPs only, GDIs only and all 
vertebrate sequences), and all sequences were performed. Alignments were not 
manually adjusted. Alignments were inspected by eye to confirm the location of 
REP-specifc and GDI-specific phenylalanine residues F279 and F135 respectively. 
Separation of yeast, worm and ciona REP sequences from higher eukaryote REP 
sequences by the GDIs in alignments reflects the absence of the -120 amino acid 
REP specific insert in the lower eukaryotes. 
The final alignments were used to calculate phlyogenic trees using the 
Neighbour-Joining method (Saitou & Nei 1987). The NJ method is relatively fast and 
performs well when the divergence between sequences is low. The algorithm 
converts protein sequences into a distance matrix representing an estimate of the 
evolutionary distance between the sequences. This method does not account for the 
possibility that the observed differences may not reflect the true distance between 
two sequences; there may be multiple substitutions at a single site or back-mutations. 
Bootstrapping involved 1000 trials; the bootstrapping involves random re- 
sampling of the data to produce replicate data sets to which the tree building 
algorithm is applied. Scores indicate the frequency with which the predicted 
phylogeny concurs with the outcome of the bootstrap replicate. Thus bootstrapping 
can highlight which parts of a phylogeny are weakly supported. Bootstrap values 
above 70% are generally considered to indicate strong support for the proposed 
phylogeny at a given node. Trees were rooted using A. thaliana REP as an outlier 
and viewed using TreeView software (Page 1996; 
http: //taxonomy. zoology. gla. ac. uk/rod/ treeview. html). 
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2.7 Common materials 
2.7.1 Antibodies 
2.7.2 Concentration of antibodies used for immunocytochemistry 
Polyclonal rabbit anti-GRP78; 1: 200 (Stressgen) 
Polyclonal rabbit anti-calnexin; 1: 250 (Stressgen) 
Polyclonal rabbit anti-caspase-6; 1: 200 (Stressgen) 
Polyclonal rabbit anti-caspase-9; 1: 200 (Oncogene) 
AlexaFluor® 568 goat anti-rabbit IgG; 1: 200 (Molecular Probes) 
2.7.3 Concentration of antibodies used for immunoblotting 
Polyclonal rabbit anti-caspase-9; 1: 1000 (Cell Signalling) 
Polyclonal rabbit anti-caspase-9; 1: 200 (Santa Cruz) 
Polyclonal rabbit anti-fibulin-3 [Pep-1]; 1: 25 (C. Gregory-Evans) 
Goat anti-rabbit AP-conjugated IgG FAb fragments; 1: 500 (Stressgen) 
Polyclonal rabbit anti-GFP [Ab290]; 1: 2500 (AbCam) 
Monoclonal mouse anti-GFP; 1: 1000 (Roche) 
Monoclonal rabbit anti-Rab1 batch D576; 1: 1000 (M. Seabra) 
Monoclonal mouse anti-Rab5; 1: 1000 (M. Seabra) 
Monoclonal rabbit anti-Rab7; 1: 1000 (M. Seabra) 
Monoclonal mouse anti-Rab8; 1: 1000 (Santa Cruz) 
Monoclonal mouse anti-Rab11; 1: 1000 (M. Seabra) 
Monoclonal mouse anti-Rab27a; 1: 10 000 (M. Seabra) 
Polyclonal Goat anti-Rabbit HRP conjugated antibody; 1: 10000 (Dako Cytomation) 
Polyclonal Goat anti-Mouse HRP conjugated antibody; 1: 10000 (Dako Cytomation) 
2.7.4 Primers 
Primer name Sequence 
CHM Forward GCA GGA GGA TGG TGA TCA TT 
CHM Reverse GGT CCC TGA GGT TGT AGG GT 
Efl Forward TAC GCC TGG GTG TTG GAC AAA 
Efl Reverse TCT TCT TGA TGT ATC CGC TGA C 
CIIM Clal Forward GTC ATT GCT GCG GCC TGC TCC AGA GAT CGA 
CHM Clal Reverse GTG TTA AAC CAA ATG TTC CAG TIT AAT TGG 
Table 2.2 Primer sequences 
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2.7.5 Common buffers 
50X TAE buffer: 242g Tris base 
57.1 ml glacial acetic acid 
100ml EDTA 0.5M, pH8 
5x DNA loading buffer: O. 1M EDTA pH8.0 
50% (v/v) glycerol 
0.5% Orange G 
PIPES buffer: 4.8g PIPES 
0.05% saponin 
5mM EGTA 
I mM MgC12.6H20 
Make up to 200mL with DEPC-dHZO, pH6.8 
SDS PAGE loading buffer: 0.3M Tris pH6.8 
10% (w/v) SDS 
40% (v/v) glycerol 
0.02% (w/v) bromophenol blue 
9% (v/v) ß-mercaptoethanol 
5x SDS PAGE running buffer: 15. lg Tris base 
72g glycine 
5g SDS 
make up to 1L with dH2O 
5x Transfer buffer: 18g Tris base 
87g glycine 
make up to 1L with dH2O. 
to prepare, mix 200m1 buffer, 200m1 methanol, 600m1 dH2O 
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Cellular Responses to R345W 
Mutation in Fibulin-3 
3.1 Cellular responses to mutation of fibulin-3 
Fibulin-3 is a monomeric extracellular matrix protein which has been linked 
to the inherited maculopathy Dominant Drusen. An R345W substitution in fibulin-3 
segregates with Dominant Drusen disease. (Stone et al 1999). It has been suggested 
that the fibulin-3 R345W is misfolded, inefficiently secreted and leads to 
accumulation of fibulin-3 in the ER (Marmorstein eta! 2002). 
Proteins are synthesised and folded in the ER with the assistance of 
constitutively expressed chaperones. Unfolded proteins are retained by the ER and 
retrotranslocated to the cytoplasm by the machinery of ER Associated Degradation 
(ERAD), wherein they are degraded in the proteasome. If the level of protein 
synthesis exceeds the capacity of the folding apparatus and ERAD, misfolded 
proteins accumulate in the ER. Aggregates of misfolded protein may form in the ER 
through association between exposed hydrophobic residues; these protein aggregates 
have been implicated in a range of degenerative disorders which further restrict the 
ability of the ER to function correctly (Shastry 2003, Dobson 2003, Cohen & Kelly 
2003, Rutishauser & Spiess 2002, Kimera & Kakizuka 2003, Sherman & Goldberg 
2001). 
Aggregation of protein in the ER further impedes the protein folding 
machinery and may lead to activation of the ER stress response. The mammalian ER 
stress response consists of. (1) attenuation of further protein synthesis; (2) 
upregulation of chaperone protein transcription; (3) induction of ERAD genes; and 
(4) activation of apoptosis to maintain survival of the organism. 
Expression of fibulin-3 R345W may impair cellular capacity for protein 
folding, leading to accumulation of protein in the ER and induction of an ER stress 
response. This chapter of my thesis addresses several questions relating to the 
cellular responses to expression of fibulin-3 R345W. Primarily, I seek to confirm the 
retention of fibulin-3 R345W in the ER and investigate whether an ER stress 
response is induced. I also examine the trafficking pathway undertaken by fibulin-3 
prior to secretion. Induction of an ER stress response by accumulation of misfolded 
fibulin-3 and subsequent apoptosis would suggest a molecular pathogenic 
mechanism underlying Dominant Drusen disease. 
Prior to the completion of this research, Roybal et al published a report 
connecting the expression of fibulin-3 R345W with upregulation of VEGF. The 
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implications of Roybal's work will be discussed at the end of this chapter (Roybal et 
al 2005). 
3.2 Accumulation of mutant fibulin-3 within cells 
To assess the effect of the R345W mutation upon intracellular localisation of 
fibulin-3, the localisation of fibulin-3 wild type and R345W was studied in three 
cells lines. ARPE-19 cells are an immortalised cell line derived from human RPE 
tissue which arose spontaneously in culture (Dunn et al 1996) and thus may offer an 
appropriate model for study of protein trafficking in retinal tissue. They are readily 
available and easy to maintain and cultivate. COST and Hela cells are commonly 
used immortalised cell lines which can be readily manipulated to express 
recombinant proteins and were used in concert with ARPE-19 cells. 
All three cell lines were transfected with constructs encoding either wild type 
or R345W fibulin-3 in fusion with EGFP (figure 3.1). EGFP is linked by to the C- 
terminus of FBLN3/EFEMPI, due to possible post translational cleaving of the N- 
terminal end of fibulin-3 protein. GFP fusion constructs were preferred to the direct 
immunostaining of fibulin-3 used by Marmorstein et al (2002) as both ARPE-19 and 
COST cells have been shown to express endogenous fibulin-3 (Blackburn et al 
2003). The settings on the confocal microscope used to capture these images were 
maintained throughout the experiment so these images can be internally compared 
within each figure. 
In all cell lines tested, cells transfected with EGFP-fibulin-3 wild type 
showed little intracellular fluorescence (figures 3.1a, 3.1c and 3.1e). Faint 
fluorescence is observed in the perinuclear area, concordant with the folding and 
glycosylation of over-expressed fibulin-3 wild type prior to secretion. In contrast, in 
cells transfected with EGFP-fibulin-3 R345W appears to localise throughout the 
cytoplasm, indicative of endoplasmic reticulum retention (figures 3.1b, 3.1d and 
3.1 f). 
In repeated trials (n=3) a very low transfection efficiency of only 5% was 
achieved when using ARPE-19 cells. This was consistent with similar difficulties 
experienced by collaborators using this cell line (P. Chapple, personal 
communication; V. Lopes, personal communication). Use of microinjection 
technology may have improved the efficiency with which DNA could be introduced 
to ARPE-19 cells; however, this equipment was not readily available at the time 
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these experiments were performed, hence subsequent experiments were performed in 
COST and HeLa cell lines only. 
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Figure 3.1 Intracellular accumulation of iibulin-3 11345N\ in cultured cells : \KIT-19 : cII, 
transiently transfected with (a) WT or (b) R345W EGFP-fibulin-3; COS7 cells transfected with (c) 
WT or (d) R345W EGFP-fibulin-3, and Hela cells transfected with (e) WT or (f) R345W EGFP- 
fibulin-3; and fixed after 24 hours. Scale bar in a, b, e, IF = 50µm; scale bar in c, d = 100µm 
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3.3 Chaperone upregulation in cells expressing mutant fibulin-3 
Fibulin-3 R345W appears to localise throughout the cytoplasm in a punctuate 
fashion, suggestive of retention in the ER. To confirm the subcellular localisation of 
fibulin-3 R345W and examine the cellular response to its expression, 
immunocytochemistry with antibodies for chaperones was performed upon cells 
expressing fibulin-3 wild type and R345W. The settings on the confocal microscope 
used to capture these images were maintained throughout the experiment so these 
images can be internally compared within each figure. 
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Figure 3.2 (o-localisation of LGI I'-libulin-3 R345\\ with chaperone GRP78 suggests retention 
of protein in the ER COS7 cells transiently transfected with WT (a - c) or R345W (d - i) EGFP- 
fibulin-3, fixed after 24 hours, and immunostained with antibody to GRP78. Faint EGFP fluorescence 
in (a-c) suggests fibulin-3 WT is successfully trafficked through the ER and out of the cell. GRP78 
staining in (b) reflects constitutive expression levels. Increased intensity of GRP78 staining in (e) and 
(h) suggests upregulation of chaperone. Scale bars a-f = 50µm, g-i = 20µm 
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Immunocytochemistry with an antibody to the chaperone GRP78 was 
performed on cells expressing EGFP-fibulin-3 WT and R345W (figure 3.2). Cells 
expressing EGFP-fibulin-3 WT show faint perinuclear staining, suggesting normal 
trafficking through the ER and Golgi apparatus (figure 3.2a). Immunostaining with 
GRP78 in these cells reflects the low level of constitutive expression of this 
chaperone (figure 3.2b). Cells expressing EGFP-fibulin-3 R345W show an increased 
intensity of GRP78 staining (figure 3.2e). GRP78 co-localises with EGFP-fibulin-3 
R345W, indicating that the mutant fibulin-3 is localised to the ER. 
This experiment was repeated using an antibody for calnexin, another ER 
chaperone (figure 3.3). Again, faint staining of EGFP-fibulin-3 WT and calnexin was 
observed (figures 3.3a, 3.3b, 3.3c). Calnexin staining in these cells is of a similar 
intensity to untransfected cells in shown in the same panel (figure 3.3b), reflecting 
constitutive chaperone expression. 
Cells transfected with EGFP-fibulin-3 R345W exhibit much stronger green 
fluorescence compared to WT, suggesting a greater level of protein is retained within 
the cell (figure 3.3d). The intensity of calnexin staining is also increased in these 
cells relative to untransfected cells shown in the same view (figure 3.3e), suggesting 
upregulation of this chaperone. Examination of these cells at higher magnification 
(figure 3.2g, 3.2i, 3.2h) shows co-localisation of EGFP-fibulin-3 R345W with 
calnexin throughout the cytoplasm, confirming the mutant protein is retained in the 
cytoplasm. Additionally, strong perinuclear staining suggests some protein may also 
be retained in the Golgi apparatus, although this cannot be confirmed without use of 
a Golgi specific stain. These images have not been digitally manipulated, but 
increasing contrast in the red channel may improve clarity of the co-localisation in 
panels 3.3h and 3.3i. 
Unfortunately no untransfected cells are visible in panels 3.2d to 3.2f, and 
thus comparison between constitutive expression of GRP78 and expression in 
response to fibulin-3 R345W is limited to comparison with panels 3.2a to 3.2c. 
Multiple attempts were made to improve the immunocytochemistry subsequent to 
this experiment through differing concentrations of primary antibody, alternative 
fixation methods utilising cold methanol, filtration of antibody solutions to remove 
aggregates and different aliquots of anti-GRP78 antibody. However, despite these 
variations in method, high levels of background staining were frequently observed. 
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Figurc 3.3 ( u-luc; ili. atiun of F(. l P-fibulin-3 R345N1 nnith chaperone calncxin Confirms 
localisation of protein to the ER and suggests induction of ER stress response COS7 cells 
transiently transfected with WT (a - c) or R345W (d - i) EGFP-fibulin-3, fixed after 24 hours, and 
immunostained with antibody to calnexin. Panels g-i show enlargement of panels d-f. Increased 
staining of cells expressing EGFP-fibulin-3 R345W relative to untransfected cells (e) suggests 
upregulation of calnexin expression. Scale bars a-f = 50µm, g-i = 20µm 
Similar difficulties were experienced initially in immunostaining for 
calnexin, however these were resolved using cold methanol for fixation instead of 
3% paraformaldehyde, and the images in figure 3.3 are consequently of improved 
quality, although unfortunately some artefacts remain. Bright green staining in one 
cell (figure 3.3a) is likely to be an artefact rather than retention of EGFP-fibulin-3 
WT in the Golgi apparatus, as the structure appears to lie across the nucleus rather 
than adjacent to it. Similarly, intense red staining in panels 3.3b and 3.3e are likely to 
be artefacts, as they appear to be distinct from any cells or cellular structures. 
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Calnexin staining of untransfected cells in panel 3.3e is much brighter compared to 
untransfected cells in figure 3.3b despite maintaining fixed microscope settings 
throughout the experiment. This discrepancy may be due to variation in strength of 
antibody binding between coverslips. However, as there is increased staining for 
calnexin in cells expressing fibulin-3 R345W compared to untransfected cells shown 
in the same panel (3.3e), these data still suggest the upregulation of this chaperone in 
response to mutant fibulin-3, assuming equal levels of fibulin-3 WT and R345W 
protein expression. This could be quantified further by examining expression of 
chaperone proteins by Western blotting, or chaperone mRNA by Northern blotting, 
in response to these constructs. 
These results imply fibulin-3 R345W is retained in the ER. Furthermore, 
expression of the chaperones GRP78 and calnexin appears to be upregulated in 
response to expression of fibulin-3 R345W but not fibulin-3 WT. Fibulin-3 WT is 
also observed in the ER and possibly the Golgi apparatus, but the signal is weaker 
suggesting a greater proportion of this protein is secreted from the cell. 
It has been suggested that the R345W mutants of fibulin-3 may be misfolded 
(Marmorstein et al 2002); in light of this, it is reasonable to suggest that the 
upregulated GRP78 and calnexin may be binding to the mutant fibulin-3 to promote 
correct folding. GRP78 belongs to the Hsp70 family of chaperones, which bind to the 
hydrophobic portions of partially folded proteins and ensure that they do not 
aggregate together. Calnexin is a lectin, which assists the folding of proteins carrying 
monoglucosylated N-linked glycans. Indeed, fibulin-3 WT staining is dim, implying 
that much of the recombinant protein that is produced successfully exits the cell, 
assuming equal levels of fibulin-3 WT and R345W expression. 
3.4 Fibulin-3 traffics through the endoplasmic reticulum and Golgi apparatus 
Many secreted extracellular proteins are trafficked via the secretory pathway. 
To investigate if the trafficking of fibulin-3 occurs via the secretory pathway, and 
thus refine our knowledge of compartments where the processing of fibulin-3 
R345W fails, a temperature block assay was employed (Leung et al 2006). 
Lowering the culturing temperature to 20°C should block trafficking in this 
pathway by preventing proteins from exiting the Golgi apparatus. COST cells were 
transfected with EGFP-fibulin-3 wild type or R345W and incubated at 20°C to 
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induce the temperature block. Cells were also transfected with EGFP-HRas, which is 
targeted to the cell membrane, as a positive control (Gomes et al 2003). 
Control Temperature block Rescue 
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shows localisation of protein to Golgi-like structures at restrictive temperature COS7 cells 
transiently transfected with EGFP fusion constructs and incubated for 24 hours at 37°C as a control (a, 
d, g). Temperature block was performed by incubating cells at 20°C for 3 hours, after which cells were 
fixed (b, e, h)or returned to 37°C for 1 hour for rescue (c, f, i), as described in Materials and Methods. 
Arrows indicate localisation to Golgi-like structures. Scale bars = 20µm 
At the non-restrictive temperature of 37°C, the EGFP-HRas positive control 
localised to the plasma membrane (figure 3.4a). On induction of the 20°C 
temperature block, EGFP-HRas was localised to the Golgi apparatus (figure 3.4b). 
Some plasma membrane staining remains, as a proportion of expressed HRas would 
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have successfully reached the plasma membrane before induction of the temperature 
block. Returning the cells to 37°C released the temperature block so that a proportion 
of EGFP-HRas regained its plasma membrane localisation (figure 3.4c). 
For EGFP-fibulin-3 WT, faint reticular staining was observed at the non- 
restrictive temperature (figure 3.4d), similar to the staining pattern observed in co- 
localisation with the ER marker calnexin (figure 3.3c). Induction of the temperature 
block caused an increase in intracellular staining, with EGFP-fibulin-3 localising to 
perinuclear Golgi-like structures (figure 3.4e). Returning the cells to 37°C appears to 
release fibulin-3 WT from the Golgi and diffuse reticular staining is observed (figure 
3.4f). 
Cells expressing EGFP-fibulin-3 R345 W also show increased perinuclear 
staining upon induction of the temperature block (figure 3.4h), which is alleviated by 
returning cells to 37°C for one hour. Fibulin-3 R345W is detected in culture media, 
although it is less abundant than fibulin-3 WT, implying a proportion of R345W 
successfully exits the cell under normal conditions. Thus the retention of some 
fibulin-3 R345W in the Golgi apparatus after temperature block is unsurprising. 
These data suggest that fibulin-3 is trafficked through the Golgi apparatus 
subsequent to protein synthesis at the ER membrane; however, there is some 
variation in the success of the temperature block, as evidenced by the variation in 
intensity of Golgi staining, and failure of some cells to regain their normal 
distribution of fusion protein (data not shown). For this reason, attempts were made 
to quantify the effect of the temperature block on fibulin-3 secretion. 
The temperature block experiment was performed on multiple coverslips 
(n=4) for each treatment. These coverslips were subsequently examined using the 
confocal microscope and cells were classified as either retaining or secreting the 
EGFP-fibulin-3 fusion protein. Where there was ambiguity cells were classified as 
"unsure". These data, expressed as both frequency and percentage of the total 
number of cells observed, are shown in tables 3.1 and 3.2 respectively. 
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EGFP-fibulin-3 WT EGFP-iibulin-3 R345W 
Treatment 37°C 20°C 20°C+37°C 37°C 20°C 20°C+37°C 
Retained 
Secreted 
Unsure 
18 
87 
10 
88 
61 
12 
30 
125 
2 
85 
27 
3 
128 
20 
7 
83 
17 
3 
Total 115 161 157 115 155 103 
Table 3.1 Frequency of COST cells either retaining fibulin-3, secreting fibulin-3 or ambiguous 
EGFP-fibulin-3 WT EGFP-fibulin-3 R345W 
Treatment 37°C 20°C 20°C+37°C 37°C 20°C 20°C+37°C 
Retained 
Secreted 
Unsure 
15.65% 
75.65% 
8.70% 
54.66% 
37.89% 
7.45% 
19.11% 
79.62% 
1.27% 
73.91% 
23.48% 
2.61% 
82.58% 
12.90% 
4.52% 
80.59% 
16.50% 
2.91% 
Total 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 
Table 3.2 Percentage of all cells observed either retaining fibulin-3, secreting fibulin-3 or 
ambiguous 
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Figure 3.5 Induction of temperature block lowers the proportion of cells secreting EGFP- 
tibulin-3 for both WT and R345W 
Figure 3.5 shows that for both fibulin-3 WT and R345W, induction of the 
temperature block reduces the proportion of cells secreting fibulin-3 by 
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approximately half. This suggests the protein's exit from the Golgi apparatus has 
been blocked at the restrictive temperature. Returning cells to the permissive 
temperature allows cells expressing fibulin-3 WT to overcome the effect of the 
temperature block and return to secreting protein. This shows that the fibulin-3 WT 
is trafficking through the Golgi apparatus along the secretory pathway. 
Cells expressing the fibulin-3 R345W show a less successful recovery, as 
only 16.5% of cells secrete fibulin-3, compared with 23.5% before the temperature 
block. This may be because the efficiency of their protein folding machinery has 
been impaired prior to the temperature block by expression of the R345W construct. 
Notably, a subset of cells retain EGFP-fibulin-3 WT (14.4% of all cells 
observed); in a given population of cultured cells, some will be less able to cope with 
over-expression of an exogenous construct, and there will be variation in the level of 
construct expression. Fibulin-3 is endogenously expressed in this cell line (Blackburn 
et al 2003), so COST cells are expected to be competent in handling and folding 
fibulin-3, but the addition of an EGFP fusion protein may impair the cellular capacity 
for fibulin-3 processing. 
A limitation of this experiment is that some transfected cells may have had 
very faint fluorescence and hence were scored. This could have been 
circumnavigated by co-transfecting cells with a second fluorescent construct, such as 
DsRed, and using the red channel to identify transfected cells before switching to the 
green channel to assess secretion or retention of EGFP-fibulin-3. 
Marmorstein et al used a pulse chase assay to measure the secretion of 
fibulin-3 from cultured cells. They observed nearly 70% of fibulin-3 WT to have 
been secreted into the media within 24 hours, whereas only 13% of mutant fibulin-3 
was secreted in the same period (Marmorstein et al 2002). While measurements of 
the number of cells secreting or retaining protein are liable to observer subjectivity 
and do not account for variation in expression levels between cells, the observed 
ratios of cells which secrete and retain protein are in line with the published data. 
The changes in intracellular fibulin-3 distribution observed in figure 3.4 following 
the temperature block therefore are likely to reflect a real alteration in fibulin-3 
trafficking. 
Incubation at 20°C blocks exit of protein from the Golgi apparatus, and given 
the perinuclear localisation of fibulin-3 observed in figures 3.4e and 3.4h, this 
indicates fibulin-3 is trafficked through the Golgi network during secretion. 
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These observations could be made more robust by using image analysis 
techniques to define the area of each EGFP expressing cell, followed by 
densitometry analysis to quantify EGFP-fibulin-3 retained within the cell, and 
scoring each cell as above or below a threshold level. 
3.5 Investigation of the subcellular localisation of mutant fibulin-3 trafficking 
defect 
Like many secreted proteins, fibulin-3 passes though both the ER and Golgi 
apparatus following translation en route to the plasma membrane. However, a 
significant proportion of fibulin-3 R345W is retained in the ER. Detection of fibulin- 
3 R345W in culture medium (Marmorstein et a12002) and the apparent blockage of 
some mutant protein in the Golgi apparatus after incubation at 20°C implies that 
some proportion of fibulin-3 R345W must be able to navigate the secretory pathway 
successfully and exit the cell. 
Glycosylation is a common post-translational modification of secreted 
extracellular matrix proteins. Indeed all the fibulins are modified with N-linked 
glycosylation (Timpl et a! 2003). Native fibulin-5 has 2-3 potential N-glycosylation 
sites and weighs approximately 48kD, but migrates at 76kD after post-translational 
modification (Mullins et al 2007). Fibulin-2 also has around twenty O-linked 
oligosaccarides (Timpl et al 2003). Fibulin-3 contains a single N-linked 
glycosylation site at residue Asn249 (Lecka-Czernik et al 1995); a further two 
potential O-linked glycosylation sites and 32 potential phosphorylation sites have 
also been identified (Blackburn, unpublished observations). It is unknown if the 
fibulin-3 which exits the cell is correctly folded and glycosylated. 
To establish the level of glycosylation of mutant fibulin-3, I sought to 
investigate the mechanism of glycosylation of fibulin-3 WT by treatment with the 
endoglycosidases peptides N-glycosidase F (PNGaseF) and Endoglycosidase H 
(EndoH). PNGaseF removes all N-linked glycans, whereas Endoll cleaves the 
chitobiose core of high mannose and some hybrid N-linked oligosacccarides. EndoH 
cannot remove complex N-glycans, which are added in the Golgi complex. 
Proteins which have correctly trafficked through the ER and Golgi, having 
been modified with branched chain oligosaccarides, are resistant to Endoll treatment; 
whereas EndoH sensitive proteins suggest a precursor form that is yet to enter the 
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Golgi complex or has not been modified by Golgi glucosidases and 
glycosyltransferases (Chen et al 2005). 
Resistance of fibulin-3 WT to PNGaseF digestion would imply the protein 
does not undergo N-glycosylation. Additionally, treatment with EndoH may reveal in 
which cellular compartment the failure of fibulin-3 R345W processing occurs. 
This approach requires tools to the detect fibulin-3 by immunoblotting to 
ascertain if incubation with endoglycosidases, and potential removal of glycans, has 
altered the apparent molecular weight of fibulin-3. Efforts were therefore made to 
develop a protocol for informative immunoblotting of fibulin-3. 
Previously in the Seabra research lab, the Pep-1 polyclonal antibody to 
residues 37-52 of fibulin-3 was raised in rabbit and used to detect fibulin-3 in 
immunoblots of ARPE-19 and COST cell extracts, and also to immunoprecipitate 
fibulin-3 from ARPE-19 culture media (Blackburn et al 2003). This antibody detects 
a 55kD fibulin-3 band from protein translated in vitro, as predicted from fibulin-3 
primary sequence, but detects a 43kD band from cells and tissues, and a 46kD band 
from immunoprecipitated ARPE-19 cell culture media. This is in contrast to the 
55kD band detected in other studies (Marmorstein et al 2002, Giltay et al 1999, 
Lecka-Czernik et al 1995). The 43kD band is likely to be the variant produced by 
cleavage of the 55kD species at the alternative signalling peptide cleavage site at 
A1a124. 
There are four potential start sites for fibulin-3 transcription in FBLN3 
mRNA, resulting in 54.6kD, 53.7kD, 48. lkD and 43. lkD proteins. Additionally, 
cleavage at the signal cleavage peptide site would produce a 40.9kD species, which 
may then be post-translationally modified and increase in size, to produce the 43 - 
46kD species observed by Blackburn et al. 
Expression of fibulin-3 WT was tested in COST, HeLa and HEK293 
cells. HEK293 cells were tested as they express high levels of exogenous proteins; 
however, in my experiments they did not produce significantly more protein than 
COST or HeLa cells, which had been used previously for immunocytochemistry 
studies. Thus HEK293 cells were not adopted as a model cell line for subsequent 
experiments. 
EGFP fusion constructs were used to allow distinction between the products 
of endoglycosidase treatment from endogenous fibulin-3 and mutant fibulin-3 
R345W in transfected cells. Using 1: 150 dilution Pep-1 and 1: 500 dilution goat anti- 
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rabbit conjugated alkaline phosphatase (AP) produced high levels of non-specific 
immunoreactivity to negative control untransfected cell lysates (figure 3.6a). Strong 
staining is not uniformly observed at the level of endogenous fibulin-3, around 45kD, 
however, this could be due to unequal loading of proteins, as this blot lacks loading 
controls. Nor does the antibody appear to detect the fusion of 45kD fibulin-3 with 
27kD EGFP, around 72kD. There is a potential band around 82kD, which could 
represent 55kD fibulin-3 in fusion with EGFP. However background staining is too 
strong to have confidence that this band results from antibody binding to EGFP- 
fibulin-3. 
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Figure 3.6 Immunoblotting of tibulin-3 with Pep-1 antibody (a) Immunoblotting of HeLa, 293 and 
COS7 cell lysates of cells transfected with EGFP-fibulin-3 WT (Fib3) and untransfected (UT) cells, 
using 1: 150 dilution Pepl primary antibody and 1: 500 dilution goat anti-rabbit conjugated AP 
secondary antibody. Pepl recognises a potential band at 45kD of endogenous fibulin-3.45kD fibulin- 
3 in fusion with 27kD EGFP is expected to migrate at 72kD but no band is visible. Potential band at 
82kD may reflect fusion of 55kD fibulin-3 species with EGFP. (b) Immunoblotting of pellet (P) and 
supernatant (S) fractions of cell lysates from COS7 and HeLa cells transfected with EGFP-fibulin-3 
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(Fib3) and untransfected (UT) cells, using 1: 25 dilution Pep! primary antibody and 1: 3000 dilution 
goat anti-rabbit conjugated AP secondary antibody. No antibody specific binding is observed. M, 
marker. 
Supernatant and pellet fractions of cell lysates were immunoblotted to ensure 
the full cellular content of fibulin-3 was examined. Incubation with 1: 25 dilution 
Pep-1 and 1: 3000 dilution goat anti-rabbit conjugated alkaline phosphatase (AP), as 
described in J. Blackburn's thesis (University of London, 2004), showed no specific 
antibody binding (figure 3.6b), despite successful protein transfer as confirmed by 
Amido black staining prior to immunostaining. Replication of these experimental 
conditions produced the same result (data not shown). 
Non-specific binding was also obtained when blots were developed with the 
more sensitive Enhanced Chemiluminescence (ECL) system (data not shown). 
Further optimisation of antibody concentrations used for immunodetection, 
combined with ECL detection, may allow these results to be improved. 
As there is some uncertainty regarding the specificity of the Pepl antibody 
for fibulin-3 species, and how expression as a fusion with EGFP would affect post- 
translational modification of fibulin-3, an alternative approach of immunoblotting 
with a-GFP antibodies was attempted and used with ECL detection. Initial trials 
using 1: 2500 dilution a-GFP primary antibody with 1: 5000 or 1: 10000 goat anti- 
rabbit HRP conjugated secondary antibody, and 1: 2000 dilution a-GFP primary 
antibody with 1: 5000 goat anti-rabbit HRP conjugated secondary antibody produced 
no antibody specific staining (data not shown). 
Following optimisation of antibody concentrations, use of 1: 2500 dilution a- 
GFP primary antibody with 1: 5000 goat anti-rabbit HRP conjugated secondary 
antibody produced specific staining at around 82kD in lysates from cells transfected 
with EGFP-fibulin-3 (figure 3.7). However, the detected signal is very faint, and high 
levels of background staining can be seen in negative control lanes which cannot be 
discounted. The figure also lacks a positive control lane of cells transiently 
transfected with GFP only, and loading controls. It is possible therefore that this 
staining is not EGFP-fibulin-3, and this blot is inconclusive. Should the experiment 
be repeated, the above concerns would need to be addressed, and in addition the 
experiment would benefit from further resolution of the gel in the 70kD-lOOkD 
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region to aid identification of which species of tibulin-3 is expressed in fusion with 
EGFP. 
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Figure 3.7 Detection of ECFP-tibulin-3 by immunoblotting for (; FP Immunohlutting of cell 
lysates prepared from COS7 and IIeLa transiently transtccted with I: GFP-fihulin-3 W'I' (tih3), and 
untransfeeted (UT) cells. Band detected around SOW in lanes of transtected cell Iysates indicates 
EGFP-fibulin-3 fusion. M, marker. 
Published immunoblots of fihulin-3 show fibulin-3 in both cell lysates and 
culture media. Immunoprecipitation was performed to enhance the detection of 
tibulin-3 in culture media (Blackburn et (/ 2003, Marmorstein et 411 2002). 
Immunoprecipitation of fibulin-3 would confirm the secretion of tibulin-3 WT, 
which is suggested by its faint immunocytochemistry signal, as opposed to the 
degradation of tibulin-3 WT. Additionally, immunoprecipitation of fihulin-3 R345W 
would permit study of secreted mutant protein, for example by endoglycosidase 
treatment. 
This approach was chosen to allow examination of the glycosylation state of 
secreted fibulin-3, and in combination with immunoblotting of cytosolic and pellet 
fractions of cell lysates, it was believed this would täcilitate the study of' the total 
population of' tibulin-3 molecules produced. Analysis of secreted tibulin-3 would 
also be necessary for planned studies of strategies promoting fibulin-3 folding and 
their impact in ameliorating the effect of the R345W mutation. 
Antibody concentrations were increased from 1: 2500 to 1: 1000, and 1: 1500 
to 1: 10000 for the primary and secondary antibodies respectively. A monoclonal 
antibody to GFP was used for the primary incubation of the blot, to avoid detection 
of the polyclonal precipitating antibody. Again, culture media immunoprecipitates 
were enriched with fibulin-3 to the extent where fibulin-3 could not be detected in 
the cell lysates (supernatant fraction) under the sane detection conditions (figure 
3.8). In addition, it was observed that tibulin-3 was not migrating at 82kl) as 
expected, instead a hand was detected around 100kl) (figure 3.8). This may be due to 
glycosylation of EGFP-fibulin-3, or erroneous labelling of protein molecular weight 
markers. A larger molecular weight hand was also observed around 200k1), 
suggesting dimerisation ol'the detected protein (figure 3.8). 
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Figure 3.8 Detection of GFI' fusion in immunoprecipitates of cell culture media EG I-I'-tibulin-3 
was immunoprecipitated from culture media using u-GFP polyclonal antibody. Cell lysates (L) and 
immunoprecipitated media (M) frone COS7 cells transiently transfected with EGFP-fibulin-3 WT or 
R345W, or untransfected cells, are detected with u-GFP monoclonal antibody. Unexpectedly, hands 
are detected at approximately IOOkD and 200k1), suggesting dimerisation of immunoprecipitated 
protein. Enrichment of immunoprecipitates prevents detection of . 
G1 1'-fihulin-3 in cell lysates. 
As there was some uncertainty surrounding the composition of butlers used 
in figure 3.8, this experiment was performed under reducing conditions with fresh P- 
mercaptoethanol and newly prepared immunoprecipitates. This produces a band 
around 82kD, consistent with the expected weight of the EGFP-tibulin-3 fusion 
protein (figure 3.9). Cell lysates were omitted while the migration of' 
inimunoprecipitated samples was investigated. The larger hand around 200kD was 
still present under reducing conditions, indicating that it is not dimerised protein. It 
may represent large aggregates of protein trapped in the stacking gel, which has not 
been separated on the basis of size, or unsuccessful reduction of intermolecular 
bonds resulting in the continued presence of protein dimers or trimers, although the 
latter is unlikely. 
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Figure 3.9 Migration of irnmunoprecipitated fibulin-3 under reducing conditions I: GI I -tibulin-3 
was immunuprecipitated from culture media using u Gf P polyclonal antibody. Cell lysates (L) and 
immunoprecipitated media (M) from C'OS7 cells transiently transfected with WT or R345W IA&T- 
fibulin-3, or untransfected cells, are detected with u-GFP monoclonal antibody. Bands observed at 
82k1) may represent EGFp-fibulin-3 fusion protein. Larger bands are likely to be proteins trapped in 
stacking gel. 
To attempt to resolve these uncertainties, a positive control was added. Initial 
attempts using the empty GFP vector as a positive control failed to produce the 
expected 27kD band in cell lysates (data not shown). Successful transtection of cells 
should have been confirmed first by viewing under a fluorescence microscope prior 
to preparation of cell lysates. The integrity of the construct could also have been 
confirmed by sequencing prior to repetition of the experiment. 
Instead, EGFP-Rab5 was used as a positive control. EGFP-RabS would be 
expected to migrate around 60kD in cell lysates, and as Rab5 localises to the early 
endosomes, would not he expected to he secreted into the media. In this sense, it was 
a poor choice of control for comparison secreted tibulin protein. Cell lysates were 
prepared and GFP immunoprecipitated from culture media and resolved under 
reducing conditions on the same gel. The proteins were transferred to PVI)F 
membrane, and the blot was divided between the lanes containing lysates and 
inimunoprecipitated media. The two halves were developed separately to counteract 
differing signal strengths between lysates and enriched media. Although a hand 
consistent with EGFP-tihulin-3 R345W was detected, several controls Riled (tigere 
3.10). 
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The expected 60kD Rab5-EGFP fusion protein was not observed in cell 
lysates. This protein localises to the early endosomes, and clathrin coated vesicles 
(Stenmark & Olkkonen 2001), so it was not expected to he secreted. These cell 
lysates contain the membrane fraction, as they were not centrifuged at I00000xg to 
remove cellular membranes. Failure of u-GFP antibody to detect EGFP-Rab5 fusion 
protein at 60kD leads to uncertainty regarding the nature of bands observed in 
tibulin-3 transfected cell lysates. 
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Figure 3.10 Immunoblotting of cell lysates and immunoprecipitated culture media ('ell lysates 
and immunoprccipitated media from COS7 cells transiently transfected with F(iFl -tihulin-3 WT or 
R345W, or EGFP-Rab5, or untranstected cells, are detected with cr-GIP monoclonal antibody. F. GFP- 
tibulin-3 and E(FP-Rab5 was immunoprecipitated from culture media using a-GFl polyclonal 
antibody. EGFP-tibulin-3 WT and R345W are detected in cell lysates. However, EGFP-Rah5 lysate 
binding appears to be non-specific, as Rab5 is expected to migrate -60ki). An unidentified IOOkI) 
hand is detected in all immunoprecipitates, including untransfected cell culture media. 
Staining of immunoprecipitated media is observed in both the untranstected 
negative control and the EGFP-Rab5 culture media, despite the intracellular 
localisation of' Rab5, suggesting non-specific binding of antibodies either during 
immunoprecipitation or immunoblotting. Furthermore, while FGFI'-1ihulin-3 
R345W migrates as expected in cell lysates, larger immunoprecipitated secreted 
proteins are detected at I OOkD. 
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It is improbable that these blots were misaligned in this figure as the markers 
are correctly aligned in the original images and it can be clearly seen at the top of this 
figure that the wells at the top of the gel are aligned. This implies that the EGFP- 
fibulin-3 detected in the immunoprecipitates is larger than intracellular protein, 
around 70kD without the EGFP tag, or that the staining does not represent EGFP- 
fibulin-3. As a 100kD band is also detected in EGFP-Rab5 transfected and 
untransfected cell culture media it is unlikely that the staining represents EGFP- 
fibulin-3. Thus, this blot is also uninformative. 
These issues were not addressed by further experiments owing to the 
publication of a report by Roybal et al, discussed fully in section 3.9, and the 
subsequent refocusing of my research towards investigation of choroideremia in 
zebrafish (Roybal et al 2005). 
3.6 Expression of mutant fibulin-3 is toxic to cells 
Expression of fibulin-3 R345W results in intracellular accumulation of 
protein and upregulation of the chaperones GRP78 and calnexin. Upregulation of 
chaperones is invoked in the ER stress response and may lead to apoptosis and cell 
death. ER stress and intracellular protein aggregation has been implicated in a range 
of diseases (Yoshida 2007). Furthermore, a range of dominantly inherited genetic 
diseases, including retinitis pigmentosa and Stargart-like autosomal dominant 
macular dystrophy, result from the dominant negative effect of misfolded protein 
aggregates (Vasireddy et al 2005, Karan et al 2005, Grayson & Molday 2005, 
Mendes et al 2005). Induction of apoptosis in RPE cells by ER stress could produce 
a phenotype consistent with dominant drusen. 
To ascertain the effect of fibulin-3 R345W expression on cells, a method to 
measure cell survival was devised. Monitoring survival within a population of live 
cells would have been preferable; unfortunately due to the construction of the 
available fluorescence microscope this was not possible as cells have to be fixed and 
mounted before examination. 
Cells were seeded onto coverslips and were co-transfected with DsRed to 
allow identification of transfected cells, and fibulin-3 WT or R345W constructs, or 
the empty vector only. To avoid interference in cell survival from GFP expression, 
the constructs used did not contain EGFP. For each condition, four coverslips of co- 
transfected cells were fixed at 24hour intervals post-transfection for seven days. 
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To remove observer bias, images of each coverslip were taken at eight 
equidistant points along the perimeter of the coverslip (see section 2.3.7). The total 
number of transfected cells surviving in each view was calculated for each coverslip, 
at each time-point, and the raw data obtained are shown in tables 3.3 and 3.4 for 
COST and HeLa cells respectively. The experiment was performed in quadruplicate 
for each condition. 
DsRed onl 
day 1 2 3 4 5 
coverslipl 523 261 312 168 166 
coverslip2 521 147 389 156 220 
coverslip3 463 371 290 133 242 
coverslip4 477 294 177 84 235 
total 1984 1073 1168 541 863 
ematy vector + DsRed 
day 1 2 3 4 5 
coverslipl 243 211 153 149 174 
coverslip2 218 166 230 231 140 
coverslip3 126 257 133 184 159 
coverslip4 217 292 136 116 136 
total 804 926 652 680 609 
WT + DsRed 
day 1 2 3 4 5 
coverslip1 484 223 343 168 170 
coverslip2 426 316 360 161 220 
coverslip3 455 333 412 150 148 
coverslip4 442 358 282 161 137 
total 1807 1230 1397 640 675 
R345W + Ds Red 
day 1 2 3 4 5 
coverslipl 337 338 155 82 136 
coverslip2 375 325 113 75 76 
coverslip3 308 223 173 74 72 
coverslip4 656 150 143 86 112 
total 1676 1036 584 317 396 
Table 3.3 Frequency of COS7 cells expressing fibulin-3 constructs during five day time course 
Cells were seeded onto coverslips and co-transfected with DsRed, and either fibulin-3 WT or R345W. 
As positive controls, cells were co-transfected with DsRed and empty pc318 vector, or DsRed only. 
Cells were fixed at 24 hour intervals for 6 days post transfection. The number of cells expressing 
DsRed, a marker for successful transfection, was recorded in eight pre-designated regions of the 
coverslip (see section 2.3.7) and totals for each coverslip are given here. These data reflect 
approximately 40% of the coverslip surface. 
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DsRed onl 
day 1 2 3 4 5 
coverslipl 17 6 4 9 10 
coverslip2 96 14 5 7 20 
coverslip3 56 13 22 2 18 
coverslip4 31 123 9 18 8 
total 200 156 40 36 56 
empty vector + DsRed 
day 1 2 3 4 5 
coverslipl 69 16 28 12 14 
coverslip2 17 58 15 36 69 
coverslip3 88 94 19 10 13 
coverslip4 49 45 13 1 10 
total 223 213 75 59 106 
WT + DsRed 
day 1 2 3 4 5 
coverslip1 26 36 10 39 11 
coverslip2 22 101 9 36 18 
coverslip3 39 24 17 29 23 
coverslip4 65 37 15 39 11 I total 152 198 51 143 63 
R345W + DsRed 
day 1 2 3 4 5 
coverslipl 43 33 18 55 8 
coverslip2 17 29 33 27 56 
coverslip3 13 57 5 13 28 
coverslip4 61 49 9 13 8 
total 134 168 65 108 100 
Table 3.4 Frequency of HeLa cells expressing fibulin-3 constructs during five day time course 
Cells were seeded onto coverslips and co-transfected with DsRed, and either fibulin-3 WT or R345W. 
As positive controls, cells were co-transfected with DsRed and empty pc318 vector, or DsRed only. 
Cells were fixed at 24 hour intervals for 6 days post transfection. The number of cells expressing 
DsRed, a marker for successful transfection, was recorded in eight pre-designated regions of the 
coverslip (see section 2.3.7) and totals for each coverslip are given here. This data reflects 
approximately 40% of the coverslip surface. 
The number of cells observed reflects approximately 24% of the surface area 
of each coverslip (see Materials and Methods for calculation of surface area and 
assumptions used). Data have not been adjusted to estimate the total number of cells 
surviving across the whole area of -the coverslip 
to avoid introducing further 
assumptions, such as even distribution of transfected cells. 
Cell survival is calculated by finding the percentage change in number of 
cells observed each day, relative to the baseline (day 1,24 hours post-transfection, 
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when cells numbers are highest following transfection and cell division), then taking 
the mean percentage change at each time-point. This accounts for the variability in 
baseline data. These data are displayed in tables 3.5 and 3.7 for COST cells and HeLa 
cells respectively, and summarised in tables 3.6 and 3.8 for COST and HeLa cells 
respectively. 
DsRed oni 
day 1 2 3 4 5 
coverslipl 100.00 49.90 59.66 32.12 31.74 
coverslip2 100.00 28.21 74.66 29.94 42.23 
coverslip3 100.00 80.13 62.63 28.73 52.27 
coverslip4 100.00 61.64 37.11 17.61 49.27 
mean 100.00 54.97 58.52 27.10 43.88 
SD 0.00 21.75 15.68 6.48 9.12 
SEM 0.00 10.87 7.84 3.24 4.56 
empty vector + DsRed 
day 1 2 3 4 5 
coversiipl 100.00 86.83 62.96 61.32 71.60 
coverslip2 100.00 76.15 105.50 105.96 64.22 
coverslip3 100.00 203.97 105.56 146.03 126.19 
coverslip4 100.00 134.56 62.67 53.46 62.67 
mean 100.00 125.38 84.17 91.69 81.17 
SD 0.00 58.22 24.66 42.98 30.26 
SEM 0.00 29.11 12.33 21.49 15.13 
WT + DsRed 
day 1 2 3 4 5 
coverslip1 100.00 46.07 70.87 34.71 35.12 
coverslip2 100.00 74.18 84.51 37.79 51.64 
coverslip3 100.00 73.19 90.55 32.97 32.53 
coverslip4 100.00 81.00 63.80 36.43 31.00 
mean 100.00 68.61 77.43 35.47 37.57 
SD 0.00 15.42 12.26 2.09 9.53 
SEM 0.00 7.71 6.13 1.05 4.77 
R345W + DsRed 
day 1 2 3 4 5 
coverslipl 100.00 100.30 45.99 24.33 40.36 
coverslip2 100.00 86.67 30.13 20.00 20.27 
coverslip3 100.00 72.40 56.17 24.03 23.38 
coverslip4 100.00 22.87 21.80 13.11 17.07 
mean 100.00 70.56 38.52 20.37 25.27 
SD 0.00 33.77 15.46 5.23 10.38 
SEM 0.00 16.89 7.73 2.61 5.19 
Table 3.5 Survival of COS7 cells expressing fibulin-3 constructs: Cells observed at each time- 
point as percentage change relative to baseline 
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day DsRed only empty vector + DsRed WT + DsRed R345W + DsRed 
1 100.00 100.00 100.00 100.00 
2 54.97 125.38 68.61 70.56 
3 58.52 84.17 77.43 38.52 
4 27.10 91.69 35.47 20.37 
5 43.88 81.17 37.57 25.27 
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Table 3.6 Summary of mean percentage change of COS7 cells surviving relative to baseline 
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Figure 3.11 Survival of COST cells expressing fibulin-3 constructs Mean percentage of COS7 cells 
surviving relative number of cells observed per coverslip at day 1, as given in table 3.6. Error bars = 
Standard Error 
Figure 3.11 shows the mean percentage change in COST cells surviving 
relative to the number of cells observed on day 1. Co-transfection of the empty 
vector with DsRed, as a positive control, has little killing effect on the cells up to six 
days post transfection. Expression of fibulin-3 R345W appears to have a more toxic 
effect on cells than expression of fibulin-3 WT from 2 days post-transfection 
onwards: the half-life for decrease in cell numbers is around 3.8 days for cells 
expressing fibulin-3 WT, but only around 2.6 days for cells expressing fibulin-3 
R345W. This is exemplified by the lack of overlap in standard error (error bars) 
between WT and R345W conditions from day 2 onwards, and between empty pc318 
vector and the other conditions. This suggests that expression of R345W has a toxic 
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killing effect upon COST cells. However, cells were also transfected with DsRed 
only as a further positive control. These cells die at a faster rate than those expressing 
fibulin-3 WT; therefore no substantiated conclusions can be drawn from these data 
regarding the effect of fibulin-3 on cell survival. 
DsRed oni 
day 1 2 3 4 5 
coverslip1 100.00 35.29 23.53 52.94 58.82 
coverslip2 100.00 14.58 5.21 7.29 20.83 
coverslip3 100.00 23.21 39.29 3.57 32.14 
coverslip4 100.00 396.77 29.03 58.06 25.81 
mean 100.00 117.47 24.26 30.47 34.40 
SD 0.00 186.40 14.28 29.02 16.93 
SEM 0.00 93.20 7.14 14.51 8.46 
empty vector + Ds Red 
day 1 2 3 4 5 
coverslipl 100.00 23.19 40.58 17.39 20.29 
coverslip2 100.00 341.18 88.24 211.76 405.88 
coverslip3 100.00 106.82 21.59 11.36 14.77 
coverslip4 100.00 91.84 26.53 2.04 20.41 
mean 100.00 140.75 44.23 60.64 115.34 
SD 0.00 138.49 30.42 100.95 193.71 
SEM 0.00 69.24 15.21 50.47 96.86 
WT + DsRed 
day 1 2 3 4 5 
coverslipl 100.00 138.46 38.46 150.00 42.31 
coverslip2 100.00 459.09 40.91 163.64 81.82 
coverslip3 100.00 61.54 43.59 74.36 58.97 
coverslip4 100.00 56.92 23.08 60.00 16.92 
mean 100.00 179.00 36.51 112.00 50.01 
SD 0.00 190.43 9.20 52.38 27.36 
SEM 0.00 95.22 4.60 26.19 13.68 
R345W + DsRed 
day 1 2 3 4 5 
coverslipl 100.00 76.74 41.86 127.91 18.60 
coverslip2 100.00 170.59 194.12 158.82 329.41 
coverslip3 100.00 438.46 38.46 100.00 215.38 
coverslip4 100.00 80.33 14.75 21.31 13.11 
mean 100.00 191.53 72.30 102.01 144.13 
SD 0.00 170.25 82.10 58.92 155.27 
SEM 0.00 85.13 41.05 29.46 77.64 
Table 3.7 Survival of HeLa cells expressing fibulin-3 constructs: Cells observed at each time- 
point as percentage change relative to baseline 
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day DsRed only empty vector + DsRed WT + DsRed R345W + DsRed 
1 100.00 100.00 100.00 100.00 
2 117.47 140.75 179.00 191.53 
3 24.26 44.23 36.51 72.30 
4 30.47 60.64 112.00 102.01 
5 34.40 115.34 50.01 144.13 
Table 3.8 Summary of mean percentage change of HeLa cells surviving relative to baseline 
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Figure 3.12 Survival of HeLa cells expressing fibulin-3 constructs Mean percentage of HeLa cells 
surviving relative number of cells observed per coverslip at day 1, as given in table 3.6. Error bars = 
Standard Error 
The same experiment was performed in HeLa cells. No firm conclusions can 
be drawn from these data either. Here, expression of DsRed had the most toxic effect 
observed, followed by co-expression with the empty vector only. The unexpected 
reaction of HeLa cells in this assay may be partly explained by reports of unexpected 
apoptotic responses by HeLa cells to ER stress (Hitomi et al 2004). Also, the 
transfection efficiency achieved in HeLa cells, or at least the proportion of cells 
expressing DsRed as a marker of transfection, in this experiment was low: frequently 
less than 100 transfected cells were observed across the four coverslips counted, and 
consequently the standard errors overlap across all conditions. 
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There are several further limitations to these experiments. Expression of 
DsRed does not guarantee expression of the co-transfected fibulin-3 construct. A 
single population of cells was not imaged throughout the course of the experiment, as 
live fluorescent cell imaging apparatus was not available at the time this work was 
performed. Thus statistical analysis was required to take account of variability in the 
baseline readings. Robust statistical analysis was not possible due to the small 
sample number (n=4). Use of a live cell imager, or cell proliferation assays 
quantified by FACS analysis, in multiple replicates would have produced more 
informative, reliable data, and could negate the need for comparison between 
different populations (coverslips) of cells. 
In conclusion, despite the apparent trend towards toxicity in cells expressing 
mutant fibulin-3, the data obtained from COST cells are unreliable but could be 
confirmed through development of improved experimental design. 
3.7 Expression of mutant fibulin-3 may induce an apoptotic response 
Accumulation of fibulin-3 R345W in the ER and upregulation of chaperone 
proteins implies an ER stress response may be occurring, which can lead to 
apoptosis. Expression of mutant fbulin-3 may also have a toxic effect upon COST 
cells. 
Apoptosis is defined as physiological cell suicide, as opposed to necrosis, 
characterised by DNA aggregation and formation of membrane-enclosed apoptotic 
bodies and blebs containing well preserved organelles (Budihardjo et al 1999). 
Apoptosis may be triggered via an extrinsic pathway through binding of an 
extracellular death ligand, or intrinsic pathways triggered by death stimuli within the 
cell, such as oncogene activation, DNA damage or abnormal protein accumulation. 
Two intrinsic pathways have been identified - the mitochondrial pathway, 
initiated by caspase-9, and the ER pathway (Kumar 2006, Breckenridge et a12003, 
Creagh & Martin 2001, Riedl & Shi 2004). 
Caspases are a family of cysteine-dependant aspartate-directed proteases, 
some of which signal apoptotic pathways. Mammalian apoptotic caspases may be 
classified as either initiators (caspase-2, -8, -9, -10, -12) or effectors (caspase-3, -6, - 
7). The initiator caspases of the caspase cascade have autocatalytic activity, 
activating effector caspases, which are responsible for the characteristic 
morphological changes of apoptosis. (Caspases -4 and -5 are involved in cytokine 
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maturation rather than apoptosis. ) (Kumar 2006, Breckenridge et a12003, Creagh & 
Martin 2001, Riedl & Shi 2004). 
Caspase-12 localises to the ER membrane, and was originally thought to be 
the initiator of the ER stress pathway whereby long term or acute ER stress leads to 
apoptosis (Nakagawa et al 2000). Caspase-12 is redundant in most human 
populations due to a nonsense mutation in human caspase-12 (Nakagawa et a! 2000). 
Full length caspase-12 is produced in two populations of African descent, but has no 
significant effect on apoptotic sensitivity (Saleh et al 2004). It has been suggested 
that caspase-4, a homologue of mouse caspase-12, can function as an ER stress 
specific caspase in humans (Hitomi et al 2004). 
The mitochondrial and ER stress pathways converge at caspase-9, thus the 
role of caspase-12 in ER stress is now unclear. Recent reports suggest that ER stress 
is dependant on activation of Apaf-1 within the apoptosome, which then activates 
caspase-9, upstream or independent of caspase-12 (Shiraishi et al 2006, Di Sano et al 
2006, Obeng & Boise 2005). Instead, caspase-12 may play a role in inflammation 
rather than apoptosis. Mitochondria-initiated apoptosis may also be involved in ER 
stress, due to the calcium exchange between ER and the cytosol, eventually leading 
to release of cytochrome c from the mitochondria and onset of apoptosis (Xu et al 
2004, Zhao & Ackerman 2006). 
To test if fibulin-3 R345W induces an apoptotic response in cells via 
induction of an ER stress apoptotic response, immunocytochemistry and 
immunoblotting approaches were employed. Confirmation of this hypothesis would 
imply a mechanism whereby mutant fibulin-3 expression could lead to macular 
disease. 
3.7.1 Immunocytochemistry for caspases 
At the time these experiments were performed, caspase-12 would have been 
the preferred caspase to study as it was thought to be the initiator of ER stress 
apoptotic response. However, as caspase-12 is redundant in humans, caspase-6 was 
chosen instead as it is the effector caspase purported to be activated by caspase-12. 
To investigate how the fibulin-3 R345W mutation may lead to cell death in macular 
disease, cells were transfected with EGFP-fibulin-3 WT or R345Wconstructs, and 
immunostained for caspases of the intrinsic apoptotic pathway: the initiator caspase- 
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9 and effector caspase-6. Transfected cells were fixed at 24,36 and 48 hours post 
transfection, to follow activation of the caspase cascade in a time-dependant manner. 
Immunostaining of cells was performed using an antibody which recognised 
the effector caspase-6. Immunostaining of cells fixed at 48 hours post transfection is 
shown in figure 3.13. Unfortunately, the digital files containing images of cells fixed 
and 24 and 36 hours post transfection were corrupted during storage; therefore these 
data are not shown. 
EGFP merge 
M 
Figure 3.13 Immunostaining of ('OS7 cells expressing EGFP-fibulin-3 W7' and R345W for 
cleaved caspase-6 at 48 hours post-transfection COST cells were transfected with WT (a-c) or 
R345W (d-f) EGFP fibulin-3 constructs. At 24,36 and 48 hours post transfection, cells were fixed and 
immunostained for caspase-6. No specific caspase-6 activation is observed in cells expressing WT 
EGFP-fibulin-3 at 48 hours post-transfection. Activation of caspase-6 is not restricted to cells 
expressing mutant fibulin-3 at 48 hours post-transfection. Panels (d-f) are digital files. Digital files for 
panels (a-c) were corrupted; images have therefore been scanned from original hard copies, obtained 
in 2003, and consequently are of reduced quality relative to digital images in panels (d-f). Scale bars 
(a-c) = 100µm; scale bars (d-f) = 50µm 
At 24 and 36 hours post transfection, no staining of caspase-6 was observed 
(data not shown). One cell did show high levels of caspase-6 staining, but levels of 
mutant fibulin-3 were also abnormally high so this was likely to be an artefact, and 
unrepresentative of the population (data not shown; digital files corrupted). 
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a- caspase 6 
At 48 hours post-transfection, cells transfected with EGFP-fibulin-3 WT 
showed no specific caspase-6 activation, even among cells apparently expressing a 
high level of EGFP-fibulin-3 WT (figure 3.13a and 3.13c). A proportion of cells 
expressing R345W displayed caspase-6 staining (figure 3.13d, 3.13e, 3.13f). Lack of 
caspase-6 staining in other cells suggests variation between cells' ability to cope with 
the R345W mutation. Alternatively, caspase-6 activation may have been induced by 
abnormally high expression of fibulin-3. Not all structures which show high 
fluorescence in both the green and red channels have typical cellular morphology; 
these may be condensed apoptotic cells, or contaminating artefacts. Additionally, 
high levels of background staining in the red channel by caspase-6 antibody are 
observed. This may be due to non-specific staining by the caspase-6 antibody, or 
improper adjustment of the microscope settings. This could have been controlled for 
by staining cells with the secondary antibody only, to ascertain if it bound non- 
specifically. 
The experiment also lacks a negative control, of sham transfection and 
untransfected cells, and a positive control for caspase-6 activation. This could have 
been achieved by treating cells with staurosporine, a non-selective protein kinase 
inhibitor causing apoptosis, or another known inducer of apoptosis, for three and five 
hours, to show increase in caspase activation. 
Overall, the results of this experiment are inconclusive. It is possible that 
expression of fibulin-3 R345W may induce apoptosis in some cells within 48 hours. 
However, the activation of effector caspase-6 may also require longer than 48 hours 
of fibulin-3 R345W expression, during which time COST cells become over- 
confluent, and publication quality immunocytochemistry images can no longer be 
obtained. 
The data sheet provided with this antibody by the supplier (Stressgen) states 
that caspase-6 is processed from its inactive to active caspase-6 form during 
apoptosis; from this it was inferred that the antibody would show only active 
caspase-6. However, closer scrutiny of the antibody following this experiment 
revealed that the manufacturer (Chemicon) considers the antibody to be reactive with 
both the inactive procaspase and active caspase-6. Unfortunately, no antibody which 
claimed to identify only cleaved caspase-6 was commercially available at the time of 
these experiments. 
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As activation of effector caspase-6 could not be identified within 48hours 
port-transfection, caspases activated earlier in the caspase cascade were investigated 
by immunocytochemistry. The initiator caspase-9 was examined, as it is activated 
upstream of caspase-6 in the ER stress apoptotic pathway. The initiator of the ER 
stress pathway in human cells was unknown at the time this work was performed, but 
subsequently has been suggested to be caspase-9 (Shiraishi et al 2006, Di Sano et al 
2006, Obeng & Boise 2005). 
Immunocytochemistry of COST cells expressing fibulin-3 WT and mutant 
with an antibody which recognised cleaved caspase-9 only was unsuccessful (data 
not shown; digital files corrupted). With hindsight, it is probable this was because the 
antibody used was not cross-reactive with monkey caspase-9, and COST cells are 
immortalised African Green Monkey kidney cells. 
A concurrent study of caspase-9 activation in human-derived HeLa cells 
expressing EGFP-fibulin-3 WT and R345W was performed by BSc student C. 
Craddock under my supervision, also using the human-specific antibody. This study 
showed activation of caspase-9 in HeLa cells expressing fibulin-3 R345W, but not 
fibulin-3 WT. However, cells treated with actinomycin-D (an inhibitor of RNA 
polymerase, DNA polymerase and serine proteases and thus is a potent inducer of 
apoptosis) did not show activation of caspase-9, implying either failure of 
actinomycin-D to induce apoptosis, or non-specific binding of the a-caspase-9 
antibody. 
3.7.2 Immunoblotting for caspases 
As immunocytochemistry analysis of caspase activation in COST cells had 
been inconclusive or unsuccessful, an alternative immunoblotting approach was 
attempted. 
To confirm the observations seen in HeLa cells, immunoblots were 
performed against HeLa cell lysates, which showed strong activation of caspase-9 in 
cells expressing fibulin-3 R345W, and cells treated with staurosporine (an alternative 
inducer of apoptosis) for three or five hours (Short et al 2007). Activation was not 
seen in lysates from untransfected cells. However, this experiment lacks loading 
controls so comparisons cannot be made between the levels of caspase-9 activation 
under the various conditions. 
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Cell lysates were prepared from cells transfected with fibulin-3 WT or 
R345W constructs, untransfected cells, and cells treated with staurosporine for three 
hours. Proteins were resolved by SDS-PAGE, transferred to PVDF membranes, and 
successful transfer was confirmed by amido black staining. Blots were developed 
using the AP conjugated system, and checked at hourly intervals for signs of 
staining, or left to develop overnight. Repeated attempts to immunoblot from COST 
cell lysates produced no specific antibody staining (data not shown). 
Immunoblotting of untransfected cells and staurosporine treated COST and 
HeLa cell extracts showed the Stressgen a-caspase-9 antibody which was used 
initially, and in section 3.7.1, was not cross reactive with monkey caspase-9 (data not 
shown). 
A review of literature in related fields identified the a-caspase-9 
manufactured by Santa Cruz as being cross-reactive with COST cells (Liu et al 
2004); this antibody was used in subsequent experiments. 
Optimisation experiments were performed with untransfected and 
staurosporine treated COST and HeLa cell lysates to identify the most effective 
concentrations of antibodies, and development system (figure 3.14). SDS-PAGE was 
performed such that the 25kD marker band reached the bottom edge of the gel, to 
allow maximum resolution in the 50kD to 30kD range, where Liu et al had observed 
cleavage products of caspase-9 activation in COST cell lysates. 
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Figure 3.14 Optimisation of immunoblotting conditions with a-caspase-9 antibody Immunoblots 
of cell lysates treated prepared from HeLa and COST cells treated for 3 hours with staurosporine (S) 
or untreated (U). Antibody concentrations and development systems for each blot (a-d) are given in 
table. Human procaspase-9 migrates at 46kD. M, Marker; S, staurosporine treated; U, untreated. 
Antibody specific bands were detected using 1: 200 dilution primary antibody, 
and 1: 500 AP conjugated secondary antibody. No staining was detected using 1: 1000 
dilution primary antibody. Use of HRP conjugated secondary antibody at the 
recommended concentration of 1: 5000 produced a fainter signal and took longer for 
bands to develop compared with AP; AP development was therefore used for 
subsequent experiments. 
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Some uncertainty surrounds the providence of the bands observed in figure 
3.14. The manufacturer's data sheet recommends this antibody for detection of 46kD 
procaspase-9, and the IOkD C-terminus cleavage fragment. Presumably, these 
molecular weights refer to the human protein. Liu et al detected a 50kD procaspase- 
9, and 32.5kD and 16.5kD cleaved caspase fragments in apoptotic COS7 cells using 
this antibody (Liu et al 2004). There is no entry in UniProt or NCBI databases 
describing the molecular weight of African Green Monkey caspase-9. While this 
antibody does appear to cross-react with both human (HeLa) and COST (monkey) 
cell lines, the sizes of bands are slightly larger than expected. 
The detected uncleaved human (HeLa) and monkey (COST) procaspase-9 
may indeed represent 47kD and 50kD proteins respectively. However, staurosporine 
treated cells do not show any reduction in procaspase-9 band intensity, or 32.5kD 
bands of cleavage products in COST cell lysates. This may reflect failure of 
staurosporine to induce apoptosis, but without proper loading controls or resolution 
of fragments below 25kD, it is difficult to know where the source of error lies. 
Having established cross-reactivity between Santa Cruz antibody and COST 
caspase-9, experiments to investigate the effects of fibulin-3 mutation on caspase 
activation were commenced (figure 3.15). 
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Figure 3.15 Effect of fibulin-3 expression of caspase-9 cleavage. Cell lysates were prepared from 
COS7 cells transfected with vector only (VO), fibulin-3 wild type (WT), Fibulin-3 R345W (R345). 
Lysates from COS7 and HeLa cells incubated and treated for 3 hours with staurosporine (STS) were 
used as positive controls, untreated untransfected (UT) COS7 and HeLa cell lysates were used as 
negative controls. Procaspase-9 is detected at -47kD; and an apparent cleavage produce is detected at 
-4 1 W. M, Marker 
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Immunoblotting was performed on cell lysates prepared from COST cells 
transfected with fibulin-3 WT and 8345 W, without the GFP fusion, and also cells 
transfected with empty vector. Lysates from staurosporine treated and untreated 
COST and HeLa cells were added as positive and negative controls respectively; 
HeLa cells were included to check cross-reactivity of the antibody. 
An apparent procaspase band is observed at -47kD in STS treated and 
untreated HeLa cells. STS treated COST cells have both a procaspase band and an 
apparent cleavage product at 4lkD. All other treatments show only an apparent 
cleavage product at 4lkD. 
The immediate interpretation of figure 3.15 was that apoptosis was occurring 
in all COS7 lysates tested, as an apparent cleavage product, smaller than the apparent 
procaspase, was detected. Even with this erroneous interpretation, an unexpected 
pattern of binding was observed. Subsequently, attempts were made to re-optimise 
the production of COST lysates without inducing apoptosis, and also to ensure 
efficacy of staurosporine treatment as an inducer of apoptosis for positive controls. 
The band observed at 41kD, assumed to be cleaved caspase-9, is inconsistent 
with the results published by Liu et al of caspase activation in COST (Liu eta! 2004). 
They report cleavage of 50kD procaspase-9 in transfected COST cells to produce 
34kD and I8kD active enzymes (although their data appear to suggest cleavage 
products to be -32kD and -18kD). Also, having noted that monkey procaspase-9 
appears larger than its human homologue in figure 3.14, here the procaspases appear 
to migrate together. 
Further consideration of my experimental results in light of the discrepancy 
with published results leads to the conclusion that there are probably multiple Santa 
Cruz a-caspase-9 antibodies available. Liu et al do not specify which particular type 
or product code of antibody was used in their experiment. 
3.7.2.1 Re-optimisation of controls 
Previously, cell lysates were prepared from cells scraped off their culture dish 
with a cell scraper. To ensure mechanical force was not inducing apoptosis in COST 
cells, cells were treated with MPer reagent to gently detach cells from culture dishes. 
Fresh lysates were prepared on the day of each experiment, in the presence of 
protease inhibitors to ensure that caspases were not being degraded by endogenous 
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proteases, during storage, or by freeze-thawing. Also, all antibody solutions were 
filtered prior to incubation with blot membranes to ensure aggregation of antibodies 
was not producing erroneous binding patterns. 
Repeated trials with these revised experimental conditions failed to produce 
any marked improvement in clarity of immunoblots, or success of control treatment 
conditions (figure 3.16). 
(a) 
25kD 
(b) 
50kD ,* 
37kD w` 
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Figure 3.16 Re-optimisation of staurosporine treated and untreated COST controls COS7 cells 
were harvested using MPer reagent and lysed in presence of protease inhibitors. Antibodies were 
filtered prior to incubation with blots. Loading of 25Ftg/lane (a), and 50Etg/lane (b) of protein from 
each treatment, gave a reproducible pattern of antibody binding, but no discernable difference in 
antibody binding pattern can be found between positive staurosporine treated (STS) and negative 
untreated (UT) control lanes. M, Marker. 
As untreated cells appear to produce the same antibody binding pattern as 
those treated with the apoptosis inducer staurosporine, a final attempt was made to 
obtain samples from non-apoptotic cells. 
Reasoning that cells which grew successfully in culture for up to 3 days 
would be unlikely to experience apoptosis until they reached overconfluence, a time 
course was performed. COST and HeLa cells were seeded and grown in culture for 1, 
2 or 3 days, and then either treated or not treated with fresh staurosporine for 3 hours 
before harvesting and preparation of lysates. 
The experiment was performed twice, and on neither occasion was a 
recognisable pattern of cleaved caspase-9 detected (figure 3.17, figure 3.18). 
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Figure 3.17 Preparation of lysates from healthy cells shows no discernable pattern of caspase-9 
cleavage. COS7 (C) and HeLa (H) cells were seeded and grown in culture for 1,2 or 3 days before 
harvesting. Cells were treated (STS) or untreated (UT) with staurosporine at each time-point. Samples 
were run over two gels, blots are aligned according to position of marker bands, dashed line denotes 
join. Procaspase-9 band detected -47kD in all HeLa cell lines and -50kD in untreated COST cells at 
day I and day 2. Cleavage product of -34kD detected in untreated COS7 cells at day I and day 2, and 
STS treated COS7 cells at day I and day 3. Possible cleavage product detected --41 kD in 
staurosporine treated HeLa cells at day 2, and staurosporine treated COS7 cells at day 3. M, marker. 
COS7 HeLa 
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Figure 3.18 Preparation of lysates from healthy cells shows no discernable pattern of caspase-9 
cleavage (repeat of experiment 3.17) COS7 (C) and HeLa (H) cells were seeded and grown in 
culture for I day (1), 2 days (2), or 3 days (3) before harvesting. Cells were treated (STS) or untreated 
(UT) with staurosporine at each time-point. Samples were run over two gels, blots are aligned 
according to position of marker bands, dashed line denotes join. Procaspase-9 detected - 50kD in 
COST cell lysates at day 2 and day 3. Possible cleavage products detected at 41 kD in COST and HeLa 
cells at day 2 and day 3, and at 36kD in COST cells at day 2 and day 3. No discernable difference in 
antibody binding pattern can be found between positive staurosporine treated (STS) and negative 
untreated (UT) control lanes. M, marker. 
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Lysates from COS7 and HeLa are resolved on separate gels and blots to allow 
detection of COS7 caspases without overexposure of HeLa lysates (figure 3.18). 
Again, antibody binding of COST cell lysates is very faint, and so the visible bands 
may be background staining. No cleavage products are seen following STS treatment 
of HeLa cells. Examination of amido black stained control blots suggests that all the 
day 1 cell lysates were loaded at very dilute concentration (data not shown), despite 
quantification of cell lysate protein concentrations prior to loading. Also, there was 
more HeLa cell lysate protein loaded in day 3 than day 2 lanes. This is reflected by 
the increasing intensity of staining over the time course. However, without proper 
loading controls no significance can be attached to the variation in intensity of 
staining of lysates between day 1 and day 3 in figure 3.18. 
No cleavage products of caspase-9 were observed in STS treated HeLa cells 
in figure 3.17 and 3.18, except for the HeLa cells treated with STS at day 2 in figure 
3.17. However, the possible band at 4lkD does not correspond with the antibody 
specificity described by the manufacturer. 
Specific detection of caspase-9 in COST cell lysates was inconsistent in 
figure 3.17 and non-existent in figure 3.18. In figure 3.17, all lysates exhibiting 
antibody binding show a band at -34kD, which was assumed to indicate a cleaved 
caspase fragment. However, as outlined in section 3.7.2, the source of this band is 
unknown. 
To summarise, these experiments did not produce any conclusive findings 
regarding the activation of apoptosis in response to expression of mutant fibulin-3. In 
section 3.7.1, no specific upregulation of effector caspase-6 was observed in 
response to mutant EGFP-fibulin-3 R345W within 48 hours. This may be because 
effector caspases are not activated within 48 hours of exposure to mutant fibulin-3, 
or mutant fibulin-3 may not induce an apoptotic ER stress response, or an 
inappropriate choice of antibody. 
Immunoblotting for caspase activation was also inconclusive, for many 
reasons. Firstly, protein loading was quantified only by using BCA assay to estimate 
protein concentration and subsequently calculate required volumes of lysates for 
loading, and Amido black or Ponceau staining of blots to ensure successful protein 
transfer and even loading. However, Ponceau staining is reversible so no data are 
available to measure protein loading. Use of a-actin antibody staining or similar 
loading control would have been appropriate. Note however that a-calnexin staining 
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as a loading control would have been mis-informative as calnexin is upregulated in 
response to mutant fibulin-3. This is equally applicable to the immunoblots shown in 
section 3.5. 
Comparison of HRP and AP conjugated colorimetric detection systems 
suggested AP to be a more sensitive technique. However, sensitivity of AP for 
detection of faint bands, especially in COST lysates, was poor. The enhanced 
chemiluminescence (ECL) system has greater sensitivity, and was used in later 
experiments to detect fibulin-3; however ECL was not available in my laboratory at 
the time these experiments were performed. 
Crucially, there is ambiguity regarding the size of caspase-9 cleavage 
products detected by the Santa Cruz antibody used. Published data suggested the 
antibody detected a 34kD cleavage fragment (Liu et al 2004), and my blots were 
resolved such that this cleavage fragment would be visible. Indeed, a 34kD peptide 
was detected in COST lysates in figure 3.17. However, Santa Cruz recommend this 
antibody for use in detection of 47kD procaspase-9 and 1OkD C-terminal (active) 
plO fragment. As the antibody supposedly recognises the C-terminal lOkD plO 
fragment, it should not detect the large subunits of caspase-9, which weigh 35kD and 
37kD following cleavage. 
If these experiments were repeated, SDS-PAGE gels should be resolved such 
that lOkD peptides are also visible on immunoblots to allow identification of the 
lOkD plO fragment produced by caspase-9 cleavage, or indeed the 18kD fragment 
reported by Liu et al (2004). 
The apparent failure of staurosporine treatment may also be due to erroneous 
resolution of these blots. If the I OkD peptides were visible, it would be clear whether 
staurosporine treated cells produce a lOkD cleavage fragment. Without this 
information, it is unknown whether the positive control failed to induce apoptosis or 
whether the experiments failed to detect the positive control. 
Similarly, if this issue was resolved, further controls could be added to aid the 
interpretation of future experiments. Staurosporine treatment for five hours as well as 
three hours could confirm caspase activation in a stimulus dependent manner. Sham 
transfections without DNA should confirm that the transfection process itself is not 
toxic to cells. 
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Alternatively, other methods are available for detecting apoptotic cells. 
TUNEL staining, DNA laddering analysis or Annexin V staining would all indicate 
whether cells are undergoing apoptosis without examining the status of caspases. 
3.8 Summary of results 
Fibulin-3 R345W is retained within cells, suggesting defects in folding or 
trafficking of the protein. Co-localisation of mutant fibulin-3 with the chaperones 
GRP78 and calnexin indicates that it is sequestered in the ER. In contrast, fibulin-3 
WT shows faint intracellular staining, concomitant with its secretion and role as an 
extracellular matrix protein. Incubation of transiently transfected cells expressing 
fibulin-3 WT at 20°C results in perinuclear localisation of fibulin-3, as protein is 
prevented from exiting the Golgi apparatus. Thus, fibulin-3 is normally trafficked 
along the secretory pathway via the ER and Golgi prior to secretion from the cell. 
Expression of fibulin-3 R345W also leads to the increased expression of 
GRP78 and calnexin. Induction of ER chaperones promotes correct folding of 
nascent polypeptides, and is a constituent of the ER stress response. Thus it was 
hypothesised that prolonged ER stress in Dominant Drusen patients may lead to 
induction of apoptosis in RPE cells. A cell survival assay was performed to 
investigate if expression of mutant fibulin-3 and subsequent ER stress may have a 
toxic effect upon cells. While a trend towards toxicity in COST cells expressing the 
R345W construct was observed, the data collected were uninformative owing to low 
sample number and failure of positive controls in both cell lines assayed. 
Immunocytochemistry and immunoblotting approaches were inconclusive regarding 
the induction of an apoptosis in cells expressing mutant fibulin-3. 
3.9 Discussion in light of Roybal et al 
The autosomal dominant inheritance of Dominant Drusen suggests a gain-of- 
function pathogenic mechanism may underlie this disease. The objective of the work 
described in this chapter was to discover if reduced secretion of fibulin-3 R345W 
resulted from accumulation of mutant fibulin-3 protein in the ER, and consequently 
induced ER stress. As prolonged or acute ER stress may induce apoptosis, this could 
explain the RPE atrophy observed in Dominant Drusen patients, and contribute to the 
morphogenesis of drusen. 
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In addition, I sought to characterise the properties of fibulin-3 R345W which 
may influence its folding, with the aim of proposing therapies for amelioration of the 
suspected misfolding of the mutant protein. Misfolding of fibulin-3 R345W is 
implied by its reduced secretion, altered migration under reducing conditions, and 
numerous intramolecular disulphide bonds (Marmorstein et al 2002). While the 
research reported in this chapter was in progress, Roybal et al published a report 
linking expression of mutant fibulin-3 to activation of the Unfolded Protein Response 
and VEGF activation (Roybal et al 2005). This publication confirms much of the 
work contained in this chapter. 
3.9.1 Trafficking of fibulin-3 
The trafficking of proteins from the ER, the site of protein synthesis, to their 
target membrane is a highly regulated process. As fibulin-3 is secreted into the 
extracellular matrix, its target membrane is assumed to be the plasma membrane. The 
reduced secretion of mutant fibulin-3, combined with intracellular accumulation of 
the mutant in the rat cell line RPE-J, suggested failure in the normal processing and 
trafficking of mutant protein (Marmorstein et a! 2002). 
To investigate this further, fibulin-3 R345W was shown to accumulate within 
the cell in three cell lines, including the human RPE cell line ARPE-19 (figure 3.1). 
Furthermore, this accumulation of mutant protein was shown to localise to the ER, 
by overlapping immunostaining of chaperone proteins GRP78 and calnexin (figures 
3.2 and 3.3). Localisation of fibulin-3 R345W in the ER is confirmed in figure 1 of 
Roybal et al's recent publication (2005). The ER is the site of fibulin-3 translation, 
folding and processing prior to transport to the Golgi apparatus. Trafficking of 
fibulin-3 through the Golgi apparatus is confirmed by retention of WT fibulin-3 in 
the perinuclear region following incubation of transfected cells at 20°C, which 
blocks protein exit from the Golgi apparatus (section 3.4). Passage of fibulin-3 
through the Golgi apparatus also indicates that this protein is trafficked via the 
secretory pathway. 
The Golgi apparatus is the site of post-translational modification of many 
proteins, particularly those destined for secretion. The fibulin proteins are subject to 
N-linked glycosylation, and a potential N-glycosylation site exists at Asn249, and 
two potential O-glycosylation sites. I had hoped to investigate further the 
glycosylation state of WT and mutant fibulin-3, both within and without the cell. No 
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data have yet been published describing the glycosylation of fibulin-3, and it has not 
yet been confirmed that fibulin-3 is glycosylated. Furthermore, analysis of the 
glycosylation of fibulin-3 R345W (if indeed fibulin-3 is glycosylated) might reveal 
whether the defect in processing mutant fibulin-3 occurs in the ER of Golgi 
compartments. 
Finally, Marmorstein et al reported that 13% of mutant fibulin-3 is secreted 
from cells in their experiments. This raises an interesting question with implications 
for disease pathogenesis: are the fibulin-3 R345W molecules which exit the cell 
properly folded and glycosylated? Previously, characterisation of fibulin-3 has been 
limited to the intracellular protein population. Immunoprecipitated fibulin-3 from 
culture media of cells transfected with mutant fibulin-3 constructs, as attempted in 
section 3.5, could have been used to investigate this area further. Additionally, as 
fibulin-3 contains six calcium binding EGF-like domains, it would be prudent to 
assay the functionality of calcium binding in both intracellular and secreted fibulin-3 
R345W. The data gleaned from these experiments would provide valuable 
information for understanding of disease pathogenesis: if only correctly processed 
fibulin-3 R345W reaches the extracellular matrix, disease pathogenesis must arise 
from either reduction in levels of functional fibulin-3, or from some intracellular 
effect upon the cells synthesising the mutant protein. In Dominant Drusen disease, 
these are the RPE cells. 
3.9.2 Responses to protein misfolding 
Expression of the chaperones GRP78 and calnexin is increased in cells 
expressing fibulin-3 R345W, relative to cells expressing the WT protein (figures 3.2 
and 3.3). Roybal et al also performed immunocytochemistry and observed increased 
staining of GRP78 in cells expressing mutant fibulin-3. They confirmed this by 
immunoblotting for GRP78, and Northern blotting, to show upregulation of GRP78 
mRNA expression. Additionally, they show increased expression of the transcription 
factor XBP-1, which is activated as part of the Unfolded Protein Response (Calfon et 
a! 2002). The Unfolded Protein Response is one of four pathways which can lead to 
an ER stress response in mammalian cells. In the presence of unfolded polytpeptides, 
the reduction of free GRP78, as it is sequestered into complexes with unfolded 
proteins, is the signal for induction of the UPR (Gething 1999). The UPR is the 
pathway by which reduction in free GRP78 leads to increased expression of 
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chaperone proteins required to promote protein folding and alleviate ER stress. Thus 
my results confirm the work of Roybal et al in establishing a link between expression 
of mutant fibulin-3 and ER stress (2005). It is not known whether the lectin calnexin 
binds directly to nascent fibulin-3 R345W, or is merely one of many ER chaperones 
induced to promote clearance of unfolded proteins during ER stress. Intracellular co- 
localisation of mutant fibulin-3 with a lectin, which binds nascent glycoproteins, 
does imply that fibulin-3 undergoes post-translational glycosylation. 
Prolonged or acute ER stress may lead to the induction of apoptosis. Despite 
attempting several approaches to test for apoptosis in cells expressing fibulin-3 
constructs, no firm evidence of apoptosis was collected. The apparent trend towards 
toxicity in COST cells expressing mutant fibulin-3, shown in figure 3.11, is 
intriguing. Roybal et al report that they too found expression of mutant fibulin-3 to 
be toxic; in ARPE-19 progressive cell death occurs following expressing of the 
mutant protein for periods of greater than four days (although no data are shown to 
support their findings). 
Roybal et al also observed that expression of fibulin-3 WT constructs was 
stressful to cells, resulting in mild upregulation of GRP78 and expression of XBP-1. 
They attribute this to the additional protein production activating the UPR in an 
attempt to match ER capacity to increased ER processing demand. While I observed 
a subset of cells where expression of EGFP-fibulin-3 WT was particularly high 
(figure 3.1c and 3.13a), these were not representative of the population of cells 
expressing WT fibulin-3; they mostly showed faint intracellular fibulin-3 
fluorescence concomitant with the secretion of most fibulin-3 produced. Roybal et al 
studied the intracellular protein and mRNA populations by Western and Northern 
blotting, which requires pooling of extracts from many cells. Thus, their results 
would include measurements of the level of protein and mRNA expression across a 
whole population of cells, rather than individual cells, as I observed in my 
immunocytochemistry studies. Also, these authors used ARPE-19 cells for their 
experiments, which may respond differently to COST cells in response to production 
of exogenous fibulin-3 proteins. 
Aggregation of fibulin-3 R345W in the ER may hinder folding of other 
proteins required for normal ER function. Unfolded fibulin-3 R345W may associate 
with fibulin-3 WT molecules in heterozygotes (haploinsufficency), or accumulation 
of other unfolded protein species may increase such that the protein folding and 
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degradation machinery become overwhelmed in a dominant negative manner. 
Reduction in bioavailability of other RPE proteins could contribute to the progressive 
degeneration of RPE cell function. It is unknown whether fibulin-3 R345W interacts 
with fibulin-3 WT in vivo. This could be investigated through co- 
immunoprecipitation experiments using fibulin-3 constructs, to ascertain if co- 
expression of fibulin-3 WT and R345W results in mis-targeting of the WT protein. 
Abnormal accumulation of protein has been associated with several retinal 
dystophies. Of almost 100 identified rhodopsin mutations, the majority cause disease 
through protein misfolding (Berson 1996, Chapple et al 2001, Mendes et al 2005). 
Misfolded rhodopsin cannot form the light sensing complex with I1-cis-retinal, and 
is instead found bound to BiP and Grp94, suggestive of difficulties in folding. The 
mutant protein complexes are localised in the cell body of the photoreceptor rather 
than its functional site in the rod outer segments. Rhodopsin knockout mice do not 
suffer from photoreceptor cell death, implying the loss of rhodopsin in the outer 
segments is not pathogenic. Instead failure of mutant rhodopsin to fold overwhelms 
the UPR machinery. 
Intracellular retention of mutant retinoschisin protein has been shown to be 
the pathological mechanism responsible for X-linked retinoschisis, a recessive 
juvenile onset blinding disease. Several missense and truncating mutations have been 
identified, and these prevent the normal folding and secretion of retinoschisin (Wang 
et at 2002). 
Oculopharyngeal muscular dystrophy (OPMD) is a late onset autosomal 
dominant muscular dystrophy of the muscles surrounding the eye, caused by 
expansion of a polyalanine tract in the PABPNI gene, which resulting in formation 
of intranuclear protein inclusions. As aggregation correlates with toxicity, and the 
phenotype is worsened by treatment with lactacystin, a proteasome inhibitor, it is 
deduced that protein aggregation impairs the Ubiquitin Proteasome System, which 
labels and degrades misfolded protein, and chaperone function (Abu-Baker et at 
2003). 
Mutation of ELOVL4 in Stargardt-like autosomal dominant macular 
dystrophy exerts a dominant negative effect by causing aggregation of ELOVL4 with 
mutant species of the protein (Grayson & Molday 2005). Consequently, ELOVL4 
WT lost its ER localisation and was instead mis-targeted to perinuclear inclusion 
bodies together with the mutant protein. Thus, reduction in the bioavailability of 
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ELOVL4, which synthesises long-chain fatty acids, could have negative 
consequences for photoreceptor outer segment lipid composition and renewal 
3.9.3 Consequences of fibulin-3 mutation in Dominant Drusen 
During this research, I undertook several experiments to investigate whether 
an apoptotic response is induced in cells expressing fibulin-3 R345W, as there is a 
link between ER stress and apoptosis. Apoptotic death of RPE cells in response to 
prolonged exposure to mutant fibulin-3 could account for the macular atrophy 
observed in Dominant Drusen patients (Michealides et al 2006). However, RPE 
function and cone sensitivity are maintained for a significant period in cells 
overlying drusen, despite the formation of an extensive deposit. This implies a more 
subtle effect, whereby accumulation of mutant fibulin-3 leads to extended RPE 
dysfunction prior to cell death. 
It is unknown whether drusen formation is the cause or a consequence of RPE 
dysfunction (Hageman et al 2001). Drusen may be formed following expulsion of 
damaged cytosol or phagocytic degradation by-products, caused by a variety of 
microenvironmental and/or genetic influences (in the case of Dominant Drusen, the 
fibulin-3 R345 W mutation). Alternatively, accumulation of drusen deposits in the 
vicinity of Bruch's membrane may impair exchange of metabolites and solutes 
between the RPE and choriocapillaris. 
Dendritic cells have also been shown to associate with drusen (Mullins et al 
2007). Local, chronic inflammation at the RPE-Bruch's membrane interface may 
allow recruitment of dendritic cells towards drusen. Notably, cells undergoing 
apoptosis do not typically recruit leukocytes, including dendritic cells, implying that 
RPE cell death is most likely to be by necrosis. As I was unable to establish 
experimental procedures to test for the an apoptotic mechanism of cell death in 
response to mutant fibulin-3, I can neither confirm nor exclude either the apoptosis 
or necrosis theories as being responsible for RPE cell death in Dominant Drusen 
disease. 
Roybal et al established a link between expression of mutant fibulin-3 and 
upregulation and increased secretion of VEGF, which is associated with choroidal 
neovascularisation (CNV) and subsequent loss of vision in patients with exudative 
AMD (Churchill et a! 2006). Thus, expression of mutant fibulin-3 is proposed to lead 
to CNV and subretinal haemorrhage in Dominant Drusen patients through release of 
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VEGF from RPE cells. However, the pathway leading to the upregulation of VEGF 
following activation of the UPR under ER stress is mostly undefined (Roybal et al 
2005, Abcouwer et a! 2002). It has been shown that induction of VEGF by oxidative 
is dependant upon the transcription factor ATF4 (Roybal et al 2004, Roybal et al 
2005). ATF4 is upregulated in response to ER stress, and acts as a transducer of the 
UPR via CHOP to induce genes which combat oxidative stress (Yoshida 2007, Shao 
& Ackerman 2006, Boyce &Yuan 2006). Therefore, accumulation of mutant fibulin- 
3 does not negate the action of other UPR and an ER stress response transducers in 
contributing to RPE dysfunction and drusen formation in Dominant Drusen patients. 
Indeed, VEGF upregulation cannot be the sole cause of visual loss in 
Dominant Drusen patients. Subretinal neovascularisation is an uncommon 
complication in Dominant Drusen, where macular atrophy is the principal cause of 
loss of vision (Michaelides et a! 2006). Furthermore, the fibulin-3 R345W mutation 
is not fully penetrant in Dominant Drusen: some carriers maintain normal vision until 
late in life, while there is also extreme variation in symptoms between patients 
(Michealides et a! 2006). Finally, Dominant Drusen in genetically heterogeneous, as 
only a proportion of patients have mutations in EFEMPI (Tartellin et al 2001, Sauer 
et a12001, Guymer et al 2002, Narendran eta! 2005). 
Fibulin-3 is expressed in the extracellular matrix of brain, heart, lung, 
placenta, medium-sized vessels and eye tissue. As far as is known, Dominant Drusen 
produces only a retinal phenotype, with progressive loss of visual acuity between the 
fourth and fifth decade of life. Other subtle phenotypes may occur in tissues 
expressing fiubin-3, but none has been documented to date. Expression of mutant 
fibulin-3 throughout the body in carriers may well impede the function of protein 
folding machinery in many cell types. The restriction of disease to the retina may 
reflect the increased stresses suffered by retinal cells in the face of high metabolic 
turnover and exposure to light and oxidative species, the cumulative effects of which 
only become apparent with age. 
Mutation in fibulin-5 and fibulin-6 has been implicated in AMD, and fibulin- 
5 mutation is responsible for the autosomal recessive disease cutis laxa, which results 
in impaired elastinogenesis. Many of the fibulin-5 mutations cause reduced secretion 
of fibulin-5 protein, which could impair elastinogenesis maintenance of Bruch's 
membrane (Lotery et al 2006). Fibulin-5 mutations, unlike the Dominant Drusen- 
associated fibulin-3 mutation, are inherited in a recessive fashion, although they all 
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result in reduced secretion of fibulin protein to the extracellular matrix. The 
dominant inheritance of Dominant Drusen suggests a gain of function mutation, 
through ER stress. Interestingly, fibulin-5 mutations must be less damaging to the 
intracellular environment if heterozygotes do not display disease. As all fibulins 
contain multiple calcium binding domains and putative intramolecular disulphide 
bonds, which could make them prone to causing ER stress, other factors might 
contribute to the development of disease in R345W-mutation positive individuals. 
The functionality of secreted mutant fibulin-3 in the extracellular matrix may be one 
such factor. 
Fibulin-3 was identified as a binding partner of TIMP-3, which is another 
protein found in Bruch's membrane which is both widely expressed and associated 
with macular degeneration (Klenotic et a! 2004). In non-diseased tissues, fibulin-3 is 
found in the inner and outer segments, ONL, OPL and INL. In Dominant Drusen and 
AMD, fibulin-3 accumulates beneath the RPE (Marmorstein et al 2002). Aberrant 
accumulation of fibulin-3 beneath Bruch's membrane in Dominant Drusen and AMD 
patients provides an opportunity for association between these proteins and 
formation of potentially cross linked, degradation resistant complexes. In light of the 
observed mis-targeting of fibulin-3 in diseased tissues, characterisation of secreted 
fibulin-3 R345W molecules may have offered further insight to the disease 
mechanisms underlying macular degeneration. Previous experiments on fibulin-3 
have focused on the properties of only intracellular fibulin-3 (Marmorstein et al 
2002, Blackburn et al 2003). 
3.9.4 Conclusions 
Genetic and phenotypic variability in Dominant Drusen suggests that multiple 
factors are involved in disease pathogenesis. 
Patients with R345W mutation in fibulin-3 experience intracellular 
accumulation of protein and subsequent induction of the UPR and ER Stress 
response. Prolonged exposure to ER stress may have multiple pathogenic effects. 
Upregulation of VEGF may, in some cases, lead to neovascularisation. However, the 
atrophy of the macula is the major cause of loss of vision. It is unclear whether 
drusen formation is a cause or consequence of Dominant Drusen disease. Similarly, 
it is unclear how fibulin-3 R345W leads to aberrant accumulation of fibulin-3 in the 
sub-RPE extracellular matrix. 
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Environmental and genetic factors will establish the severity of macular 
disease. Genetic variation in genes for proteins involved in the processing of nascent 
and unfolded polypeptides, and environmental factors such as oxidation leading to 
DNA damage or protein oxidation, will determine cellular ability to handle fibulin-3 
mutation. The recent implication of immunoregulated proteins in drusen formation 
and macular disease may also contribute to the progression and severity of disease 
experienced. 
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Chapter Four 
Choroideremia Phenotype in 
Zebrafish 
Choroideremia Phenotype in Zebrafish 
4.1 Identification of Homozygous and Heterozygous Fish 
4.1.1 Zebrafish Breeding 
Over a 15 month period, 236 crosses were performed; 56 crosses produced 
eggs, resulting in a total of 3830 eggs. Of these eggs 1863 were fertile, 204 of which 
were mutants (10.95%), suggesting wild type interference in the breeding of 
heterozygous individuals. 
4.1.2 Identification of Heterozygous Adults 
To maximise production of homozygous embryos we sought to identify and 
isolate heterozygous individuals, thus preventing fertilisation of eggs from 
heterozygous females by wild-type males and vice versa. 
Three protocols were trialled for extraction of DNA from embryonic 
zebrafish. The Finclip buffer extraction method is recommended for use with 
zebrafish tissues (Westerfield 2000). NaOH and GNT-K buffers are used to extract 
DNA from mouse tail clips in our laboratory (Tolmachova et al 2004). All three 
protocols successfully extracted DNA from zebrafish tissue, however only GNT-K 
buffer extracted DNA produced a PCR product (figure 4.1). 
GNT-K buffer was used to extract DNA from adult and embryonic zebrafish 
tissues. 
DNA extraction buffer 
NaOH 
GNT-K 
Finclip 
Mean Yield (ng/pL) 
72 
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Figure 4.1 Optimal DNA extraction achieved using GNT-K buffer Three DNA extraction buffers 
were trialled for extraction of DNA from adult zebrafish finclips are embryonic zebrafish. PCR was 
performed on DNA extracts using control zebrafish efla primers as described in Gilmour "The 
Zebrafish Book". PCR product was only achieved with DNA extracted using GNT-K buffer. Despite 
successful DNA extraction no product is obtained with mouse DNA as primers are specific for zebra 
fish sequence. 
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To identify heterozygous adult fish for breeding, fish were anaesthetised with 
tricaine solution and a portion of the caudal fin was removed. Fish were maintained 
in isolation while their wounds healed. An assay was developed to reliably identify 
the CHM allele amongst PCR products obtained from zebrafish finclips. There are no 
restriction sites overlaying the CHM allele; therefore primers were designed to 
introduce a Clal restriction site (figure 4.2). 
Primer Design 
WT allele GTTGGAC 
CHM allele G T G A T 
Primer G AT CG A T 
Clal site GAT;; C GAT 
Amplified Region 
97bp GTGTTOCTGCO(iCCTOCTCCAGA13hTCGAtaaagtgttttgoatctqgaaaggtaatactaaagatCCIATTMACTO07ACATTT00TTTJICAC 
Clal digest 
27 and 70 bp fragments 
OTCATTGCTOCGGCCTC3CTCCAGAGAT CGAtaaagtgttttgcatctggacaggtactactaaagatCCAATTAMCTOG. ACATTTGGTTTAACAC 
Figure 4.2 Assay to identify zebrafish heterozygous for chm allele C>T substitution at chm does 
not overlie any restriction site, thus primers were designed to introduce a restriction site in the 
presence of chm allele, by substituting '1>A and G>C upstream of mutation. Digestion of PCR 
products with Clal will cut chm alleles but not WT alleles. 
Genomic DNA extracted from deceased heterozygous fish was used as a 
template for PCR with Clal primers. A FLAG vector containing a Clal site was used 
as a positive control for the digest. Initial results showed very faint bands of digest 
product. 
To improve clarity, a Qiaquick PCR Purification kit was used to remove 
contaminants prior to enzyme digest, and digests were incubated for up to 16 hours. 
The digest products remained difficult to visualise but the 97bp band appeared 
lighter, implying digest may have occurred. Increasing the volume of DNA loaded 
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onto a longer gel, which was then run further, täiled to improve clarity of the results 
sufficiently, as shown in figure 4.3. 
Hom Hom 
Fish YS Het WT 
++-+-+ 
97bp 
70bp 
Figure 4.3 ('lal digest of '('11, N] allele (IaI diet uf'I)N \ cylract, hohl I IoIi1uiýýýuu, ti, I (I ]urn 
Fish), I Iomozygous fish yolk sac (I lom YS), heterozygous fish (I let) and Wild- I ypc fish (W I) 
amplified with CIaI primers. Faint product hand, indicating chin allele observed with I)NA from 
homozygous fish, but signal is not sufficiently strong to use as diagnostic test. Genotypes were 
confirmed by sequencing. 
Although digest products are visible For honiotvgous samples. heterozygous 
dio.; est results are inconclusive. 
To confirm the genomic sequence of' INA extracts, samples were also 
prepared for sequencing. PUR was perf)rmed using ('I IM primers designed by Starr 
el (il (2004) that amplified a 375hp region spanning the disease allele. The 
sequencing reaction was primed in the forward direction with the ('I IM I primer and 
by CIaI R primer in the reverse direction, since reverse priming 'pith the ('IIM R 
primer produced poor quality chromatograms due to sequencing slippage in poly- I' 
tracts and primer degradation. In light of inconclusive data obtained droll' ('la 
diagnostic digests, sequencing was preferred tiOr genotyping studies. 
In an initial trial with six live adult fish. tinclip sequencing successfully 
identified three fish heterozygous for choroideremia. However, during the days 
awaiting sequencing results, all the heterozygous fish suI cred infection of' their 
wounds and consequently died. At the time other healthy fish in the aquarium had 
also been dying from an unidentified infection. 'I herefore we did not pursue 
genotyping methods requiring surgery as we did not wish to lose healthy breeding 
heterozygotes. Fo increase breeding of' choroideremia fish, several tanks of young 
fish were grown to maturity and encouraged to produce high numbers of offspring. 
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4.2 Degeneration of Choroideremia Zebrafish 
The phenotype of the choroideremia zebrafish was previously described by 
Starr et al. The fish were initially identified by their hearing and balance defects. In 
addition, 5dpf mutants have an uninflated swim bladder, oedema of the heart and 
abdomen, noticeably smaller eyes and discontinuous distribution of iridiphores 
across the eye. Mutant larvae began to die on the sixth day; although proper nutrition 
is precluded by the lack of a functional swim bladder, unfed wild-type larvae survive 
for ten days, hence other factors must be responsible for the early death of 
choroideremia fish. 
Choroideremia phenotype is first noticeable at 24hpf, as a delay in pigment 
development (figure 4.4). 
24hpf 48hpf 
E 
15 U 
72hpf 
'I'1 
Figure 4.4 Choroideremia phenotype in early development WT (a-d) and CHM (e-h) siblings at 
24hpf (a and e), 48hpf (b and f) and 72hpf (c, d, g, h). CHM embryos have delayed development and 
patterning of melanophore, iridiphore and xanthophore pigment cells, smaller eyes and oedema of the 
heart. Different lighting conditions are used to highlight developmental features. 
Dark pigment arises following melanocyte differentiation in the neural crest 
around 24hpf. This develops slower in mutant fish, which are visibly lighter at 24hpf. 
Iridophores normally appear by 48hpf but are not seen in choroideremia fish before 
72hpf. Xanthophores become visible as yellow coloration of the dorsal head at 
48hpf, and migrate, firstly in an anterior-posterior fashion, and then laterally, by 
72hpf (Ziegler 2003). In contrast, mutant fish show delayed posterior migration at 
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72hpf. Choroideremia fish always display abnormal pigmentation, with fewer 
iridophores and enlarged melanophores. However, delay in pigmentation alone is not 
indicative of choroideremia, and many fish with delayed pigmentation achieve 
normal development within five days. 
Oedema of the heart can be seen first at 72hpf, although some mutants do not 
display oedema until 5dpf (figure 4.4h). Restrained growth of the eye is apparent 
from between 72hpf and 4dpf; at 5dpf, the mutants' eyes have mean length of 276µm 
(SEM = 5.7) whereas the wild-type eyes reach 350µm (SEM = 10.3; P=3.45 x 10-4). 
If mutants survive beyond 5dpf, oedema of the tissues surrounding the eye is 
common. 
The mutants are shorter and often have a curved backbone as shown in figure 
4.5. After five days of growth and development, wild-type fish will have consumed 
their yolk sac and are ready to commence independent feeding. In choroideremia fish 
much of the yolk sac remains unused, possibly through inefficiency in metabolism or 
lower energy requirements of impaired growth. 
a 
-woo 
Figure 4.5 Choroideremia in 5dpf zebrafish Wild type (a and b) and mutant (c and d) zebrafish at 
5dpf. Mutants have uninflated swim bladder, unused yolk sac, generally retarded growth, oedema, 
irregular pigmentation, smaller eyes (d) and lens abnormalities. Scale bar =1 mm 
The most noticeable indicators of choroideremia are dark pigmentation, 
retarded growth, smaller eyes, and oedema. Although the age of onset of 
degeneration is variable, choroideremia is invariably lethal in zebrafish (table 4.1). 
Fish degenerating from 48hpf will have more pronounced defects by 5dpf, and a 
similarly short life span; some die within only four days. Others may not develop 
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abnormalities until as late as 5dpf, with full phenotype not displayed until 6dpf. The 
onset of oedema, lens abnormality and enlarged melanophores is repeatedly followed 
by death. Overall, the onset and severity of phenotype is strongly correlated. In a 
cohort of 31 homozygous fish allowed to develop until fatality, the mean age at death 
was 5.4 dpf (table 4.1). 
Age at death Frequency 
4dpf 9 
5dpf 12 
6dpf 3 
7dpf 2 
8dpf 5 
----------------------------- Total ------------------ 31 
Mean age at death 5.4 dpf 
Standard deviation 1.4 dpf 
Table 4.1 Lethality of choroideremia in homozygous zebrafish Data collected in association with 
M. Moosajee 
In zebrafish, as in other teleost fish, when larvae are exposed to light their 
melanosomes become clustered and the skin melanocytes appear smaller. The 
converse response in a dark environment is the distribution of the melanosomes 
across the melanocytes, which then appear larger. Several blind zebrafish mutants 
lack the melanocyte response to light as, subjectively, they exist in a permanently 
dark environment (Kelsh et al 1996, Neuhauss et al 1999). The failure of the CHM 
melanocytes to respond to light exposure indicates that the fish are visually blind 
(figure 4.6). Krock et al (2007) have performed ERG analysis showing absence of 
retinal response to light in the CHM zebrafish. 
Figure 4.6 Failure of light response in melanophores suggests functional blindness in 
choroideremia zebrafish Melanophores of light-adapted WT fish retract melanosomes (a) under 
bright light conditions whereas CHM melanosomes remain diffuse (b). Panel (c) shows detail. Scale 
bar: 200pm 
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4.2.1 Vasculature of the Choroideremia Zebrafish 
Damage to the choroidal vasculature is implicated in human choroideremia 
(Cremers 1995). We therefore sought to characterise vascular development in the 
choroideremia fish using a transgene to act as a fluorescent vascular marker. The 
transgenic zebrafish fli expresses enhanced green fluorescent protein (EGFP) under 
the flil promotor, a known endothelial cell marker (Lawson & Weinstein, 2002). The 
transparency and external development of the zebrafish embryo allows detailed 
analysis of angiogenesis during vascularisation of the eye by time-lapse imaging. 
Crossing CHM heterozygotes with flu transgenics would produce a proportion of 
offspring carrying both the EGFP and CHM genes in the F1 generation. Carriers of 
the EGFP transgene can be readily selected under UV illumination and grown to 
sexual maturity; of these, 50% can be expected to carry the CHM allele. 
Intercrossing would produce homozygous choroideremia fish expressing EGFP-fli 
within the F2 generation. 
Fli transgenic zebrafish were available on both zebra and leopard 
backgrounds. To easily identify strains, only fli leopards were crossed with CHM 
zebras. Fish heterozygous for the CHM mutation were crossed with fli transgenics on 
57 occasions, resulting in only three clutches of eggs. Details of the offspring are 
given in table 4.2. Mutation in the offspring would not be expected in the FI 
generation as only one parent carries the CHM allele. However, incidence was 
around 33%, including Cyclops mutants and fish where the lateral eye is absent, 
suggesting other genetic or environmental factors were affecting the development of 
the F1 generation. 
Parents Eggs Eggs EGFP Mutants 
Female Male produced fertilised expression 
Fli CHM 36 19 13 10 
Fli CHM 47 0 -- 
CHM fli 33 20 83 
Table 4.2 Mutation in the offspring of CHM -fu EGFP crosses 
Mutations were not caused by interbreeding of choroideremia zebrafish, as 
some mutants showed EGFP expression; in one cross, eight out of ten mutants 
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expressed GFP. It is possible there was some deleterious interaction between the chm 
and fli alleles. Alternatively, variation in temperature within the aquarium or double 
fertilisation of eggs could have inhibited normal development. As we could not 
establish the cause of these unexpected mutations in our embryos, and as we 
obtained a maximum of eleven double heterozygotes over several months, we sought 
an alternative approach to visualise the retinal vasculature. 
Microangiography injection of dyes or 0.2µm fluorosphere beads would 
highlight the vascular network at a given stage of development, but would be lethal 
to the embryo. However, concurrent studies demonstrated unexpected features of the 
choroideremia zebrafish system, as discussed in chapters four and five, necessitating 
further study before characterisation of the choroideremia fish vasculature. 
4.3 Retinal degeneration in Choroideremia Zebrafish 
Choroideremia in humans is limited to the photoreceptor, RPE and choroidal 
tissues. The retinal phenotype in 5dpf choroideremia fish was briefly described by 
Starr et al, who performed electron microscopy on the photoreceptor and RPE layers 
(see section 1.4.2). These authors reported hypertrophic and disorganised RPE 
invading the ONL, dishevelled photoreceptor outer segments. They observed 
cytoplasmic inclusions comprised of around ten well organised laminae surrounded 
by a lightly stained amorphous mass, with no bounding membrane within RPE and 
Schwann cells of the otic ganglion (see figure 1.20). They also reported small, dense, 
presumable pyknotic cells present throughout the neural retina and degeneration of 
the posterior surface of the lens. 
To further characterise the choroideremia phenotype we prepared sections of 
retinal tissue from choroideremia fish. Fish were fixed overnight in 4% 
paraformaldehyde prior to dehydration. Initially fish were dehydrated in sucrose to 
cryoprotect tissues, then mounted in OCT and cryosectioned. However the resulting 
sections were shattered, probably due to a combination of incomplete dehydration 
and air bubbles within the sample. To improve our sections we performed serial 
dehydration with ethanol before mounting in wax. Wax sections offered excellent 
resolution of morphology, which combined with H&E staining provided clear 
images of the retinal morphology of zebrafish as young as 48hpf. 
Some samples were damaged in the sectioning process by compression of the 
soft tissues giving the fish a flattened appearance. Another common fault was lateral 
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cracking of sections, caused by incomplete dehydration or technical difficulties in 
sectioning due to the small size of samples. However the overall morphology of the 
retina can still be seen. To illustrate results some flawed sections are used in 
conjunction with clearer images to emphasise detail. 
4.3.1 Retinal Degeneration in 5dpf Choroideremia Zebraüsh 
Within wild type retinas, cell types are highly organised and laminated by 
5dpf (figure 4.9). Examination of sections from 5dpf homozygotes reveals a 
phenotype resulting in widespread damage to all retinal cell types (see figures 4.7 
and 4.8). Sectioning in both transverse and sagittal orientation shows abnormalities 
throughout the retina. Histological examination clearly shows hypertrophy of the 
RPE and abnormalities of the lens. 
Severity of the phenotype is variable between individuals. The phenotype 
shown in figures 4.7c, 4.7d, 4.7e and 4.7f is less severe but still clearly indicative of 
choroideremia. The lens is smaller, opaque, and shows severe anterior abnormalities; 
the RPE has invaded the dorsal and ventral regions of the retina; photoreceptors are 
missing and the OPL is discontinuous in the underlying retina. In the peripheral 
regions, cells appear compressed and the IPL does not extend to the retinal germinal 
zone. In figures 4.7c and 4.7d the central region of the retina appears normal, with all 
seven laminae and cell types distinct and well organised, and no evidence of cell 
death. Degeneration is more advanced in figures 4.7e and 4.7f. The photoreceptors 
have receded further from the peripheral retina. Small, dense presumably pyknotic 
nuclei are now present in the dorsal peripheral retina, ganglion cell layer and optic 
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Figure 4.7 Choroideremia zebrafish experience a range of retina degenerations by 5dpf Wild 
Type (a, b) retinas are well laminated and photoreceptor morphology is clearly defined by 5dpf. 
Dashed white line in (b) denotes margin of retinal germinal zone. Choroideremia retinal phenotype at 
5dpf of increasing severity is shown in (c), (e), (g); enlargements are shown in adjacent panels (d), (f), 
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(h). Central retina is maintained while at the periphery, photoreceptors recede from the retinal 
germinal zone and RPE becomes hypertrophic (c, d). Arrowheads in (d) indicate broken OPL. This 
may be accompanied by disruption of lamination in neural retina and presence of condensed 
presumably pyknotic cells (f, g). In most severe degeneration, photoreceptor outer segments are 
completely absent and central neural retina is disrupted (g, h). Cracks in sections are artefacts of 
sample preparation. (Sections through optic nerve were not available for fish shown in panels (g) and 
(h) as sections were degenerated and cracked to such an extent that optic nerve was not reliably 
identifiable. ) Degeneration of the lens is also a feature of choroideremia phenotype, but not appear to 
directly correlate with severity of retinal phenotype. Scale bar a, c, e, g= 25µm; scale bar b, d, f, h= 
50 pm 
a 
C 
Figure 4.8 Retinal degeneration in 5dpf choroideremia fish: sagittal orientation Wild Type (a) 
and choroideremia (c) retinal sections in sagittal orientation; enlarged in adjacent panels (b) and (d). 
Arrowheads in (d) indicate invasion of the neural retina by RPE. Note also invasion of IPL by 
condensed pyknotic nuclei in (c) and (d). Scale bar a, c, e= 25 gm; scale barb, d, f= 50µm 
nerve. Pyknotic nuclei are small highly condensed nuclei, characteristic of chromatin 
condensation during apoptotic cell death (Sahara et al 1999; Zamazami & Kroemer 
1999). 
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Figures 4.7g, 4.7h, 4.8c, and 4.8d show "worst case scenario degeneration", 
where multiple cell types are damaged. The RPE is hypertrophic and invades the 
retina, in some places forming discrete "islands" of RPE; in other areas the RPE is 
depigmented or missing. The photoreceptor cell layer and OPL are almost 
completely absent. Ordered lamination within the INL is lost and the individual cell 
types cannot be visually identified. The IPL is disrupted and pyknotic nuclei are 
present throughout the neural retina. 
Histological defects are illustrated in detail in figures 4.9 to 4.11 using 
sections from homozygotes in the later stages of choroideremia (5dpf and 6dpf as 
noted in figure legends). For morphological comparison, a detailed section of wild 
type retina is shown in figure 4.9. 
RPE 
ONL 
OPL 
INL (hcl I bcl I 
acl) 
IPL 
GCL 
Lens 
Figure 4.9 Wild Type embryonic zebrafish retina RPE, retinal pigment epithelium, OS, outer 
segments, ONL, outer nuclear layer, OPL, outer plexiform layer, INL, inner nuclear layer, (hcl, 
horizontal cell layer, bcl, bipolar cell layer, acl, amacrine cell layer) IPL, inner plexiform layer, GCL, 
ganglion cell layer. Scale bar = 25µm 
Hypertrophy of the RPE is common and seemingly unrestrained (figure 4.9c 
and 4.9d). Discrete "islands" of RPE may be visible (figure 4.9d), or hypertrophic 
REP may invade up to a third of the retina. Pigment granules are present in regions 
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proximal to the IPL (see figure 4.13h and Appendix). Conversely, the RPE is absent 
in some areas, as shown in figure 4.10. Figure 4.1Ob shows a large area of RPE loss 
adjacent to an area of hypertrophic RPE, and the neurons underlying both areas are 
similarly damaged, suggesting retinal abnormalities may be independent of the 
nature of RPE degeneration. 
1 
Figure 4.10 Discontinuous RPE in Sdpf choroideremia zebrafish retina Enlargement of (a) 
Longitudinal section; (b) Transverse section of 5dpf choroideremia zebrafish showing discontinous 
REP. Scale bars = 50 pm 
During the later stages of choroideremia, photoreceptor cell death is common. 
Photoreceptors lose their distinct columnar morphology, leaving only regular or 
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pyknotic nuclei adjacent to the RPE. The OPL also disappears, as the neurons of the 
INL lose their synaptic partners. Figure 4.11 b shows an area of retina in the process 
of photoreceptor cell death. A distinct boundary runs between morphogically normal 
nuclei in the INL, and a band of pyknotic nuclei adjacent to the RPE, tracing the line 
of the defunct OPL. Presumably the pyknotic nuclei proximal to the RPE are dying 
photoreceptor cells. 
Figure 4.11 Loss of photoreceptor morphology in 5dpf choroideremia zebrafish retina Sagittal 
section of (a) WT and (b) choroideremia retina, showing loss of photoreceptor morphology in outer 
retina in choroideremia zebrafish. Dashed line denotes probable line of OPL, beyond which 
condensed nuclei likely represent dying photoreceptor cells. No outer segments are observed. Scale 
bar = 50µm 
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In other individuals, such as figure 4.7c and 4.7d, healthy photoreceptors are 
maintained in the central retina and absent in the peripheral retina. The population of 
photoreceptors in the peripheral retina are the youngest in the retina, with increasing 
maturity of photoreceptor cells towards the central retina. Zebrafish, like other fish, 
constantly renew their retinal cells in a peripheral area known as the retinal germinal 
zone, from where they migrate towards the central retina. It is tempting to speculate, 
therefore, that in these fish the renewal of photoreceptors has ceased, while 
established older cells are maintained in the central retina. 
The pathology of human choroideremia is confined to the choroid, RPE and 
photoreceptor cells. The zebrafish suffers cell death in other retinal cell types. 
Pyknotic nuclei are visible in the ganglion and inner nuclear layer in 5dpf (figure 
4.7f, 4.8d) and 6dpf fish (figure 4.12b), indicating death of neuronal cells. Pyknotic 
nuclei also invade the inner plexiform layer (figure 4.8d, 4.12b), optic nerve (figure 
4.8d) and the region between the ganglion cell layer and lens (figure 4.7d, 4.7f, 4.7h, 
4.8d, 4.12b), suggesting the neuron's cell bodies are displaced either before or during 
apoptosis. 
The IPL normally forms a smooth arc extending between the retinal germinal 
zones around the lens and ganglion. However, the IPL has unusually sharp curvature 
in choroideremia fish (figures 4.7e, f, g, h, and figure 4.12b). It also fails to reach as 
far as the retinal germinal zone (figures 4.7c, d, and figure 4.12b). In extreme cases 
the invasion of INL and ganglion cells makes the IPL indistinguishable (figures 4.8d 
and figure 4.10a). Loss of the OPL appears to correlate with photoreceptor loss, 
unlike mammalian choroideremia. Presumably the synaptic layer becomes 
disorganised following the loss of photoreceptor cell morphology (figure 4.7d, figure 
4.10, and figure 4.12b). 
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Figure 4.12 Pyknotic nuclei in neural retina of 6dpf choroideremia zebrafish retina Transverse 
section of 6dpf (a) WT and (b) choroideremia retina, with arrowheads indicating condensed pyknotic 
nuclei throughout the neural retina, including invading the OPL. Scale bar = 50 µm 
The lens contains two cell types: primary lens fibres, composing the lens 
proper, and a surrounding monolayer of lens epithelial cells. Lens fibre cells have an 
unusual intracellular organisation, involving degradation of their nuclei and 
membrane bound organelles, cytoskeleton reorganisation and crystalline over- 
expression, leaving a clear path for light through the cell. Cells at the nucleus of the 
lens are oldest, and growth proceeds circumferentially at the perimeter among the 
fibre cells. Thus defects at the lens perimeter most likely affect the youngest lens 
cells (Gross et al 2005; Dahm et al 2007). Degeneration of the lens correlates with 
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its opaque appearance amongst CHM fish prior to sectioning (see figure 4.5d). In 
mid-stage choroideremia degeneration, normal lens nucleus morphology combined 
with abnormalities at the perimeter, as illustrated strikingly in figure 4.7c and 4.7d 
(also figures 4.7h and 4.12b). In more advanced degenerations, the whole lens 
appears discoloured and smaller (see figures 4.7 g, h and 4.8c, d). Additionally, the 
degeneration and shrinkage of the lens distorts the surrounding tissues. Since 
degeneration first occurred at the lens perimeter, it appears that the youngest lens 
cells degenerate first, followed by the older cells within the lens nucleus. Increased 
opacity could be correlated with a defect in the intracellular trafficking process and 
protein over-expression during lens fibre cell differentiation. 
Overall, the choroideremia phenotype results in a loss of lamination within 
the retina (figures 4.7g, h; figure 4.8c, d; figure 4.10, figure 4.11, figure 4.12). RPE 
invades the retina, photoreceptors lose their morphology, the ONL becomes 
disordered and disappears, and the individual cell types of the INL and ganglion 
become displaced and invade the IPL. The retinal phenotype of choroideremia in 
zebrafish is much more severe than that in humans, affecting cellular subtypes 
beyond the outer retina, and is displayed at a much earlier stage in life. 
Choroideremia impairs human vision from the teenage years onwards; zebrafish 
suffer severe retinal damage within five days. 
4.4 Progression of Retinal Degeneration 
Identification of the cell types that degenerate may give clues towards the 
sequence of events leading to the severe phenotype seen in 5dpf choroideremia 
zebrafish. To improve our understanding of the pathology of the retinal degeneration, 
we examined the retinal phenotype in chm mutants in the early stages of disease by 
standard histology. 
By external inspection, homozygous mutant larvae can be reliably identified 
at 3dpf due to their body pigmentation, oedema and reduced eye size. The 
photoreceptors occupy a large proportion of the eye relative to other cell types from 
3dpf, when formation of the outer segments is initiated (Schmitt & Dowling 1996; 
Tsujikawa & Malicki 2001). Hence we examined sections of mutant and wild type 
eyes from 3pdf onwards, hypothesising that the reduced eye size would be caused by 
photoreceptor cell death as early as 3dpf. Sectioning was performed in transverse and 
longitudinal orientation to confirm findings (figures 4.13 and Appendix). 
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Additionally, the variation in degeneration onset is summarised in table 4.3 and 
section 4.5. 
WT 
CL 10 
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Figure 4.13 Retinal degeneration occurs rapidly between 4.5dpf and 5dpf Transverse sections 
through optic nerve where available. Panels show development of WT retina at 3dpf (a), 4dpf (c), 
4.5dpf (e), and 5dpf (g). Adjacent panels show development and degeneration of choroideremia retina 
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at 3dpf (b), 4dpf (d), 4.5dpf (f) and 5dpf (h). Rapid degeneration in choroideremia zebrafish 
progresses between 4.5dpf, where photoreceptors are lost in a band dorsal to the optic nerve, and 5dpf 
where all retinal and lens tissues are disrupted. (a) is 501im posterior of optic nerve; (b) is 5µm nasal 
of optic nerve; (c) is 65µm nasal of optic nerve; (h) suffered severe degeneration and thus optic nerve 
could not be identified. Additional sagittal sections are given in Appendix. Scale bars = 50µm. 
Surprisingly, sections from 3dpf (n=5) (figure 4.13b) and 4dpf (n=4) (figure 
4.13d) do not show any evidence of severe degeneration consistent with 
choroideremia, despite the smaller eye cup. The RPE has regular thickness, 
photoreceptors have normal morphology, the plexiform layers are clearly defined, 
and the different cells types of the INL and ganglion cell layer are well defined and 
laminated. 
As development proceeds, the earliest evidence of retinal degeneration was 
observed in fish euthanised at 4.5dpf (n=4). In both transverse and longitudinal 
sections, photoreceptors and the OPL were absent in a band running across the retina, 
dorsal to the optic nerve (figures 4.13f). Serial alignment of transverse sections 
reveals photoreceptor loss in corresponding regions in both eyes, in the dorsal- 
posterior quadrant of the retina (figure 4.14). A second area of photoreceptor loss is 
present in the ventral-posterior quadrant of the medial eye (figure 4.15). The 
underlying RPE is of uniform thickness, and, intriguingly, there is no evidence of 
pyknotic nuclei in place of the missing photoreceptors (figure 4.14q). 
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Figure 4.14 Photoreceptor loss in 4.5dpf chm zebrafish: Lateral eye Serial transverse sections in 
posterior (a) to nasal (p) direction. (q) detail of panel (k) Photoreceptors are lost in a band dorsal to the 
optic nerve, but no apparently pyknotic nuclei are observed. 
A similar phenotype is observed in a sagittaly sectioned 4.5dpf fish shown in 
the Appendix, where a band of photoreceptors dorsal of the optic nerve are missing. 
This individual also showed evidence of RPE hypertrophy in some areas 
photoreceptor loss. However photoreceptors were also absent from areas with 
histologically normal RPE. 
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Figure 4.15 Photoreceptor loss in 4. Sdpf chm zebrºfish: Medial e}e Serial transverse sections in 
posterior (a) to nasal (h) direction. Photoreceptors are lost in two parallel bands dorsal to the optic 
nerve, but no apparently pyknotic nuclei are observed. 
These data show the retinal degeneration in choroideremia to be catastrophic. 
We could find no histological evidence of retinal degeneration before 4.5dpf; yet 
only twelve hours later, at 5dpf, severe retinal degeneration was observed. The speed 
of degeneration hampered efforts to isolate individual cell types that were more 
susceptible to the choroideremia mutation. However, photoreceptor loss and RPE 
abnormalities suggest that both photoreceptors and RPE are damaged in the early 
stages of choroideremia in zebrafish. 
4.5 Variability in Onset of Degeneration 
The speed of retinal degeneration in choroideremia zebrafish is surprising, 
particularly compared to the decades-long progression of human disease. In zebrafish 
the degeneration appeared over a twelve hour window; with such a rapid 
degeneration, it is difficult to be certain which cell types are lost, and in which order, 
without using a model that allows live in vivo imaging of the retina. 
To fully assess the progression of degeneration observed, a survey was made 
of all sectioned retinas accumulated in this study. In transverse orientation, sections 
through the optic nerve were examined; sagittal sections were examined at the point 
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where optic nerve reached the GCL (or as close as was available thereto). Sections 
were assessed for severity of RPE, photoreceptor and lens degeneration. Severity was 
classified as four levels: (o) indicates no degeneration was observed; (x) indicates 
slight thickening of the RPE in less that half the retina, loss of photoreceptor 
morphology in less that 25% of the retina, slight disruption of the peripheral lens but 
normal lens size; (xx) indicates slight thickening of the RPE in across the whole 
retina, loss of photoreceptor morphology in less that 50% of the retina, alteration in 
size of lens; (xxx) indicates hypertrophy of the RPE such that it invades the neural 
retina or discontinuous RPE, loss of photoreceptor morphology over 75% of the 
retina, disruption of the lens core. The frequency of apparently pyknotic nuclei in 
sections was also recorded. 
Phenotype & n RPE Photoreceptors Lens Freq pyk. 
age o x xx xxx o x xx xxx 0 x xx xxx nuclei 
3dpf WT 5 100 --- 100 --- 100 --- 0,0,0,0,0 
4dpf WT 5 100 --- 100 --- 100 --- 0,0,0,0,0 
4.5dpf WT 5 100 --- 100 --- 100 -- 0,0,0,0,0 
5dpf WT 5 100 --- 100 --- 100 --- 0,0,0,0,0 
6dpf WT 5 100 --- 100 --- 100 --- 0,0,0,0,0 
3dpf CHM 5 l00* --- 100" --- 100* - 0,0,0,0,5 
4dpf CHM 4 100 --- 100 --- 100 --- 0,0,0,0 
4.5dpf CHM 4 100 --- 50 25 25 - 75 25 -- 0,0,0,0 
Sdpf CIHM 5 20 - 40 40 20 - 40 40 20 20 - 60 0,54,60, 
251,421 
6dpf CHM 5 20 20 40 20 40 - 40 20 20 20 60 - 0,2,45,72, 
188 
Table 4.3 Degeneration of zebrafish retinas throughout development Sections of WT and CHM 
zebrafish retina at the optic nerve, or as close as possible thereto as was available, were assessed for 
signs of degeneration of RPE, photoreceptors, lens, and frequency of pyknotic nuclei (Freq pyk. 
nuclei). Degeneration was assessed on a scale from unaffected (o) through increasing severity (x, xx, 
xxx) and a category of severity assigned to each retina. Percentage of retinas falling within each 
category is given. Number of fish examined is given (n); and results are given as percentage of retinas 
falling within each category. Frequency of pyknotic nuclei observed in each retina is also recorded 
(right hand column). *Two 3dpf CUM fish which exhibited delayed development, such that they 
resemble 2dpf WT retina, were classified as unaffected 
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Results from 4.5dpf animals suggest photoreceptors in the central retina are 
the first retinal cell type to succumb to choroideremia. By 5dpf, some fish showed 
loss of peripheral photoreceptors only, with central photoreceptors maintained. 
Others had already suffered severe retinal degeneration and no photoreceptors 
remained. Interestingly, some "mid-degeneration" retinas had morphologically 
normal central photoreceptors, but do not have any young photoreceptor cells in the 
peripheral retina. This implies more than one mechanism for photoreceptor loss in 
the choroideremia zebrafish. 
Further in development, at 6dpf (figures 4.12b) the retinal phenotype was not 
noticeably more severe than at 5dpf. Logically, older fish would be expected to show 
more severe disease. These counterintuitive observations suggest that the 
choroideremia phenotype is stochastically variable. Variation in disease severity at 
6dpf could also be influenced by operating procedures in the aquaria, and by the 
protocols used in rearing the fish. Age of disease onset varied between individuals: 
some would exhibit symptoms as early as 24hpf; other homozygotes did not show 
symptoms until as late as 5dpf, after which degeneration would be rapid, with no 
homozygotes surviving longer than eight days. Thus, fish that did not commence 
degeneration until 5dpf could still have relatively mild retinal degeneration when 
sacrificed at 6dpf. 
It is difficult to predict the severity of disease in fish prior to disease onset. 
As has been outlined in figure 4.7, individuals at the same developmental stage 
display varying degrees of disease; thus 6dpf fish may exhibit symptoms on a par 
with 5dpf fish. However, fish that would have exhibited the most severe retinal 
degeneration at the 6dpf time-point are highly likely to die before this time-point, 
due to the many other systemic failures choroideremia causes in fish. Unfortunately 
homozygotes that had succumbed to end stage choroideremia were unavailable for 
study, as these are consumed by protozoa in the aquarium water soon after death. 
Perhaps the variation in severity of disease with time suggests that a classification 
based severity of disease would be more useful than an absolute time-point 
measurement in describing choroideremia development. 
Although immunocytochemistry could have been used to confirm which cell 
types are lost in the later stages of choroideremia, we did not pursue this approach 
for two reasons. Firstly, we cannot predict the stage of retinal degeneration of 
choroideremia fish from age alone. Secondly, immunocytochemistry experiments on 
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the choroideremia zebrafish were displayed at the ARVO 2006 meeting by others 
working in the field. Their results showed normal rhodopsin trafficking, but 
dishevelled and disorganised cones and no staining of cone synapses in mutant fish. 
This work has since been published by Knock et al 2007. Furthermore, given the 
speed and severity of the retinal degeneration, ascertaining the underlying cause of 
disease would appear to be of greater importance in understanding the pathology of 
choroideremia in fish, thus hopefully ultimately giving insight into the human 
disease. 
4.6 Summary 
The choroideremia phenotype is lethal from 4dpf onwards in the 
choroideremia fish. Homozygotes are readily identified from 3dpf onwards by their 
darker pigmentation, enlarged heart, smaller eyes and lens opacity. Later, mutants 
develop oedema of the abdomen and head, underused yolk sacs, possibly due to 
lower nutritional requirements of retarded growth, and fail to inflate their swim 
bladder. 
To assess the suitability of the zebrafish as a model for human choroideremia, 
the retinal phenotype was investigated further. In contrast to the restricted phenotype 
in human disease, where only the photoreceptors, RPE and choroid are affected, 
zebrafish suffer a widespread, catastrophic retinal degeneration. It is characterised by 
hypertrophy and discontinuity of the RPE, loss of photoreceptor cells, disruption of 
lamination and cell death throughout the neural retina, and abnormalities of the 
developing lens. Severity of the phenotype varies between individuals, suggesting 
some disparity in the rate of disease progression. 
Degeneration of the retina in choroideremia zebrafish is surprisingly rapid, 
given that gross morphological abnormalities are visible from 3dpf onwards. Retinal 
abnormalities were first observed at 4.5dpf, as the loss of photoreceptors and OPL in 
a band running dorsal to the optic nerve, with extensive retinal damage observed at 
5dpf. Conversely, in other individuals, the central retina remained intact while 
degeneration occurred to the peripheral retina and lens perimeter. Due to the speed of 
degeneration, it is difficult to elucidate the sequence of cellular loss in the 
degeneration. 
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Chapter Five 
Rab Escort Protein 
Evolution 
REP Evolution 
5.1. Identification of REP and GDI Sequences 
The human X-linked retinal disease choroideremia arises when the REP-1 
gene is mutated. An autosomal homologue, REP-2 partly compensates for the loss of 
REP-1. However, a subset of Rabs remains unprenylated, leading to degeneration of 
the retina. REP-2 is an intronless gene (Cremers et al 1992), suggestive of an ancient 
reverse transcription event. The zebrafish mutant, chm, has a truncating mutation in 
a gene homologous for human REP-1 and suffers a lethal multi-systemic disease, 
including degeneration of the retina. Starr et al did not find a second REP in the early 
releases of the zebrafish genome (Starr et al 2004). 
REP homologues have also been described in yeast, known as MRS6, 
(Waldherr eta! 1993), fly (Dong et al 1999) and the plant Arabidopsis thaliana (Hala 
eta! 2005). Yeast and plants have a single REP homolog (Waldherr et al 1993, Jiang 
& Ferro-Novick 1994; Hala et a! 2005). In yeast, although neither GDI nor MRS6 
can suppress lethality following disruption of MRS6 or GDI1 respectively (Garrett et 
al 1994), four mutant MRS6 clones were found that could complement the dgdilnull 
mutation (Alory & Balch 2003). Additionally, these mrs6 mutants could complement 
dmrs6 null, so gain of GDI function does not preclude REP function. For these 
reasons, Alory and Balch propose REP was the ancestral precursor of GDI, which 
then diverged to specialise in Rab recycling. Specifically, they propose REP-2 to be 
the ancestral REP, as general Rab function is not disrupted in choroideremia patients 
in the absence of REP-1. This theory has been disputed by Hala et al, who analysed 
the phylogenic relationships of eukaryotic REP and GDI genes, focusing on plants. 
They prefer a hypothesis of a bi-functional REP/GDI protein as the evolutionary 
precursor of the REP/GDI superfamily (Hala et a! 2005). 
We sought to clarify whether there is indeed only one REP protein in 
zebrafish, and to identify the stage in mammalian evolution when duplication of the 
REP gene occurred. GDI sequences were identified to explore the possibility of 
divergence of a GDI to function as a REP, to aid rooting of dendrograms, and to 
investigate if duplication of REP parallels the expansion of GDIs. 
All the sequenced published chordate genomes available at the time of 
analysis (www. genomesonline. org, Kyrpides et al 1999), namely human, mouse, rat, 
chicken, the pufferfishes tetraodon and fugu, and the sea squirt C. intestinalis, were 
included, as well as zebrafish. It should be noted that despite its inclusion in the 
GOLD database, the zebrafish genome project remains incomplete and unpublished; 
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the preliminary assembly Zv6 used in this analysis has 6.5-7x coverage 
(http: //www. sanger. ac. uk/Projects/D_rerio/). To bridge the evolutionary gap between 
the fish and mammalian lineages, Xenopus was also included, although the genomes 
remain incomplete. To detect more sequences the analysis was extended to include 
the invertebrate model organisms Drosophila melanogasler and C. elegans, and also 
three representative fungi. The arthropods Bombyx mori and Anopheles gambiae and 
the nematode C. briggae were discarded, due to their similarity to the well 
characterised model organisms. Plants were excluded from the analysis as we 
suspected the duplication of REP to have occurred after the separation of fungi and 
animalia. Figure 5.1 shows the reference taxonomical tree of the species studied. 
MICROSPORIDIA 
FUNGI PEZIZOMYCTES 
ASCOMYCOTA I 
OPISTHOKO TA BAS IDOMYCOTA 
SACCHAROMYCTES 
S. cereviseas 
CHOANOZOA 
IMALIA 
I CNIDARIANS 
AZOA 
IIFI ITFRCICTfMIA 
Xenopus tropicalia 
Xenopus laevis 
Figure 5.1 Reference phylogenic tree of species considered in analysis Drawn by M. Tulloch 
following consultation with www. tolweb. org 
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Species Protein Reference Size (aa) 
Homo sapiens REP-1 NP_000381 653 
REP-2 001812 NP 656 
Rattus norvegicus REP-1 _ NP_058763 650 
REP-2 XP 001058878 621 
Mus musculus REP-1 _ NP 061288 662 
REP-2 _ NP 067325 621 
Gallus gallus REP _ 001026290 NP 656 
Xenopus laevis REPa _ AAH61662 643 
REPb AAH78011 643 
Xenopus tropicalis REP pg. C_scaffold_384000021 jgi177318 fgeneshl 641 
Danio rerio REP _ 982286 NP 666 
Takifugu rubripes REP _ jgi5l. 140.1 672 
Tetraodon nigroviridis REP CAF97265 656 
Ciona intestinalis REP jgi211868 fgenesh3_pg. C chr 02g000991 636 
Drosophila melanogaster REP NP 477420 511 
Caenorhabditis elegans REP _ NP 001022928 510 
Saccharomyces REP NP_015015 603 
cerevisiae (MRS6) 
Aspergillus fumigatus REP XP 747864 525 
Neurospora crassa REP _ EAA36055 490 
Arabidopsis thaliana REP NP_187306 563 
Table 5.1 REP family members in different species 
Species Protein Reference Size (aa) 
Homo sapiens GDIa NP 001484 447 
GDIß _ NP_001485 445 
Rattus norvegicus GDIa NP 058972 447 
GDID _ NP_058784 445 
Mus musculus GDIa 034403 NP 447 
GDIß _ NP_032138 445 
Gallus gallus GDI NP 990335 448 
Xenopus laevis GDIa AAH81172 447 
GDIß AAH43955 446 
Xenopus tropicalis GDIa jgi419717 e_gw1.1144.2.1 446 
GDIß jgi305813 e_gwl. 11.217.1 448 
GDIy jgi317148 e gwl. 44.342.1 419 
Danio rerio GDIa NP_001018444 447 
GDID 955949 NP 448 
Takifugurubripes GDIa _ jgil99.66.1 447 
GDIß jgiestExt_GW. C 3710018 447 
GDIy jgi87.322.1 447 
Tetraodon nigroviridis GDIa CAG03848 447 
GDI3 CAF93885 445 
GDIy CAG06863 438 
Ciona intestinalis GDI jgi284296 estExt fgenesh3jm. C_chr 12g0012 438 
Drosophila melanogaster GDI NP 523524 443 
Caenorhabditis elegans GDI NP 502788 444 
Saccharomyces GDI _ NP_011062 451 
cerevisiae 
Aspergillusfumigatus GDI XP 755448 468 
Neurospora crassa GDI EAA32823 490 
Table 5.2 GDI family members in different species 
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Candidate protein sequences were obtained by querying species-specific 
databases with human REP-1, human REP-2, human GDIa, yeast REP and yeast 
GDI using the BLAST algorithm (Altschul et al 1990). All sequences retrieved were 
verified manually by comparison with Pfam (Finn et al 2006) and Superfamily 
(Madera et al 2004) databases to ensure that they were members of the REP/GDI 
family. Also, sequences from each species were aligned and their chromosomal 
localisation was sought to identify any duplicate entries in the databases. Surplus 
sequences discarded. Where potential splice variants were identified, only the longest 
was included in the analysis. Some sequences were as yet unidentified, hence 
ClustalW (Higgins et al 1994) analyses and BLASTP against the Genbank database 
were performed to identify to which protein family they belonged. The REP and GDI 
sequences found are listed in tables 5.1 and 5.2 respectively. 
Investigation of Genbank for Xenopus sequences yielded many X laevis 
sequences, so the JGI database was used instead to find X tropicalis sequences. As 
we had originally planned to use only X. tropicalis sequences in our analysis, 
consideration was given to discarding the X. laevis sequences in favour of X. 
tropicalis. However the presence of a second REP in X. laevis (see table 5.1) 
warranted further investigation in light of the remit of this analysis, and so both frog 
species are included. It should be noted that neither of these sequencing projects is 
complete. 
Finally, the aligned sequences were inspected to locate the conserved 
phenylalanine residues indicative of the REP and GDI families (Pylypenko et al 
2003). Phenylalanine at position 279 is conserved among all REPs and mediates 
RabGGTase binding, whereas phenylalanine at position 135 is conserved among all 
GDIs. Additionally, the conserved phenylalanine at position 143 blocks interaction 
with RabGGTase, as shown in figure 1.12. Positioning of phenylalanine residues can 
therefore be used to confirm the family to which all the retrieved sequences belong 
(figure 5.2). 
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mmREP1 
rnREP1 
hsREP1 
MMREP2 
rnREP2 
hsREP2 
ggREP 
x1REPa 
xtREP 
x1REPb 
trREP 
tnREP 
drREP 
dmREP 
GTVEQVPCSRADVFNSKQLT-MVEKRMLMKFLTFCVEY 
GTVEQVPCSRADVFNSKQLT-MVEKRMLMKFLTFCVEY 
GRVEQVPCSRADVFNSKQLT-MVEKRMLMKFLTFCMEY 
GKVEQVPCSRADVFNSKELS-MVEKRMLMKFLTFCLDY 
GKVEQVPCSRADVFNSKELT-MVEKRMLMKFLTFCLDY 
GKVEQVPCSRADVFNSKELT-MVEKRMLMKFLTFCLEY 
GKVEQVPCSRADVFNSRQLA-MVEKRMLMKFLTFCLEY 
GKIEQVPCSRADVFASKQLS-MVEKRILMKFLMHYVDY 
GKIEQVPCSRADVFASKQLS-MVEKRILMKFLMHYIDY 
GKIEQVPCSRADVFASKQLS-MVEKRILMKFLMHYVDY 
GKVEQVPCSRADVFASRQLS-VVEKRKLMRFLTSCM-- 
GRVEPVPCSRADVFASRQLS-VVEKRKLMRFLTSCM-- 
GKVEQVPCSRADVFASKQLT-VVEKRMLMKFLTFCLDF 
GEIVSVPCSRSDVFNTKTLT-IVEKRLLMKFLTACNDY 
307 
302 
305 
306 
306 
307 
301 
295 
288 
294 
276 
269 
292 
180 
trGDIa GKIYKVPSTETEALASNLMG-MFEKRRFRKFLVFVANF 150 
tnGDIa GKIYKVPSTETEALASNLMG-MFEKRRFRKFLVFVANF 150 
drGDIa GKIYKVPSTETEALASNLMG-MFEKRRFRKFLVFVANF 150 
xlGDIa GKIYKVPSTETEALASNLMG-MFEKRRFRKFLVFVANF 150 
xtGDIa GKIYKVPSTETEALASNLMG-MFEKRRFRKFLVFVANF 149 
mmGDIa GKIYKVPSTETEALASNLMG-MFEKRRFRKFLVFVANF 150 
rnGDIa GKIYKVPSTETEALASNLMG-MFEKRRFRKFLVFVANF 150 
hsGDIa GKIYKVPSTETEALASNLMG-MFEKRRFRKFLVFVANF 150 
mmGDIb GKIYKVPSTEAEALASSLMG-LFEKRRFRKFLVYVANF 150 
rnGDIb GKIYKVPSTEAEALASSLMG-LFEKRRFRKFLVYVANF 150 
hsGDIb GKIYKVPSTEAEALASSLMG-LFEKRRFRKFLVYVANF 150 
ggGDI GKIYKVPSTEAEALASSLMG-LFEKRRFRKFLVYVANF 150 
xlGDIb GKIYKVPSTETEALASSLMG-MFEKRRFKKFLSYVASF 150 
xtGDIb GKIYKVPSTEAEALTSSLMG-MFEKRRFKKFLSYVANF 152 
trGDIb GNIYKVPSTETEALATKLLG-LFEKRRFKKFLGFVANI 150 
tnGDIb RGIFKVPSTETEALTTSLLG-LFDKRRFRKFLIYVANV 150 
drGDIb GSIYKVPSTETEALASSLMG-LFEKRRFRKFLVFVANF 150 
xtGDIc GKIHKVPCTEEEALASDLMG-IFEKRRFRKFLLFVVNF 149 
trGDIc GKVHKVPGTEEEAHASDLMG-MFDRRRFRKLLLFALNF 148 
tnGDIc GKLHKVPGTEEEAHASDLMG-MFDRRRFRKLLLFALNF 148 
dmGDI GKIAKVPVDQKEALASDLMG-MFEKRRFRNFLIYVQDF 149 
ceGDI GKIYKVPADEMEALATSLMG-MFEKRRFKKFLVWVQQF 151 
ciGDI GKVYKIPSNEREALSTSLMG-MFEKRRFRNFLVWLSEY 148 
afGDI ATVAKVPSDAGEALRSSLMG-MFEKRRAKKFLEWVGEF 159 
ncGDI ATIAKVPSDAAEALRSPLMG-IFEKRRMKSFIEWVGEF 160 
scGDI GKIYKVPANEIEAISSPLMG-IFEKRRMKKFLEWISSY 158 
afREP SDLYRVPSSREDVFADDVIS-VKSKRTLMRFLRRIANP 189 
ncREP --LVRIPSTREDVFSTTAIS-AKAKRGLMKFLRFVLDY 176 
ciREP EDEEFVPILQNKNFITKAEYSCYLKRSE-KGETPISEE 181 
ceREP ITLNPVPCSKGEIFQSNALS-ILEKRALMKFITFCTQW 207 
scMRS6 DCFEKLTNTKQEIFTDQNLP-LMTKRNLMKFIKFVLNW 207 
Figure 5.2 Multiple alignment of REP and GDI sequences. F279 of rat REP-1 is REP subfamily 
specific, F135 of human GDIb is GDI subfamily specific. 
5.2 Phylogenic Analysis of REP Evolution 
To investigate the evolutionary expansions of REP, we calculated Neighbour 
Joining dendrograms (Saitou & Nei 1987) using ClustaIX multiple sequence 
alignments (Thompson et al 1997). Figure 5.3 clearly shows separation of the 
REP/GDI superfamily into the two distinct functional groups, REPs and GDIs. 
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Figure 5.3 Neighbour Joining dendrogram of REP and GDI families. Duplication of REP 
occurred during the mammalian lineage. For clarity, GDlct and GDI1 proteins are not individually 
annotated - see figure 5.4 for further resolution. Mm, Mus musculus; Rn, Rallus norvegicus; Hs, 
Homo sapiens; Gg, Gallus gallus; Xl, Xenopus laevis; Xt, Xenopus tropicalis; Tr, Takifugu rubripes; 
Tn, Tetraodon nigroviridis; Dr, Danio rerio; Dm, Drosophila melanogaster; Ce, Caenorhabdilis 
elegans; Ci, Ciona inteslinalis; Af, Aspergillus fumigalus; Nc, Neurospora crassa; Sc, Saccharomyces 
cerevisiae 
Fish have a single REP isoform, which we assume is responsible for all Rab 
prenylation within the zebrafish. It is possible to obtain bi-functional REP mutants 
with GDI-like function in vivo, although the converse GDI mutant with REP-like 
function has not been shown (Alory & Balch, 2003). Given the divergence in 
function between REP and GDI, and the distribution of phenylalanine residues in fish 
GDIs (shown in figure 5.2), it is highly unlikely that a GDI could be functioning as a 
second prenylating agent in zebrafish. Two isoforms of REP are present in mammals, 
and complete bootstrap support is shown for the separation of human, mouse and rat 
REP-1 and REP-2, suggesting the duplication occurring between the divergence of 
Ce GDI Tr GDIc 
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low 
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birds and mammals. (The frog X laevis also has two isoforms, and is discussed 
specifically in section 5.3. ) 
xr r; ni, 
Tn 
Xt GDIb 
Figure 5.4 Separation of GDIu and GDIß isoforms Mm, Mus musculus; Rn, Rallus norvegicus; Hs, 
Homo sapiens; Gg, Gallus gallus; Xl, Xenopus laevis; Xt, Xenopus tropicalis; Tr, Takifugu rubripes; 
Tn, Tetraodon nigroviridis; Dr, Danio rerio 
Multiple duplications of GDI have occurred in vertebrates, creating three 
distinct GDI isoforms. It can be seen from Figure 5.4 that there has been little 
expansion within the GDIa and GDI(3 clades, suggesting primary structure evolution 
may be constrained by functional requirements. The separation of GDIs by isoform 
reflects their different functions. GDI(3 is the "housekeeping" GDI being universally 
expressed, whereas GDIa is mostly expressed in the brain or at specific 
developmental stages (Alory & Balch 2001). This is supported by study of the 
vertebrate G. gallus, in which the single GDI most closely aligns with the ß isoforms, 
as shown in figure 5.4. It does however raise the interesting question of why two 
other GDI isoforms have been maintained in some vertebrate species and what 
specialised function they might serve. 
Contrasting models of REP/GDI superfamily evolution have been proposed. 
Alory and Balch suggested a model where REP-2 is the evolutionary precursor of 
REP-I and GDI (Alory & Balch, 2003). These data suggest this is untrue and that 
REP-2 is a recent phenomenon. Instead, the findings support a bifunctional REP/GDI 
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protein as an ancestor of the REP/GDI superfamily, where REP and GDI had 
diverged separate function in the last common ancestor of the eukaryotes, as 
proposed by Hala et al. 
5.3 A Second REP in X. laevis 
The presence of a second REP in X laevis is an interesting phenomenon. X 
laevis is an allotetraploid, meaning that speciation occurred following the 
interbreeding of two diverging diploid parent species, and that both diploid parent 
genomes are maintained in the hybrid offspring species. This is reflected in its 
pseudotetraploid genome, whereas the genome of X. tropicalis is diploid (see table 
5.3). These complicated genetics make X tropicalis the favoured model organism for 
sequencing projects. 
X. laevis X tropicalis 
Ploidy Allotetraploid Diploid 
Number of Chromosomes 18 10 
Genome size 3.1 x 109 bp 1.7 x 109 bp 
Generation time 1-2 years 4 months 
Table 5.3 Characteristics of X. laevis and X tropicalis genomes. (Taken from 
www. xenbase. org/intro. html) 
Thus it is conceivable that each REP gene in X laevis is derived from a single 
ancestral parental species, as has been demonstrated for RAG-i proteins in X laevis 
(Evans et al 2005). In light of this, we have renamed the X laevis REPs "a" and "b" 
(REPa being that most similar to X tropicalis REP), denoting that they have arisen 
through whole genome duplication (alloploidy) rather than a gene duplication event. 
This could be confirmed by examining the gene structure of the REPb gene: if 
introns were present this would rule out a reverse transcription event like that seen in 
mammals. Unfortunately, the REPb sequence AAH78011 is derived from a cDNA 
clone, and no genomic sequence for this gene could be found. Mapping the X laevis 
cDNAs onto X. tropicalis genome would only provide information on the structure of 
the X. tropicalis REP gene, and while there would be strong similarities in the gene 
structures between the two species, there is no second X. tropicalis gene with which 
to draw a comparison. Ultimately, until the frog genomes are complete no firm 
conclusions can be drawn. 
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5.4 Duplication of REP-1 in the Mammalian Lineage 
Our investigations suggest the duplication of the REP gene occurred after the 
divergence of the mammals and birds. Hala et al searched the initial release of 
genomic sequence of the opossum Monodelphis domestica, finding two REP genes. 
To clarify the evolution of REP within the mammalian lineage, we reviewed the 
latest release of marsupial and monotreme genomes, the closest relatives of 
eutherians (placental mammals) for whom sequencing projects are underway. 
Monotremata: Orinthorhynchus anatinus 
Multituberculata 
Marsupialia: Monodelphis domestica 
Palaeoryetoids 
Eutheria: Homo sapiens 
Rattus norvigicus 
Mus musculus 
Figure 5.5 Evolutionary relationships of mammalia Eutherians (placental mammals) diverged from 
metatherians -180MYA, before the radiation of extant eutherians -100MYA. (adapted from 
www. tolweb. org) 
BLAST searches of the Ensembl genome browser identified candidate REP 
sequences in M domestica (release 5.0) and platypus Orinthorhynchus anatinus 
(release 5.0). Sequences were verified by examining chromosomal localisation to 
identify duplicates and alignment with known GDI and REP sequences to confirm 
membership of the REP family. 
Two potential REP sequences were found in platypus that upon inspection 
localised to the same gene, ENSOANG0000007635 on contig 1968. Indeed, the 
sequences are identical at protein level and appear to represent splice variants of the 
gene. The product peptide 12168 is a 486 residue protein; peptide 12169 lacks exon 5 
so is only 447 residues long but is otherwise identical. The 486 residue protein is 
used in this analysis. 
Two REPs had been reported in M domestica (Hala et al 2005), but their 
genomic and protein sequence are not referenced. Our initial analysis of the M 
domestica genome revealed a third REP protein, as summarised in table 5.4. 
177 
REP Evolution 
Repetition of the analysis following the release of the completed draft M. domestica 
genome (Mikkelson et a12007) confirmed our initial findings. 
Gene ID ENSMODG 
00000014364 
ENSMONDG 
00000025293 
GENSCAN 
00000023284 
ENSMODG 
00000013343 
Chromosome x 7 7 6 
Contig 57065 19535 19535 47486 
Site 5735481- 
5741539 
58602594 - 
58604510 
26939 - 
28861 
1357175- 
1658816 
Transcript ID ENSMODT000 
00018281 
ENSMODT000 
00039195 
GENSCAN000 
00019628* 
ENSMODT000 
00016997 
Transcript 
length 
1476 1848 1923 1500 
Introns many - normal one none many - short 
Protein ID ENSMODP000 
00017951 
- - ENSMODP000 
00016690 
Protein length 492 616 640 500 
Proposed name REP-1 - REP-2 REP3 
Table 5.4 Candidate Monodeiphis domestica REP proteins ENSMONDG00000025293 is reported 
to have two exons of 723 and 1125 bases separated by a 69 base intron. *GENSCAN00000023284 
localises to the same chromosomal location as ENSMODG00000025293, the site reference given 
denotes a contig location rather than a chromosomal location. 
The opossum REP gene ENSMODG00000014364 aligns with other 
mammalian REP-Is. It is also on the X chromosome and has normal intron size, like 
the other mammalian REPs. For these reasons, we have labelled this gene REP-1. 
Gene prediction by GENSCAN (Burge & Karlin 1997) and Ensembl 
(Curwen et al 2004) algorithms provide conflicting data regarding exon-intron 
structure of the second REP. GENSCAN, an ab initfo gene prediction method, 
suggests the transcript is intronless; while Ensembl describes a single intron of 69 
bases, but gives no peptide sequence. GENSCAN is an ab initio gene prediction 
method, whereas the Ensembl annotation method includes mapping of cDNAs and 
ESTs onto genomes. However, Ensembl's use of transcript data from distantly 
related organisms (mostly mammals) to annotate evolutionary distant genomes, such 
as chicken and M. domestica, has been unreliable and can remove exons (Hubbard et 
al 2007). Translation of the transcript predicted by Ensembl 
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(http: //www. expasy. ch/tools/dna. html; 5'3'frame 1) reveals the predicted intron 
removes residues 241 to 265 of the peptide. Alignment of the product peptides with 
other vertebrate REPs, as shown in figure 5.6, reveals the missing 23 amino acids are 
highly conserved among other vertebrates, and correspond to the b2 strand of a 0- 
sheet of domain 2 of REP. Therefore, it is assumed that the protein expressed is an 
intronless gene, as described by GENSCAN00019628, and the 640 residue peptide is 
used in further analysis of mammalian REP evolution. 
mdGS23284 SQIVKEGRRFNIDLTSKLLYSRGLLIDLLIKSNVSRYAEFKNVTRILGFQEGSVLQVPCS 268 
mdENSMODT39195peptideSQIVKEGRRFNIDLTSKLLYSRGLLIDLLIKSN----------------------- VPCS 245 
mmREP1 SQIIKEGRRFNIDLVSKLLYSRGLLIDLLIKSNVSRYAEFKNITRILAFREGTVEQVPCS 289 
rnREP1 SQIIKEGRRFNIDLVSQLLYSRGLLIDLLIKSNVSRYAEFKNITRILAFREGTVEQVPCS 274 
hsREP1 SQIIKEGRRFNIDLVSKLLYSRGLLIDLLIKSNVSRYAEFKNITRILAFREGRVEQVPCS 277 
mmREP2 SQMVKESRRFNIDLVSKPLYSQGSLIDLLIKSNVSRYAEFKNVTRILAFWEGKVEQVPCS 278 
rnREP2 SQMVKESRTFNIDLVSKLLYSQGSLIDLLIKSNVSRYAEFKNVTRILAFREGKVEQVPCS 278 
hsREP2 SQIVKEGRRFNIDLVSKLLYSQGLLIDLLIKSDVSRYVEFKNVTRILAFREGKVEQVPCS 279 
ggREP SQIVREGRRFNIDLVSKLLYSRGLLIELLIKSNVSRYAEFKNATRILAFREGKVEQVPCS 273 
drREP QKLLKEGRRFNIDLVSKLMYSRGALVDLLIKSNVSRYAEFKNIGRILTCRNGKVEQVPCS 264 
Figure 5.6 Alignment of candidate opossum REP-2 sequences with other vertebrate REPs 
According to Ensembi protein prediction method, intron splicing removes 23 residues conserved 
among other vertebrate REPs. 
The presence of an intronless REP-2, and a third REP with very short intronic 
sequences, suggests REP gene duplication events have occurred in the marsupial 
(metatherian) lineage. Interestingly, we also identified four candidate GDI sequences 
in the M domestica genome (see table 5.5), of which one is intronless and another 
contains only a single intron. 
Species Protein Reference Size (aa) 
Monodelphis domestica GDIa ENSMODP00000010983 447 
GDIß ENSMODP00000023077 456 
GDIc ENSMODP00000037351 intronless 433 
GDId ENSMODP00000037357 single intron 498 
Table 5.5 Candidate Monodeiphis domestica GDI proteins 
Having found only a single REP in platypus, and multiple REPs in the 
opossum, we performed further phylogenic analysis to investigate whether REP gene 
duplication occurred before or after the divergence of eutherians and metatherians. 
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diREP 
xlREP 
99REP 
eaREP 
h+REP2 
mrREP2 
rnREP2 
MREPI 
mmREPI 
rnREPI 
mdREPI 
mdREP2 
mdREP3 
Figure 5.7 Expansion of REP in vertebrates: Separate REP duplications in marsupials and 
eutherians Dr, Danio rerio; Xt, Xenopus tropicalis; Gg, Gallus gallus; Oa, Orinthorhynchus 
anatinus; Hs, Homo sapiens; Mm, Mus musculus; Rn, Rail us norvegicus; Md, Monodelphis domestica 
Separate duplications of the REP gene have occurred in marsupial and 
eutherian evolution. Figure 5.7 shows the expansion of the REP proteins within the 
vertebrate lineage, highlighting the independent duplication of REP-1 to create REP- 
2 in placental mammals (also shown in figure 5.3). In the marsupial M. domestica, 
two duplication events appear to have occurred since the divergence of marsupials 
and eutherians, and three REP proteins have been conserved in this marsupial. 
This phylogeny was produced using the Neighbour Joining method, an 
approximate, distance based approach. This involves measuring the changes that 
have occurred between the sequences and using this to infer the evolutionary 
distance between them, but it does not take into account that multiple substitutions 
may have occurred at the same site, while other sites may be highly conserved due to 
their function. This approach can be insufficiently powerful to resolve the 
relationships between divergent sequences, and these trees are intrinsically unrooted 
(Holder & Lewis 2003). The Neighbour Joining method was unable to identify the 
evolutionary root of the marsupial, eutherian and non-mammalian REPs in figure 
5.7, and hence some nodes lack bootstrap support and are therefore uninformative. A 
Maximum-Likelihood approach, which considers all possible mutational events and 
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then selects the phylogenic tree most likely to have resulted in the specified 
sequences, would accurately calculate the pattern of REP evolution in mammals. 
This work is a computationally intensive approach, and is being currently undertaken 
with the assistance of our collaborators. 
Duplication of the REP gene in placental mammals is thought to have arisen 
through an ancient reverse transcription event, because REP-2 genes contain no 
introns (figure 5.8). Human, rat and mouse REP-I genes all possess 14 or 15 exons, 
and normal introns ranging from 370 to 58000 bases in length. Examination of REP 
evolution and gene structure in M. domestica suggests REP-1 is the ancestral REP 
inherited from the last common ancestor of mammals. It has twelve exons and 
introns between 380 and 8700 bases in length, and is located on the X chromosome 
like other REP-Is. Without functional data it is difficult to ascribe nomenclature to 
the duplicate REPs. Notably, the introns in these genes are absent or drastically 
reduced. 
HUMAN REP-2 1.97kb 
RAT REP-2 1.87kb 
MOUSE REP-2 1.87kb 
OPOSSUM REP-2 1.92kb 
OPOSSUM REP-3 1.64kb 
Figure 5.8 Gene structure of duplicate REPs in mammals 
As a second REP protein has been maintained following gene duplication in 
mammalia on several occasions, the question of utility of multiple REPs is raised. It 
is possible there are more, as yet unsequenced or unidentified, REPs in monotremes. 
Also, we do not know if multiple REPs are a feature of M. domestica or of 
marsupials as a whole. 
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5.5 Summary 
Our bioinformatic analysis suggests the zebrafish, like other fishes, possesses 
only a single REP gene. Independent duplications of the REP gene occurred in the 
mammalian lineage, creating REP-2 in placental mammals, and three REP 
homologues in marsupials. The duplicate REPs share an intronless gene structure, 
suggestive of an ancient reverse transcription event. While two REP isoforms are 
also maintained in the frog X. laevis, these arose via alloploidy during speciation, 
rather than a gene duplication event. 
Considering the highly constrained evolution of GDIs and the distribution of 
phenylalanine residues within helices D and E of fish GDI, it is highly unlikely that 
that GDI could be functioning as a second REP in zebrafish. Therefore, the 
choroideremia mutation in zebrafish, which truncates the only zebrafish REP gene, 
must be considered to be a null mutation. In yeast, a null mutation in the REP gene is 
lethal. A null mutation would imply that the choroideremia zebrafish lacks a supply 
of prenylated Rabs, and yet these fish survive for up to five days. This is in contrast 
to the human disease, where REP-2 is expressed and can compensate for the lack of 
functional REP-I in choroideremia patients. 
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6.1 Genotype of Choroideremia Zebrafish 
Zebrafish ru848 mutants harbour a nonsense mutation at codon 33 of the 666 
codon REP gene. Mendelian genetics suggests the choroideremia mutation is 
recessive, as approximately 25% of offspring of heterozygous parents display the 
choroideremia phenotype. To confirm the identity of mutant offspring, larvae were 
genotyped by sequencing the REP gene, as described in Chapter Three. 
Initially, whole mutant larvae were individually treated with GNT-K buffer to 
extract DNA. Sequencing of DNA unexpectedly revealed a heterozygous genotype 
amongst mutant fish displaying the choroideremia phenotype, as shown in figure 6.1. 
The presence of wild-type genomic sequence in choroideremia zebrafish at 5dpf 
raises the possibility that wild-type REP mRNA and protein may be present too. 
Unaffected siblings were either genetically wild-type or heterozygous. 
ab 
TTGGA! ýAAAGT TTGGANAA:. G"f 
Vvý 
A 
cd 
TTGGACAAAGT TTGG AN AAAGT 
Figure 6.1 Sequencing of mutant 5dpf whole larva gives heterozygous genotype DNA extracts 
from phenotypically mutant (a, b) and unaffected (c, d) were sequenced at the REP gene. REP 
sequence at the chm allele for each pictured fish is shown below panels. Unexpectedly, mutant larvae 
show a heterozygous genotype. 
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In the embryonic zebrafish, all processes occurring before zygotic gene 
activation rely on maternal products produced during oogenesis and present in the 
egg at fertilisation. These maternal factors must support all cellular functions such as 
metabolism, nuclear and cellular divisions and intercellular adhesion (Pelegri 2003); 
thus it can be assumed that early REP activity is supplied by maternal factors. During 
the follicle phase of primary growth phase of the oocyte, both the oocyte and the 
surrounding maternal follicle cells begin to extend microvilli to reach one another. 
Once formed, these connections allow oocyte-follicle cell communication and the 
uptake of small molecules by the oocyte (Kessel et al 1985, Pelegri 2003). Several 
hundred embryonically lethal homozygous recessive zebrafish mutants have been 
identified where survival of the developing embryo is attributed to a maternal load of 
proteins and mRNAs, presumably acquired during the follicular stage of oogenesis 
(Golling et al 2002, Amsterdam et al 2004, Gross et al 2005, Kane et al 1996, 
Driever et al 1996). Cleavage of the developing embryo results in a blastoderm 
located above a large yolk cell. At the 500-1000 cell stage, some of the marginal 
blastomeres fuse with the yolk cell to start the formation of the yolk syncytial layer 
(YSL). The YSL of zebrafish and other teleosts contain a large number of giant 
highly polyploidy nuclei (Bachop & Ramsey 1970 cited in Williams et al 1996). 
FISH YOLK SAC 
I GG AI AAAG IGGA! HAAG 
f0 
J ý, ýI' ýj 
III 
T: chm allele T: chm allele 
C: WT allele 
Figure 6.2 Sequencing of separated fish and yolk sac partitions allelic transcripts Yolk sacs were 
dissected from embryonic fish and DNA extracts prepared from yolk sac and fish. Yolk sacs contained 
both WT and chm transcripts, whereas mutant fish were genetically homozygous for the chm allele 
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The yolk sac was removed from the embryonic fish before preparation of new 
DNA extracts. As shown in figure 6.2, sequencing of DNA extracts prepared from 
separated yolk sac and embryonic fish revealed the mutant fish to be homozygous for 
the chm allele (figure 6.2). Unaffected fish had either heterozygous or wild-type 
genotypes. Notably, the yolk sacs of affected fish contained both wild-type and chm 
transcripts, reflecting the heterozygous genotype of the mother. The yolk sac may 
therefore be the source of wild-type transcripts, which had contaminated the earlier 
sequencing of homogenates of individual mutant embryos with their yolk sacs. While 
the transfer of maternal mRNAs and proteins to the oocyte is implied by the initial 
survival of many embryonic lethal zebrafish mutants, there is no known explanation 
for the transfer of maternal DNAs to the developing oocyte, nor its' localisation to 
the yolk sac. RT-PCR analysis of RNA extracted from separated choroideremia 
embryos and yolk sacs, as outlined in section 6.2, may give further insight into the 
distribution of maternal REP products throughout the developing embryo. 
6.2 Activity of REP in Choroideremia Zebrafish 
Zebrafish express a single REP protein that is truncated in choroideremia 
homozygotes. A null mutation in REP would be expected to be lethal, as in yeast, 
yet chm homozygotes survive for up to eight days. However, our results suggest that 
a source of wild-type REP transcript is available to the developing choroideremia 
zebrafish, which would imply the production of full-length wild-type protein too. 
Functional REP protein would allow the survival of chm homozygotes by creating a 
supply of prenylated Rab proteins in the early embryo. As the maternal REP and 
prenylated Rabs are turned over, choroideremia disease would develop. 
Alternative approaches were considered to investigate the presence of wild- 
type REP in the choroideremia mutant. Semi-quantitative RT-PCR of RNA extracts 
from mutants at various developmental stages would trace changes in levels of full- 
length REP transcripts, tracking the predicted turnover of maternal REP transcripts. 
Dissection to remove the yolk sac prior to RNA extraction, combined with use of C- 
terminal and N-terminal primers, would allow measurement of the proportions of 
full-length and truncated transcripts within the fish itself at each developmental 
stage. 
While RT-PCR would provide valuable data for the investigation of REP 
transcription and transcript turnover, both are technically challenging and require 
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significant time to optimise methodologies. In addition, this method monitors 
changes in functional protein indirectly via RNA observation. This is a significant 
disadvantage when applied to the zebrafish system, since the information about 
protein activity must be inferred from data on RNA transcription, rather than being 
measured directly. A more direct approach would be preferable in this case because 
the choroideremia mutation directly affects the supply of REP protein within the fish. 
For these reasons, we decided upon an approach that would assay functional REP 
activity in the zebrafish. 
The in vitro prenylation assay is routinely used in our laboratory to assess 
activity of proteins involved in Rab prenylation (Seabra et al 1993; Seabra et al 
1995; Larijani et al 2003; Tolmachova et al 2006). By following the incorporation of 
radiolabelled geranylgeranyl phosphate (GGpp) into Rab proteins, the kinetics and 
biochemistry of the prenylation process can be monitored. 
unprenylated Rab + [cellular REP] + RabGGTase + GGpp* -i [prenylated Rab*] 
Equation 6.1 In vitro prenylation: chm fish extract as a source of REP 
A protocol was developed that would use choroideremia fish as a source of 
REP, as described in equation 6.1. This protein was targeted for specific study, since 
the chm mutation directly affects the supply of REP within the embryonic fish. The 
assay was performed with recombinant rat RabGGTase, canine Rabl (identical 
primary structure to human Rab 1), human Rab27a, human Rab5 and human Rac 1a 
proteins. Racla is singly prenylated by the prenyltransferase GGTaseI, which 
recognises substrates with a CxxL C-terminal motif (Casey & Seabra 1996). 
6.2.1 Optimisation of the In vitro Prenylation Assay 
The assay requires a source of active REP for prenylation to occur. 
Throughout these experiments the greatest challenge was extracting sufficient REP 
protein from a very small mass of tissue; embryonic fish are no more than 3mm long. 
Fish were pooled to increase protein availability, necessitating storage of fish for 
many months in order to allow sufficient numbers of homozygotes to be bred. To 
maintain functional REP activity fish were snap frozen in liquid nitrogen and stored 
at -80°C. Sonication and homogenisation methods were considered and compared for 
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preparation of extracts, as sonication can be too harsh for some systems, causing 
damage to functional protein. On comparison yield was greater using sonication, due 
to loss of material in transfer between pestle, syringe barrel and final receptacle when 
homogenising whole fish (table 6.1). 
Yield 
Concentration Volume recovered Total 
Homogenisation 1.50 µg/µI 30µI 45µg 
Sonication 1.55 µg/tI 481I 74.4µg 
Table 6.1 Protein yield: comparison of extraction protocols Five 5dpf wild-type zebrafish were 
lysed into 55µI lysis buffer; yields achieved are given 
6.2.1.1 Control experiment: Fish extract vs cultured mammalian cell extract 
To compare the activity of REP in cultured mammalian cells and zebrafish, 
and optimise the assay conditions, cytosolic protein extracts prepared from cultured 
Hela cells and wild-type zebrafish. Aliquots were removed in duplicate from a 
mastermix reaction at each data point, as described in the tables following each 
graph. Counts below 500dpm are considered to be background radiation, according 
to blank measurements with the scintillation counter. 
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[Rab l] [RabGGTase] [hot GGpp] [cold GGpp] T Time 
5µM 50nM 50nM 2µM 37°C 30mins 
Figure 6.3 Zebrafish extract has lower REP activity than Hela cell extract 
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REP activity is significantly lower in total extract from zebrafish relative to 
Hela cell extract (figure 6.3). This could be could be caused by a lower concentration 
of REP in zebrafish extracts. Total cytosolic protein extracts from zebrafish will 
include structural and tissue specific proteins, which could decrease the proportion of 
REP in the total extract relative to mammalian protein extracts. Alternatively, 
mammalian REP may have higher intrinsic activity, or be more efficient in 
conjunction with mammalian RabGGTase than fish REP. 
Although REP is a promiscuous enzyme, it was necessary to ensure that fish 
REP was compatible with recombinant mammalian Rabs. To investigate if the choice 
of Rab substrate was limiting zebrafish REP activity, assays were performed with 
mammalian Rab1, Rab5 and Rab27a as substrates (data not shown). A similar profile 
was obtained with all three Rabs tested. Rabl was found to be a marginally better 
substrate for fish REP under these conditions, perhaps unsurprisingly as Rab27a and 
Rab3, are known to be a poorer substrate for REP than CC Rabs (Rak et al 2004, 
Cremers et al 1994). As no recombinant fish Rab was available, recombinant human 
RabI was used in subsequent experiments. 
6.2.1.2 Effect of temperature on fish extract activity 
The previous experiment was performed at 37°C, which is the optimal 
temperature for mammalian proteins. Zebrafish naturally inhabit shallow rivers in a 
subtropical climate, replicated as a constant water temperature between 27°C and 
28.5°C in our aquarium. Incubation temperature of the assay was varied between 
23.5°C and 37°C to confirm fish REP activity was not inhibited outside its normal 
environmental temperature (figure 6.4). The experiment was performed in triplicate 
(n=3). Although fish REP activity does increase with temperature, mean counts only 
reached 1478dpm, whereas Hela extracts reach 12000dpm under identical conditions. 
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Figure 6.4 Effect of temperature variation on fish extract activity Zebrafish extract activity is 
maintained at optimal temperature of mammalian enzymes. 
Zebrafish REP activity was highest when reactions were incubated at 37°C, 
hence this temperature was used for subsequent experiments. 
6.2.1.3 Compatibility of fish REP with mammalian RabGGTase 
Having excluded incompatibility between fish REP and mammalian Rab as 
the cause of low extract activity, the interaction between fish REP and recombinant 
human Rab GGTase was examined. 
Contact occurs between helices D and E of REP domain 2, and helices 8,10 
and 12 of RabGGTase (Pylypenko et al 2003). Residue F279 of REP helix D 
protrudes into a cleft and forms hydrophobic interactions with bounding RabGGTase 
1171, L214, A218 and possibly T172. REP Helix E M286 interacts hydrophobically 
with RabGGTase F220, REP M291 with RabGGTase L377, and REP K294 forms a 
hydrogen bond with RabGGTase E378. In addition, R290 is known to be essential 
for REP: RabGGTase binding. In GDIs, the conserved REP V287 is substituted with 
phenylalanine, which is thought to prevent GDI binding to RabGGTase (see figure 
1.12). 
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The sequences of human and zebrafish REPs were aligned to investigate the 
similarity of the RabGGTase binding regions, as shown in figure 6.5. It should be 
noted that the structure of REP-1 was solved using a crystal of rat REP-l, so when 
reading the human sequences given in figure 6.5, conserved residue F279 
corresponds with human residue F282, etc. 
Helix D Helix E 
NP000381hsREP1 277 SPADVFNS}'nQ TMVE RMLMKFLTFCMEYE YPDEY 311 
NP001812hsREP2 279 SVADVFNSKE. TMVE RMLMKFLTFCLEYEQHPDEY 313 
NP_982286_drREP 264 S1ADVFASKQ TyVE RMLMXFLTFCLDFEQHPEEY 298 
Figure 6.5 High sequence similarity between helices D and E of fish and human REPs Residues 
that bind RabGGTase are coloured black. In helix D, F279 is conserved among all REPs and forms 
hydrophobic interactions with several RabGGTase residues. In Helix E, M286 and M291 also form 
hydrophobic interactions with RabGGTase. V287 is substituted for a phenylalanine in all GDIs. R290 
is essential for interaction with RabGGTase. K294 hydrogen bonds to RabGGTase. Asterisks denote 
identical residues. 
One residue involved in RabGGTase binding, M286, is not conserved in fish 
REP. This methionine is conserved in mammals, frogs and birds, but is substituted 
for valine in fishes, and other aliphatic side-chains (leucine, alanine, valine or 
isoleucine) in invertebrates. M286 forms a hydrophobic interaction with RabGGTase 
F220, which is conserved between fishes and mammals. As M286V fish REP is 
capable of interacting with zebrafish RabGGTase, it is unlikely to be incompatible 
with human RabGGTase F220. 
While the ß-subunit of RabGGTase has catalytic activity and transfers prenyl 
groups to Rab proteins, helices 8,10 and 12 of the a-subunit interact with REP. Fish 
and human RabGGTase sequences were aligned by the ClustalW algorithm for 
comparison (figure 6.6, table 6.2). 
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Helix 8 
NP_004572_hsRGGTase PEPNWTRELELCARFLEVDERNFHCWDYRRFVATQAAVFIAEELAFTDSLITRN'SNYSS 180 
AAI24250 drRGGTase PQPDWTRELGLCDRCLSLDERNFHCWDYRRLVVKESGVS'. 'HQELQFTDRLI2SN: SNYSS 180 
Helix 10 
NP 004572 hsRGGTase WHYPSCLLPQLHPQ------------ PDSGPQ---G" LPÖDVLLKBLBLVQNAFFTDPND 225 
AAI24250 drRGGTase WHY? STLLPQL1PQPVLDSAHNTSPSPSASPQSHSH"VCEBQLLXSYELAHNAFFTDPND 240 
NP 004572hsRGGTase QSAPWFYH: WLLGI-ADPQD1L: CI. HVS"DES'CLTVSFSRPLLVGSRMEILLLMVDDSPLIV 285 
AAI24250_drRGGTase QSAWFYYRWLLGRAEREEMISCVYAS<EGERVSVAFSKPVHAGS--VGLMLVLDGQPQQV 298 
NP 004572 hsRGGTase EWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTAGDVQKECVLLKGRQEGWCRDS 345 
AAI24250 drRGGTase QWRNAHPRLRHSPVCLRDLPAGSISDTSNEHNLTIHWTDKHTHRDCALYTGCAESWCRDS 358 
Helix 12 
NP_004572_hsRGGTase TTDEQLFRCELSVZKSTVLQSSLHSCKSLQZLSPENLWCLLTIILLMRALDPLLYEKETL 405 
AA124250_drRGGTase ATDQELFRSELSyslCSSVLQAzLQSCNQLLDLEPQN'. 'WCLLTIILLMPALDPLGHEi<ETL 418 
Figure 6.6 High sequence similarity between fish and human Rab GGTase Residues that bind 
REP are coloured black, T172G substitution in underlined in black. In helix 8,1171 has hydrophobic 
with REP F279, and adjacent T172 may also contribute to interaction. L214 and A218 of helix 10 also 
form part of the same hydrophobic cleft. F220, and L377 and E378 of helix 12 form hydrophobic 
interactions with REP M286, M291 and K294 respectively. Asterisks denote identical residues. 
Residue change Helix Potential Effect? 
Thr -* Gly 8 Possible effect: T172 may form hydrophobic interaction with REP F279 
Arg 4 Ser 8 Possible effect: adjacent to binding site 
Pro 4 Cys 10 Little effect: Too far from binding site 
Leu 4 Tyr 10 Little effect: Too far from binding site 
Gln 3 Lys 12 Little effect: adjacent to binding site but side chain on far side of helix 
Table 6.2 Non-conserved residues among REP binding regions of RabGGTase 
Viewer Pro software was used to view the human Rab GGTase structure 
retrieved from the RCSB Protein Databank. Residues bordering helices 8,10 and 12 
were defined, and the binding site viewed through rotation. Examination of non- 
conserved residues did not suggest an obvious candidate to preclude binding of fish 
REP to human RabGGTase (table 6.2). The R173S substitution is unlikely to have an 
effect on REP: RabGGTase interactions, as serine is a smaller and less reactive 
residue. A T172G substitution in zebrafish RabGGTase is a potential source of 
incompatibility between fish REP and human RabGGTase. However, Pylypenko et 
al report only a "possible" interaction between RabGGTase T172 and REP F279. 
Also, as F279 is conserved amongst all REPs, including zebrafish REP, it is likely 
human RabGGTase would still bind F279 efficiently. 
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6.2.1.4 Effect of RabGGTase concentration on fish extract activity 
Concentration of RabGGTase was titrated to enhance the prenylation signal 
of zebrafish REP. A linear relationship between Rab GGTase concentration and REP 
activity was observed (figure 6.7). Although 200nM RabGGTase would give the 
highest signal, IOOnM was used in subsequent experiments to conserve stocks of 
recombinant protein while still boosting signal strength. 
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Figure 6.7 Increasing RabGGTase concentration increases fish extract prenylation activity 
6.2.1.5 Revised experimental conditions 
Since the reactant proteins are compatible and incubated at a tolerable 
temperature, total protein extract from zebrafish must contain very low proportions 
of REP relative to Hela cell extracts. It is possible Hela cells have an unusually high 
level of endogenous REP. Regardless, the signals obtained from wild-type fish 
extracts are still very low, leaving little margin for reduction in signal from chm fish 
extracts before reaching background levels. 
To boost the signal obtained, we used only radiolabelled GGpp to report upon 
the assay. However, despite removing all competing unlabelled GGpp, there was 
only a slight increase in reported signal (data not shown). This suggested that there 
was phosphatase activity within the zebrafish protein extracts, which was degrading 
much of the radiolabelled GGpp before it was incorporated into Rab proteins. 
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Therefore a proportion of cold GGpp was used in subsequent experiments to 
preserve radiolabelled GGpp. 
When GGpp concentration is low, the REP: Rab: RabGGTase complex forms 
and catalyses a single reaction. However the complex cannot dissociate without 
binding of a new GGpp to the RabGGTase active site (Thoma et al 2001a), and thus 
RabGGTase can not catalyse further reactions. In order to be confident of 
interpreting the reaction kinetics correctly an excess of GGpp is required. 
Having observed some evidence of phospatase activity in zebrafish total 
protein extracts, and considering the importance of GGpp concentration in our 
system, it was necessary to reassess our experimental design. 
Several adjustments were made to our protocol to improve the experimental 
conditions. To increase the proportion of REP extracted from fish, NP40 detergent 
was added to the lysis buffer. In the presence of NP40, approximately 25µg of 
protein was extracted from each fish, an increase of around 8µg per fish (50%). 
However the increased presence of disrupted membranes in the cytosolic extract 
interferes with the accuracy of protein concentration measurements. 
Phosphatase inhibitors were added to the reaction buffer to prevent 
degradation of GGpp by endogenous phosphatases, which might in turn lower GGpp 
concentration and inhibit RabGGTase. Protease inhibitors were also added to the 
reaction buffer to prevent degradation of the catalytic enzymes (and substrate) by 
endogenous fish proteases. 
Having improved yield of protein extraction and safeguarded the reaction 
constituents from degradation, we re-evaluated the concentration of protein extracts 
used in our experiments. A serial dilution starting from 32µg/µl of zebrafish extract 
showed high counts (over 1500dpm) were still achieved using less than 5µg/µl of 
extract in each reaction (data not shown). Removal of Rabla as a negative control, as 
shown in figure 6.8, proves this to be a reaction-dependant effect. Given the limited 
availability of choroideremia fish, and the low levels of protein extraction expected, 
we sought to optimise our assay using a minimal concentration of extract (see figure 
6.8). 
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Figure 6.8 Optimisation of zebratish extract concentration under new reaction conditions 
It is important for these biochemical assays that reactions occur within a 
linear range of protein concentration, thereby ensuring that variation in reported 
signal reflects variation in reactant protein activity. Within the linear range, increase 
in product formation (signal) reflects increased REP activity and therefore 
concentration. From this experiment, the linear range appears to be under 2µg/µl. 
To equilibrate protein extract concentration between reactions and report on 
GGpp concentration, a new control was introduced to our experiments. RabGGTase 
and GGTasel are both prenyltransferases that catalyse attachment of geranylgeranyl 
lipids to small GTPases, but GGTasel does not require REP as an accessory protein 
for prenylation. Measuring the activity of GGTasel activity in fish extracts would 
control for GGpp availability and extract protein concentration. Thus we performed 
parallel in vitro experiments using fish extracts as a source of GGTasel for 
prenylation of recombinant Racl, a non-Rab small GTPase. Trial experiments 
confirmed successful prenylation of recombinant Racl by fish GGTasel, as shown in 
figure 6.9. 
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Figure 6.9 Racl prenylation reporting zebraiish extract GGTasel activity is a suitable internal 
control 
Additionally, this experiment shows the linear range for GGTasel reaction 
also to be under 2µg/µl. Using a concentration of extract where both 
REP/RabGGTase and GGTasel activity are in the linear range allows internal 
comparability between experiments, validating the use of GGTasel and Rac Ia as an 
internal control for variations in protein extract concentration. 
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6.2.2 REP activity is reduced in Choroiderernia Zebratish 
Choroideremia and WT cytosolic extracts were assayed for prenylation 
activity using the improved protocol (figure 6.10). Background measurements in the 
absence of Rab/Rac were subtracted. 
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Figure 6.10 Prenylation activity of W'1' and ('u Ni zehratish prcnYIt ranst'cr: ºses: 
RI? P: RabCGTase (shaded) and (CTaseI (white) Experiment pcrtürmed hN R. Barem 
Disparity in GGTasel activity between WT and C'1 IM extracts (reported by 
transfer of geranylgeranyl lipid to Rae) is attributed to inaccurate measurement of 
protein concentration in cytosolic extract, clue to presence of detergent. In WI' fish, 
prenyl transfer to Rab is twice that to Rae, because Rabla is douhly prenylated while 
Rae I is singly prenylated. 
Assuming that WT and CHM fish have equal GGTasel activity, RFP activity 
(reported by geranylgeranyl lipid transfer to Rahla) is normalised to GG'I'asel 
activity (figure 6.11). Alternatively, CFIM activity is normalised to WT activity 
(table 6.3). 
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Figure 6.11 Rab prenylation activity of PVT and C{IM zcbr fish REP: Normalised to GCTascl 
activity 
Wild Type 
Raw results 
Rab la0.36 ± 0.022 
Rac1 0.19±0.042 
Chm 
Raw results Normalised to WI' 
0.26+0.024 0.15+0.016 
0.30 ± 0.006 0.19±0.004 
Table 6.3 Prenyltransferase activity in choroideremia iebratish: normalised to wild-type 
GGTasel activity Data given as pmols G(i lipid transtcrred per 30 minutes 
Once normalised, this data shows choroideremia fish have only 41% of Wild- 
type REP activity. This experiment reflects zcbrafish REP activity when G(ipp is in 
excess. 
GGpp availability is known to regulate RabGGTase activity, as the 
Rab: REP: RabGGTase complex cannot dissociate without binding of a new GGpp 
molecule to the RabGGTase active site (Thoma el a! 2001a) 11' GGpp becomes 
limiting the RabGGTase will not dissociate from the catalytic complex, and will be 
unavailable to catalyse further reactions. 't'hus if GGpp concentration is limiting data 
1 88 
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that could be interpreted as a decrease in REP activity could instead be due to a loss 
of RabGGTase activity. 
This experiment is performed with a high concentration of GGpp. Continued 
availability of GGpp will displace REP: Rab from the catalytic complex after 
prenylation and release free RabGGTase. Therefore the rate limiting factor is 
availability of REP. Thus the reduced prenylation of' Rabs by choroideremia 
cytosolic extracts can be interpreted as resulting from reduced REP availability in the 
mutant fish. 
Eventually, REP availability will become limiting in vitro f'or wild-type 
extracts too. After delivery of Rab to membranes in vivo, REP is recycled. I lowever 
with the absence of cellular membranes in the in vitro assay REP remains hound tu 
Rab, and therefore unavailable for further reaction. 
6.3 Rabs in Choroideremia Zebrafish 
To further our understanding of the hiochemistry of churoideremia in 
zebratish, we investigated the prenylation state of the Rab population in c h1n 
mutants. 
Firstly, an effective antibody was needed to probe for zebralish Rabs. 
Zebrafish total protein extracts were blotted to PVI)F membranes and probed with a 
range of mammalian Rab antibodies (see section 2.7.1, antibody dilutions). 
Antibodies for mammalian Rab I, Rab7, RabS, Rab 11 and Rab27a were all found to 
cross react with zebratish Rabs (figure 6.12). Protein loading was tit ated against u- 
Rab8 and a-Rab27 to optimise antibody binding and reduce backt round staining, and 
2µg of protein extract per lane was found to be sufficient for imill unodetectloll of 
zebratish Rabs. 
Rabla Rab5 Rab7 Rab8 Rabil Rab27a 
(a) 
20 10 5 2.5 1.25 
SPSPSPSPSP 
(b) a-Rab8 qgftgp 0' 'P 
Figure 6.12 Intmunohlotting zebrafish proteins with mammalian antibodies (a) I lybridisation of 
mammalian u-Rah antibodies to iehriIish cvtosolic and membrane tractions (h) Serial dilution (pi, 
protein loaded / lane shown) of fish SIOU (S) and PIOO (P) fractions, probed nth (Rabb antibody 
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To illustrate the prenylation state of chin Rab proteins, total protein extracts 
from wild-type and mutant fish were separated by electrophoresis and transferred to 
membranes for immunostaining. Protein extract from mevastatin-treated 293 cells 
was applied as a positive control. Mevastatin blocks the synthesis of GGpp by the 
mevalonate pathway and hence prevents prenylation of Rab proteins. A 4-8% 
gradient urea gel was used to maximise separation and resolve the shift between 
prenylated and unprenylated Rabs. 
Immunostaining of' protein extracts with a-Rabl I and a-Rab27a tailed to 
detect a population of unprenylated Rabs in total protein extracts from 5dpf 
choroideremia zebrafish (figure 6.13). Prenylated Rab II and Rab27a are observed in 
choroideremia fish at 5dpf. Resolution of the prenylated and unprenylated Rabs in 
the blots probed with a-Raba is inconclusive regarding the prenylation state of RahS 
in chin fish. Rabb is a singly prenylated CAAX box protein and so would be 
expected to exhibit a smaller shift upon prenylation. 
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Figure 6.13 Prenylated Rabs persist in chin tish until 5dpf Total protein extracts from 5(lpi WT 
fish (WT), 5dpf mutant tish (chm), mevastatin treated 293 cells (positive control). Upper band 
represents unprenylated Rab proteins (u), IoNNer hand represents prenylated Rab proteins (p). 
Considered together, these blots require significant refinement. Loading 
controls are needed to correctly correlate staining between lanes. Immunostaining 
with our u-Rab27a at 1: 10 000 dilution leaves high levels of background staining 
making interpretation of blots difficult. 
Partitioning of the membrane and cytosolic fractions of zebratish protein 
extract to allow comparison between the membrane bound and cytosolic Rab 
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populations was also attempted. However the results were inconclusive due 
unsatisfactory clarity of blots, and poor membrane partitioning, leaving high levels of 
cytosolic Rabs in the wild-type S100 fraction (data not shown). Strong staining of 
Rabs was also seen in the S100 fractions of wild-type fish in figure 6.12. 
The lack of unprenylated Rabs visible in figure 6.13 is surprising, considering 
the severity ofchoroideremia disease in the zebralish. It is possible that Rabb, RabI I 
and Rab27a are all fully prenylated by the residual maternal REP, shown to still have 
some activity in figure 6.10. Alternatively, unprenylated Rabs may be rapidly 
degraded in vivo and so are not resolved in figure 6.13. As there is a limited shill 
observed in figure 6.13 upon prenylation, a more sensitive in vitro approach was 
undertaken. 
Cytosolic extracts were used as a source of Rab for the in vi/-o prenylation 
assay, catalysed by recombinant RabGGTase and REP-I. Aliquots were separated by 
electorophoresis and exposed to a film for two weeks (ligure 6.14). This approach is 
more sensitive because it examines the prenylation state of the entire population of 
cytosolic Rabs, rather than a selected Im for which good antibodies are available. 
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Figure 6.14 In vitro prenylation of unprenylated Rabs in chit zebratish cytosolic fraclion 
Cytosolic extracts from embryonic W'I' (WT) and mutant (chm) zcbrafish, I II: K293 cells (control) and 
HEK 293 cells treated with mevastatin (control 4- MVL) ýOhere subjected to in %'ih"u prenylation with 
radiolabelled GGpp. Radiolabelled GGpp becomes incorparated into any unprenylated Rabs, which 
resolve at approximately 25kDa. Unbound radiolabelled GGpp migrates in the loading buffer. 
Unprenylated Rabs are present in chin cehratish and III: K293 cells treated with the prenylation 
inhibitor mevastatin. Ik: xperiment pertormed by R. Baron 
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Cytosolic extracts from mevastatin-treated HEK293 cells were used a 
positive control. By blocking the synthesis of GGpp and subsequent Rab prenylation, 
mevastatin treatment causes accumulation of unprenylated Rabs in the cytosol. When 
subjected to in vitro prenylation these Rabs are then prenylated and visible in figure 
6.14. Untreated 293 cells and wild-type zebrafish have properly prenylated Rabs, and 
hence none remain in the cytosol as a substrate for in vitro prenylation. 
Cytosolic extracts from choroideremia zebrafish contain unprenylated Rabs, 
which were then prenylated in vitro. It is highly likely the failure of prenylation of 
this subset of Rabs is involved in the lethal pathology of choroideremia in zebrafish. 
The increased sensitivity of this assay allows detection of all unprenylated Rabs that 
remain in the cytosol, and are therefore non-functional. Data obtained by this method 
are more reliable than those depicted in figure 6.13, as this method does not have the 
limitations outlined above. 
6.4 REP content of the Embryonic Yolk Sac 
Previous results suggest the yolk sac to be the likely source of functional REP 
in choroideremia zebrafish. Functional data describing REP activity in the chm yolk 
sac and embryonic fish could confirm this hypothesis. Isolation of distinct tissues for 
in vitro prenylation analysis was therefore attempted. 
Yolk sacs were dissected from wild-type and mutant fish, and total protein 
extracts prepared from yolk sacs, fish only and whole undissected fish. Very small 
amounts of yolk sac tissue were available; therefore a much lower extract 
concentration was used in yolk sac experiments (see table in figure 6.15). Protein 
concentration was also low in chm fish-only extracts, so whole fish and fish-only 
reactions were prepared with equal protein concentration. For ease of comparison, 
results are given as GGpp transferred per mg protein extract (figure 6.15). 
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Sample [extract] [Rabl] [RabGGTase] [hot GGpp] Time T 
WT whole 1.23µg/µ1 5µM 200nM 1µM 30mins 3TC 
WT fish 1.23µg/µ1 5µM 200nM 1µM 30mins 3TC 
WT yolk 0.21µg/µ1 5µM 200nM 1µM 30mins 3TC 
chm whole 1.23µg/µ1 5µM 200nM 1µM 30mins 37'C 
chm fish 1.23µg/µ1 5µM 200nM 1µM 30mins 37°C 
chm yolk 0.12µg/µ1 5µM 200nM 1µM 30mins 37'C 
Figure 6.15 REP activity is higher in yolk sac relative to other tissues of chorolderemia fish 
REP activity is unexpectedly high in the yolk sacs of wild-type and mutant 
fish. Given that mutant fish have a heterozygous genotype in their yolk sacs (see 
figure 6.2), a reduction in REP activity in chm yolk sacs relative to wild-types might 
be expected if half of REP transcripts are truncated. High REP activity could be 
caused by differences in the composition of the protein population in the yolk sac 
and fish. Protein REP-1 accounts for around 1/20000`h of the protein in cultured 
lymphoblast cell extract, and 1/30000`h of protein extracts from rat brain (Seabra et al 
1993a, Seabra et al 1992b). If fish total protein extracts contain many more types of 
protein such as structural molecules than yolk sacs, a lower proportion of the fish 
total protein population will be REP molecules. Additionally, the yolk sac 
accumulates high levels of Golgi, ER and other protein making machinery to produce 
high levels of protein products (Pelegri 2003), which could contribute to high 
endogenous levels of REP and other essential genes required for cellular growth. 
Activity in choroideremia fish-only extracts is 95% that of wild-type fish- 
only extracts. However, fish-only extracts are likely to be contaminated with yolk sac 
tissues which have higher activity, due to extreme difficulty in separation of yolk 
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sacs from fish without rupturing the yolk sacs. Given the high activity of yolk sac 
samples, a very small volume of yolk sac material could distort the fish-only data, 
masking any decrease in activity of chm fish. While the increased REP activity 
within yolk sacs is intriguing, it has not been possible so far to link this observation 
with the choroideremia pathology and the distribution of prenylated Rabs within the 
fish. 
Dissection of the head and tail portions only of mutant fish, avoiding the 
midsection and yolk sac, may circumvent this issue. Similarly, this method could be 
used to prepare tissues from chm-fish-only for analysis of Rab prenylation. This 
could indicate whether the prenylated Rabs persisting in choroideremia fish are 
confined to the yolk sac, and so likely prenylated by maternally derived REP. 
Unfortunately this would be extremely difficult technically given the small size of 
the fish. Alternatively, whole mount staining of mutants with an antibody 
recognising zebrafish fish REP could illustrate the tissue distribution of REP, from 
which prenylated Rab distribution could be inferred. 
6.5 Summary 
In conclusion, choroideremia zebrafish have maternal wild-type REP 
transcripts in their yolk sacs. This offers an explanation for their survival of a null 
mutation to their only REP gene. To obtain a complete picture of Rab prenylation in 
choroideremia zebrafish we studied the functional activity of both REP and Rabs. 
Choroideremia fish have only 40% of wild-type REP activity, resulting in 
accumulation of unprenylated Rabs within the cytosol. 
Following the same logic applied in Chapter Three, it is probable that fish 
surviving until 5dpf received a generous supply of maternal REP that facilitated their 
extended survival. Fish that succumb to the fatal effects of choroideremia earlier than 
5dpf are likely to have had a lower initial REP content and therefore reduced survival 
time. Comparative assays of mutant fish at different developmental stages would 
give insight into the progression of loss of REP function. It is likely that the levels of 
REP within choroideremia zebrafish decrease with turnover of maternal factors and 
consumption of the yolk sac, and that this could be the under lying trigger for 
disease. 
It remains unclear which tissues are particularly affected by Rab 
hypoprenylation, and if all Rabs or only a subset accumulate unprenylated. It would 
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seem logical that the tissues which first exhibit gross disease are those most sensitive 
to Rab hypoprenylation; and that Rabs with low relative affinity for REP will be the 
first to accumulate in the cytosol when REP availability is limiting. These issues will 
be difficult to resolve without accumulating large numbers of mutant fish and 
performing precise dissections. 
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Discussion 
This thesis presents evidence that the REP protein family underwent a gene 
duplication event in the mammalian lineage, preventing lethality in loss-of-function 
REP mutations. When the mammalian REP-1 is mutated, the choroideremia 
phenotype is restricted to the retina. No disease has yet been linked to REP-2 
mutation. In chm zebrafish, the loss of the single REP gene is lethal by 6dpf, and the 
early survival may be attributed to a maternal supply of REP activity. 
The retinal phenotype in choroideremia zebrafish 
The retinal phenotype was described in detail in Chapter Four of this thesis to 
assess its suitability as a model for human choroideremia degeneration. While the 
human pathology is limited to the photoreceptors, RPE and choroid, degeneration in 
zebrafish includes all retinal laminae. 
Due to the speed of the degeneration, it is difficult to elucidate the sequence 
of cellular loss in the retina. In some individuals, the central retina remained intact 
while degeneration occurred in the peripheral retina and lens perimeter. Conversely, 
in other individuals, the first abnormalities were loss of a band of photoreceptors 
running dorsal to the optic nerve. 
The population of photoreceptors at the periphery are the youngest, with 
increasing maturity towards the central retina. The zebrafish continues to renew 
retinal neurons, including photoreceptors, throughout life from the retinal periphery 
(Marcus et al 1999). It is therefore tempting to speculate that in some choroideremia 
zebrafish the renewal of photoreceptors has ceased, while established older cells are 
maintained in the central retina. If these younger cells cannot produce REP, and 
subsequently prenylate a supply of Rabs, this could parallel the lethal phenotype 
observed in dmrs6 yeast, leading these cells to trigger apoptosis and explaining the 
appearance of pyknotic nuclei in the peripheral retina. Furthermore given the 
migration of differentiated cells towards the central retina, if the renewal of 
photoreceptors at the periphery fails, the limit of the photoreceptor cell layer will 
recede from the periphery. TUNEL staining of retinal sections would confirm the 
extent of apoptotic cell death, and failure of proliferation. 
This logic could be extended to the abnormalities of peripheral lens cells. A 
group of zebrafsh mutants with lens defects which showed normal formation of the 
central lens with apparent defects of the surrounding cortex were postulated to derive 
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from failure in formation or differentiation of newly generated lens cells (Gross et al 
2005). 
REP function in zebrafish retina 
The observed loss of central photoreceptors can also be explained by a lack of 
functional REP. If these cells possess a finite supply of functional REP, obtained 
from a maternal source, this would allow prenylation of a pool of Rabs. Experiments 
in yeast have shown that that reduced levels of REP prenylation activity are 
sufficient to maintain a functional Rab pool in vivo, and REP function is only 
transiently required to support normal growth. Furthermore, prenylated Rabs are 
relatively stable, requiring at least a single generation for turnover, and only 10-20% 
of normal levels of prenylated (membrane-bound) Rabs are sufficient to allow 
cellular growth (Alory & Balch 2000). Therefore, it is conceivable that if older 
photoreceptor cells received a supply of functional REP at differentiation, they could 
then have prenylated a pool of Rabs. These functional Rabs could then maintain 
cellular trafficking processes until they are turned over within the cell. As the 
supplies of REP and prenylated Rabs are exhausted, cell death could be expected. 
Either or both mechanisms may occur in an individual, but it is difficult to tell 
which has occurred due to speed of degeneration. Examination of the outer retina 
failed to identify the primary site of disease, and which tissues suffered secondary 
damage. However, given that there is degeneration in cell types beyond the outer 
retina, and indeed the eye, it would be appropriate to suggest that all degenerations 
are secondary to a loss of REP, rather than the attempting to pinpoint a particular cell 
type as the source of retinal degeneration. 
Non-specific retinal degenerations have also been described in large-scale 
mutagenesis screens (Malicki et al 1996, Fadool et al 1997). These were 
characterised by reduced eye size, pyknotic cell nuclei across multiple retinal cell 
types, abnormal and variable plexiform layers, and are often associated with reduced 
brain size. It was proposed that these non-specific retinal degenerations may be 
caused by mutations to essential house-keeping genes, whereas other more restricted 
retinal phenotypes would attributed to retinal-specific genes (Wagner et al 2004, 
Golling et a! 2002). Indeed according to the criteria used to identify retinal mutants, 
in one screen (Gross et a12005) eighty mutants with eye phenotypes accompanied by 
CNS or multi-systemic defects were uncharacterised, as the study sought mutations 
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affecting the development and function of the visual system only. Under these 
criteria, the chm mutant may well have been excluded from study of retinal 
phenotypes, as it has multiple diseased tissues at 5dpf. 
While this work was in progress, Krock et al published an extensive 
description of the retinal phenotype in the chm zebrafish and provided evidence of a 
lack of visual function (Krock et at 2007). Immunostaining of the retinal sections 
from chm zebrafish showed normal distribution of rhodopsin, blue opsin and green 
opsin; but irregular morphology of double cones and disrupted synapse formation in 
the in the OPL and IPL, suggesting cone degeneration may affect bipolar and other 
inner retinal cells. However, they do not state which developmental stage these 
sections were collected at. This is pertinent, as all other experiments in this paper 
were performed at the 4.5dpf developmental stage. 
These authors also observed normal retinal lamination at 4.5dpf, but 
abnormalities in the outer retina. The RPE was hypertrophic, and contained fewer, 
smaller immature melanosomes, and large vacuoles of undigested outer segment 
discs, suggesting loss of REP disrupts melanosome maturation and phagocytosis in 
the RPE. The photoreceptors were compressed against the hypertrophic RPE, their 
outer segments dishevelled and degenerating and discernable tiering of rods and 
cones apical and basal of the OLM was lost. These observations are consistent with 
the zebrafish being an appropriate model for human choroideremia. The cloudy 
appearance of the lens was attributed to loss of pigment in the RPE, rather than 
abnormalities of the lens itself. 
Krock et al also performed mosaic experiments in 4.5dpf chm zebrafish and 
conclude cell nonautonomous photoreceptor degeneration, contrary to the results 
obtained in the mouse model (Tolmachova et a! 2006).. They report cell death when 
wild-type cells are transplanted into mutant retinas. When mutant cells were 
transplanted to WT they have normal morphology at 4.5dpf which they have termed 
"rescue". We would suggest this is a misnomer, as the retinal degeneration of 
choroideremia is not yet underway at 4.5dpf. Examination of retina from 4dpf shows 
morphologically normal retina, in figures 4.15,4.16, and 4.17. Also, they 
transplanted RPE cells from mutants into albino zebrafish and performed mosaic 
analysis at 4.5dpf. RPE cells from mutant donors disrupted the morphology of host 
photoreceptors, leading them to conclude RPE is the primary site of disease, and 
photoreceptor death is secondary to RPE defects. Crucially, these experiments were 
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performed at the 4.5 dpf stage, which according to the data shown in section 4.4 of 
this thesis is prior to the development of full blown retinal degeneration. As the 
experiments are not pursued until final stages of choroideremia, where all retinal 
layers degenerate, these authors do not address the issues surrounding comparability 
of the retinal phenotypes in humans and zebrafish. Furthermore, the mosaic 
experiments are assessed at a stage before the retinal phenotype is fully penetrant. 
Therefore the mutant clones would not be expected to have degenerated in mutant 
retinas, let alone when transferred to a wild-type environment. Although the recent 
publication by Krock et al addresses interesting questions regarding the development 
of choroideremia in zebrafish, we feel that the contradictory results we have achieved 
are also of merit in understanding the choroideremia zebrafish, which we will 
address fully in future publications. 
Choroideremia zebrafish suffer multi-systemic disease 
We observed mutli-systemic disease in the chm zebrafish, of much greater 
severity than human. The choroideremia phenotype is lethal from 4dpf onwards in 
the zebrafish. In addition to inner retinal and lens degeneration, chm zebrafish have 
uninflated swim bladders, oedema of the heart, abdomen, and occasionally head, 
irregular iridophore distribution, and stunted growth, which is often associated with 
spinal curvature. They also have unusually dark pigmentation, but it is unknown 
whether this is a result of visual blindness, or lack of REP. As loss of visual function 
has now been established (Krock et al 2007), it is prudent to assume the former. All 
these phenotypes must be attributed to a shortage of functional REP and subsequent 
hypoprenylation of a subset of Rabs, although the molecular pathways leading to the 
disease remain unknown. 
As we were unable to produce af iEGFP/chm double mutant, we were unable 
to examine the effects of the chm mutation on vasculogenesis, specifically within the 
choroidal vasculature. However, as concurrent results revealed the fish to have only a 
single REP gene, we decided focus investigations on characterising REP 
functionality within the chm zebrafish to assess its suitability as a model for human 
choroideremia, before developing a vascular reporter model for the choroidal 
degeneration. 
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Essential function of REP in zebrafish 
The extreme pathology of zebrafish choroideremia can be explained if this 
disorder is considered to be a null mutation in an essential gene, rather than strictly a 
retinal degeneration. Embryonic essential genes are classified as those that, when 
disrupted, result in a phenotype visible by 5dpf (Amsterdam et a! 2004). These are 
almost invariable lethal. Additionally, failure to inflate the swim bladder by 5dpf is 
associated with death within two weeks in embryonic fish. By this definition, chm is 
an embryonic lethal gene as REP is essential for embryonic development; its loss in 
chm zebrafish results in lethality, with some mutants dying before 5dpf and those 
that have not died failing to inflate their swim bladder. 
It has been proposed there are only -1400 genes that when mutated result in 
visible defect at 5dpf. Many of these genes are required for cell viability, others for 
more specific developmental pathways such as patterning and differentiation. Of 
333 insertional mutants found to be essential for early zebrafish development in a 
large mutagenesis screen, 18 (5%) disrupted genes are involved in protein post- 
translational modification (Amsterdam et al 2004, Amsterdam 2006). These included 
vacuolar sorting protein 18 (vsp18), a zebrafish model for vesicle trafficking disease 
(Maldonado et al 2006). The vsp18 mutant has hypopigmentation and reduction in 
RPE melanosomes and visual capacity due to defects in lysosome-related organelle 
biogenesis and maintenance. Vspl8 is acts in vesicular traffic tethering, participating 
in the formation of endosomes and lysosomes. It is unsurprising that defects in 
vesicular trafficking pathway genes REP and vsp18 should also both result in visual 
phenotypes. Pigmentation defects are often associated with retinal degeneration. 
The zebrafish fading vision mutant is caused by mutation in the silver gene, 
which plays a role in melanosome biogenesis (Schonthaler et al 2005). The fade out 
mutant is a model for Hermansky-Pudlak syndrome (Bahadori et al 2006), which in 
the mouse model gunmetal (Detter et al 2000) is caused by mutation to the 
RabGGTase gene. These zebrafish hypopigmentation models both display visual and 
retinal phenotypes, most likely linked to the pigment requirements of the RPE. 
Although as discussed above, the abnormal pigmentation in choroideremia is likely 
to be secondary to REP loss. 
Another insertional mutagenesis screen uncovered forty mutants with retinal- 
specific degenerations (Gross eta! 2005). This screen also created a range of mutants 
with retinal phenotypes coupled with multi-systemic disease, but unfortunately these 
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data were not included in detail in the publication, so we are unable to compare these 
phenotypes with that of the choroideremia zebrafish. 
Multiple REP homologues in the mammalian lineage 
Chapter Four presents bioinformatic analysis of REP evolution within 
vertebrates. Our data suggests the zebrafish, like the other fishes, possesses only a 
single REP gene. Indeed, a single REP gene was found in all organisms except the 
mammalia, and the frog X laevis. The two REP isoforms maintained in X laevis are 
thought to have arisen via alloploidy during speciation. In contrast, gene duplication 
events in the mammalian lineage created REP-2 in placental mammals, and three 
REP homologues in marsupials. The multiple mammalian REPs are thought to have 
originated by gene duplication because they contain no introns, and suggestive of 
ancient reverse transcription of spliced mRNA back into the genome. The rat, mouse 
and human REP-1 and REP-2 separate with complete bootstrap support, suggesting 
this gene duplication occurred before the radiation of extant placental mammals. 
The study by Amsterdam et al highlighted that orthologous genes which are 
essential in yeast and worm are likely to be essential in zebrafish, and by extension, 
mammals too (Amsterdam et a! 2004). The REP gene is almost the converse of this, 
as following gene duplication, a gene which is essential in yeast (and zebrafish) is 
not essential in mammals, although total loss of REP in mammals would likely be 
lethal. Amsterdam et al suggest the genes they detected in early viability screens are 
absolutely required for biological processes, whereas other genes not conserved in 
yeast and worm serve to make these essential purposes more robust. The 
maintenance and expression of multiple REPs in the mammalian lineage could 
therefore be justified as aiding the essential prenylation requirement of cells. 
However, functional excess of REP activity has been suggested in yeast cells, which 
harbour only a single REP (Alory & Balch 2000), so it is unclear why further REP 
activity would be required, and indeed maintained, on several occasions throughout 
mammalian and marsupial evolution. 
Evolution of the REP/GDI superfamily 
Two contrasting models have been proposed for evolution of the REP/GDI 
superfamily. Alory and Balch suggest an ancestral REP to be the precursor of the 
REP/GDI superfamily, with subsequent acquisition of GDI activity leading to 
212 
Discussion 
separate REP and GDI proteins (Alory & Balch 2003). Furthermore, they argue 
REP-2 is the original REP, which has been maintained in all eukatyotes, and REP-1 
is a sub-functionalisation of REP-2. A contrasting model is favoured by Hala et al, 
who assume a mono-prenylated common ancestor of Rho(Ras)/Rab GTPases which 
was prenylated by GGTase without assistance (Hala et a! 2005). They propose a bi- 
functional REP/GDI was acquired to aid specialisation and radiation of Ras 
superfamily GTPases; and later separate REP and GDI emerged, allowing assisted 
double prenylation of Rabs by RabGGTase. We would favour this model, as our 
phylogenies show no later evolution of GDI from REP. Furthermore, REP-2 is a 
recent mammalian phenomenon. 
A whole genome duplication occurred in the evolution of the teleost lineage 
around 350MYA (Jaillon et al 2004, Aparicio et al 2002, Christoffels et al 2004, 
Volff 2005). This has led to multiple paralogs of some teleost gene clusters such as 
hox genes (Amores et al 1998). Following genome duplciation some of these 
paralogues have since been lost through relaxation-mutation (Postlethwaite 2006; 
Woltering & Durston 2006). 
At the time of our analysis, the zebrafish genome sequencing project had 
released assembly version 6 (Zv6), although the final analyses had not yet been 
published. As the zebrafish genome has not been fully sequenced, we cannot wholly 
discount the possibility of further multiple REPs being expressed. However, only a 
single REP is present in pufferfishes, so we would suggest that a second REP gene 
has not been maintained in the zebrafish. We do not know if the single REP is 
maintained in all fish, or if a second REP gene was lost following the divergence of 
zebrafish and pufferfish, during which the pufferfishes underwent genome 
compaction. Following the completion of this study, the draft genome of the medaka 
fish was published (Kasahara et al 2007), which includes analysis of evolution of 
ancestral karyotype in zebrafish. The zebrafish genome appears to have undergone 
many interchromosomal rearrangements. 
To strengthen our conclusion, we therefore performed functional assays to 
measure REP activity in the choroideremia zebrafish. The functional assays 
described in Chapter Five show only 40% of wild type REP activity in the 
choroideremia zebrafish, leading to an accumulation of unprenylated Rabs in the 
cytosol. If indeed a second REP is expressed in the zebrafish, we would expect this 
to be able to compensate for lack of chm REP, in manner similar to human 
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choroideremia. However, the severe lethal degeneration experienced by the 
choroideremia zebrafish suggests that the chm REP gene is indeed essential, and 
therefore the only functional REP present in zebrafish. 
If an ancestral second REP gene has been maintained in fishes, it is 
interesting to speculate that it could have diverged away from function as a REP. 
This paralogue could have acquired a new function (neo-functionalisation); notably, 
fishes have three GDI isoforms. It is conceivable that the odd number of GDIs has 
resulted from neo-functionalisation of an ancient duplicate REP, or indeed, GDI. 
Comparison with the newly sequenced medaka genome, a powerful genetic tool for 
the study of paralogous genes in teleosts (Furutani-Seiki & Wittbrocht 2004), could 
yield further insight into this intriguing issue. 
It is interesting to note, given the X-linked transmission of choroideremia in 
humans, and also the localisation of rat, mouse and opossum REP-1 to the X 
chromosome, that there are no sex chromosomes in fishes. Teleosts employ a range 
of methods in sex determination (Volff 2005). Zebrafish sex determination is 
controlled by environmental factors, such as temperature and the concentration of 
sex hormones in the water. It is therefore important when raising young zebrafish for 
breeding to maintain appropriate stock densities to encourage development of male 
and female fish. 
A role for maternal REP in chroroideremia zebrafish survival 
The survival of choroideremia zebrafish until Sdpf is likely to be facilitated 
by a maternal source of functional REP. 5dpf mutants contain wild-type chm 
transcripts, which are present in the yolk sac but not the embryonic fish. (Presence of 
wild-type transcipts in mutant fish may also explain the limited success of the 
positive control in the Clal assay devised to genotype fish in Chapter Three. ) We 
have shown by a functional in vitro prenylation assay that some functional REP 
activity remains in the 5dpf chm zebrafish; however, this is not sufficient to maintain 
Rab prenylation and a subset of Rabs accumulates unprenylated in the cytosol. 
We propose that the yolk sac of the homozygous mutant contains maternal 
products necessary for embryonic growth, which include full length functional REP 
protein. This dosage of full length may vary between individual mutants, but the 
supply is always finite. This REP can prenylate a pool of Rabs, which are relatively 
stable in vivo. As the functional REP is turned over, the embryonic fish is unable to 
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replenish supplies, and subsequently no further Rabs are prenylated. Once the initial 
supply of prenylated Rabs are turned over, the zebrafish begins to exhibit disease. 
It remains unclear which tissues are particularly affected by Rab 
hypoprenylation, and if all Rabs or only a subset accumulate unprenylated. It would 
seem logical that the tissues which first exhibit gross disease are those most sensitive 
to Rab hypoprenylation; and that Rabs with low relative affinity for REP will be the 
first to accumulate in the cytosol when REP availability is limiting. There is little 
reference in the literature to the Rab population in zebrafish. In humans, over sixty 
Rab proteins have been indentified to date. Interestingly, Rab32 is known to be 
overexpressed in the RPE, relative to the neural retina, at 52hpf (Leung et al 2007). 
If dosage of REP varies between individuals, this could perhaps explain 
variation in disease severity. Some mutants die at 4dpf, whereas others survive for 
several days longer. It is probable that fish surviving until 5dpf received a generous 
supply of maternal REP that facilitated their extended survival. Fish that succumb to 
the fatal effects of choroideremia earlier than 5dpf are likely to have had a lower 
initial REP content and therefore reduced survival time. As yet, we do not know the 
distribution of full length maternal REP within the embryo, nor the rate at which it is 
turned over. 
The issue of maternal load in embryonic mutants has been addressed by 
Gross et al. Retrovirus-mediated insertional mutatgenesis was used to identify forty 
genes responsible for development and function of the visual system (Gross et al 
2005). Their observations suggest a significant maternal complement of mRNA or 
protein, and/or maternally derived proteins must be highly stable to persist for 
several days, as has been previously suggested (Kane et al 1996, Driever et al 1996, 
Golling et al 2002). Several mutations affecting the central and peripheral retina 
were caused by genes encoding proteins functioning in transcription, translation and 
cell cycle regulation. These genes surely are utilised in early retinal development 
also, and yet the phenotypes are not visible for several days. Early retinal 
development is normal thanks to a maternal factor, but upon depletion, the 
proliferative peripheral retina exhibits pathology. Indeed, maternal products have 
been shown to function beyond the midblastula transition, when most maternal 
mRNAs are degraded (Wagner et al 2004; Pelegri 2003). The largest class of 
mutants identified by Wagner et al were pleiotrophic degenerations, associated with 
widespread cell death, and they predicted these had been caused by disruption to 
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essential housekeeping genes. The time lag between turnover of maternal REP and 
zebrafish death in choroideremia could be attributed to an enduring population of 
prenylated Rabs. 
Parallels can be drawn with the requirement of REP in the developing 
zebrafish embryo, and the observed loss of photoreceptors in both the peripheral and 
central retina in the early stages of choroideremia retinal degeneration. Within the 
framework of Gross's observations, mutants with peripheral retinal phenotype 
exhibit a mild pathology, having received a high dose of the relevant maternal gene 
product, whereas the choroideremia zebrafish's pleiotrophic lethal degeneration 
originates from insufficient maternal load to allow normal development beyond 5dpf. 
Conclusions 
This thesis provides evidence of a single REP protein being present in the 
zebrafish, whereas two REP homologues are expressed in humans. This prevents 
lethality in choroideremia patients, who suffer disease restricted to the outer retina. 
In contrast, REP is an essential gene in zebrafish. Consequently, when REP is 
disrupted in choroideremia mutants, zebrafish experience severe multi-systemic 
disease, including the degeneration of multiple cell types in the retina. 
While many studies have sought to identify the primary site of choroideremia 
disease in the human retina, the catastrophic nature of the retinal degeneration in 
zebrafish precludes similar characterisation of this pathology. Instead, the observed 
phenotype may be considered to be the consequence of lack of a protein essential for 
cellular function in cells throughout the retina. Survival of choroideremia zebrafish 
for five days despite mutation to an essential gene can be attributed to the persistence 
of a maternal supply of functional REP protein, allowing early prenylation of a pool 
of Rabs. 
The absence of a second compensatory REP limits the application of 
zebrafish as a model for choroideremia. REP-2 plays an essential role in disease 
pathogenesis in humans; hence the study of choroidal and retinal pathology in 
zebrafish is not wholly informative for characterisation of disease development in 
humans. However, the introduction of human REP-2 gene to the chm zebrafish 
would create a very interesting model for the study of human eye disease. A system 
with a single REP may be of use in characterising therapies which aim to boost REP- 
1 activity, such as novel drug classes which allow read-through of nonsense 
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mutations (Welch et al 2007). Such approaches will afford the zebrafish a continued 
role in efforts to further understand and seek treatments for choroideremia. 
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Appendices 
Appendix 1: Zebrafish used in studies 
Note: all figures throughout Appendix I depict choroideremia zebrafish (lower) with 
unaffected siblings (upper) 
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4.5dpf Choroideremia zebrafish 
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Sdpf Choroideremia zebrafish 
Note: Illumination adjusted to highlight lens phenotype 
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5dpf Choroideremia zebrafish (continued) 
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6dpf Choroideremia zebrafish 
Note: Illumination adjusted to highlight lens phenotype. Also notice oedema of the 
head. 
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Appendix 2: Further Characterisation of Choroideremia Retinal Phenotype 
a 
C 
e 
Appendix 2.1 Retinal degeneration in 5dpf choroideremia fish: sagittal orientation Wild Type (a) 
and choroideremia (c, e) retinal sections in sagittal orientation; enlarged in adjacent panels (b) and (d, 
f). Scale bar a, c, e= 25 µm; scale bar b, d, f= 50µm 
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Appendix 2.2 RPE hypertropy and invasion of the neural retina of choroideremia zebrafish 
Pigmented cells invade neural retina in 5dpf (a, b) and 6dpf choroideremia zebrafish (c). (b) shows 
higher resolution of (a), with arrowheads indicating RPE melanosomes invading the neural retina. 
Scale bars a, b= 25µm; scale bar c= 50µm 
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Appendix 2.3 Pyknotic nuclei in neural retina Transverse sections of 5dpf (a) and 6dpf (b) 
choroideremia zebrafish retina. Arrowheads indicate some pyknotic nuclei. Scale bars = 50µm 
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Appendix 2.4 Disruption of plexiform layers Transverse sections of 6dpf (a) and 5dpf (b) 
choroideremia zebrafish retina. Regular smooth curvature of IPL and OPL is lost. Pyknotic nuclei 
invade Plexiform layers and optic nerve, as indicated by arrowheads. Scale bars =50µm 
248 
Appendices 
WT 
a 
chm 
4- a 
ch 
C 
a 
14- OL 
10 
I0 
9 
Q 
Appendix 2.5 Retinal degeneration occurs rapidly between 4.5dpf and 5dpf: sagittal orientiation 
of whole eye showing loss of lamination in 5dpf choroideremia zebrafish Scale bars = 50µm 
249 
Appendices 
a 
M 
w CL 
M 
V 
f 4- 0- 
M 
U) 
. qi 
4. - 
0- M LE) 
$ 
p 
WT chm 
Appendix 2.6 Retinal degeneration occurs rapidly between 4.5dpf and 5dpf: sagittal orientiation 
of central retina showing alteration of cellular morphology in 4.5dpf and 5dpf choroideremia 
zebrafish Scale bars = 50µm 
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